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ABSTRACT 
Arabidopsis thaliana is an established model plant system for studying plant-
pathogen interactions. The knowledge garnered from examining the mechanism of 
induced disease resistance in this model system can be applied to eliminate the cost and 
danger associated with current means of crop protection. 
A specific defense pathway, known as systemic acquired resistance (SAR), 
involves whole plant protection from a wide variety of bacterial, viral and fungal 
pathogens and remains induced weeks to months after being triggered. The ability of 
Arabidopsis to mount SAR depends on the accumulation of salicylic acid (SA), the NPRI 
(non-expressor of pathogenesis related gene 1) protein and the expression of a subset of 
pathogenesis related (PR) genes. NPRI exerts its effect in this pathway through 
interaction with a closely related class of bZIP transcription factors known as TGA 
factors, which are named for their recognition of the cognate DNA motif TGACG. 
We have discovered that one of these transcription factors, TGA2, behaves as a 
repressor in unchallenged Arabidopsis and acts to repress NPRI-dependent activation of 
PRJ. TGA1, which bears moderate sequence similarity to TGA2, acts as a transcriptional 
activator in unchallenged Arabidopsis, however the significance of this activity is 
J 
unclear. Once SAR has been induced, TGAI and TGA2 interact with NPRI to form 
complexes that are capable of activating transcription. Curiously, although TGAI is 
capable of transactivating, the ability of the TGAI-NPRI complex to activate 
transcription results from a novel transactivation domain in NPRI. This transactivation 
domain, which depends on the oxidation of cysteines 521 and 529, is also responsible for 
the transactivation ability of the TGA2-NPRI complex. 
11 
Although the exact mechanism preventing TGA2-NPRI interaction in 
unchallenged Arabidopsis is unclear, the regulation of TGAI-NPRI interaction is based 
on the redox status of cysteines 260 and 266 in TGAl. We determined that a 
glutaredoxin, which is an enzyme capable of regulating a protein's redox status, interacts 
with the reduced form of TGAI and this interaction results .in the glutathionylation of 
TGAI and a loss of interaction with NPRl. 
Taken together, these results expand our understanding of how TGA transcription 
factors and NPRI behave to regulate events and gene expression during SAR. 
Furthermore, the regulation of the behavior of both TGAI and NPRI by their redox 
status and the involvement of a glutaredoxin in modulating TGAI-NPRI interaction 
suggests the redox regulation of proteins is a general mechanism implemented in SAR. 
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CHAPTER 1 - INTRODUCTION 
Plants are sessile beings that have evolved intricate constitutive and inducible 
defense mechanisms to protect themselves from invading pathogens. Constitutive 
defenses, which include physical barriers such as cuticle and waxes as well as pre-formed 
proteins and secondary metabolites, provide the plant's first level of defense (Osbourn, 
" 1996). However if this initial level of defense is breached, inducible defense pathways 
can be rapidly triggered. 
When an induced defense pathway is initiated, a series of events take place at the 
site of pathogen attack including localized cell death, known as the hypersensitive 
response (RR), and the accumulation of metabolites such as salicylic acid, jasmonic acid 
and ethylene (Greenberg, 1997, Dong, 1998). However, the key to restricting further 
pathogen growth and maintaining a resistant state during induced defense is the specific 
induction and coordination of numerous genes and proteins. A collection of genes that are 
either up- or down-regulated as a result of induced disease resistance have been identified 
through a multitude of microarray studies (Schenk et al., 2000; Reymond et aI., 2000; 
Maleck et aI., 2000). Regulation of disease resistance proceeds via de novo synthesized 
proteins or pre-existing proteins whose activity is altered as,sl a result of the addition or 
removal of post translational modifications (PTMs) (Kovtun et al., 2000; Despres et aI., 
2003; Kang and Klessig, 2005). By studying the proteins responsible for regulating gene 
expression and the post-translational control that regulates them, it will be possible to 
elucidate key steps in the signaling cascade that leads to disease resistance. Ultimately, 
this elucidation will result in the identification of key genes and pathways that can be 
engineered to enhance disease resistance in crop plants. 
1 
Systemic acquired resistance (SAR) is the most widely studied inducible defense 
pathway in plants. It is defined as being a broad-range, long-lasting defense pathway 
induced by avirulent pathogen attack and is typified by the accumulation of salicylic acid 
(SA) and the induction of a suite of pathogenesis related (PR) genes (Glazebrook, 2001). 
One of the most salient features of this defense pathway, aside from its systemic nature, 
is that once induced, the plant is primed such that subsequent pathogen attack, whether 
virulent or avirulent, is unsuccessful (Ward et aI., 1991). While key genes involved in 
regulating SAR have been identified over the past fifteen years, details concerning their 
regulation and mode of action remain elusive. 
1.1 Outline 
The goal of the research presented in this thesis is to better understand the role of 
TGA transcription factors during SAR, specifically focusing on their interaction with 
NPRI and the behavior of this complex. 
Chapter 2 is comprehensive literature review that provides background on the 
SAR pathway including details concerning key proteins and metabolites as well as 
signaling pathways and timing of events. 
Chapter 3 is a published manuscript that establis~s the role of the TGA2 
transcription factor as a repressor and explores the nature of the TGA2-NPRI complex as 
a regulator of PRJ gene expression. Protein domains critical for NPRI's co-activator 
function are identified including a novel transactivation domain, found in the C-terminus, 
regulated by the oxidation of two cysteine residues. 
Chapter 4 is a manuscript in preparation that explores the role of the TGAI 
transcription factor with respect to its interaction with NPRI. TGAI is redox regulated so 
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that in the oxidized state it will transactivate but not interact with NPRl, while in the 
reduced state, it interacts with NPRI but does not transactivate. TGAI also interacts with 
a novel glutaredoxin leading to the glutathionylation of TGAI and a loss of interaction 
with NPRl. This is one of the first instances where an atypical redox switch in plants is 
described and where a specific activity and target has been defined for a novel 
glutaredoxin. 
Chapter 5 examines the similarities and differences between TGAI and TGA2 as 
closely related transcription factors involved in SAR. Also examined in this chapter is the 
redox regulation of TGAI and NPRI and how they represent a general mechanism for 
gene activation in the SAR pathway. 
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CHAPTER 2 - LITERATURE REVIEW - SYSTEMIC 
ACQUIRED RESISTANCE 
2.1 Induced Disease Resistance 
As plants do not have the ability to physically evade pathogens, they have evolved 
an extensive network of defense mechanisms, both constitutive and induced, to aid in 
their survival. 
Induced disease resistance is a specific response and is not always initiated upon 
pathogen challenge. However all plants are able to evoke constitutive defense 
mechanisms which are present to slow down or prevent the spread of a pathogen. These 
include; (i) an oxidative burst, which creates reactive oxygen species (ROS) that have a 
broad range of effects (reviewed by Lamb and Dixon, 1997), (ii) deposition of callose 
(reviewed by Kauss, 1987) and physical thickening of the cell wall by lignification 
(reviewed by Vance et aI., 1980), which provides a physical barrier to the pathogen, and 
(iii) various pre-existing antibiotic small molecules, such as phytoalexins (reviewed by 
Dixon, 1986) and proteins, such as cell wall hydrolases (reviewed by Bowles, 1990) that 
are often toxic or destructive to the invading pathogen. Wh~J.e these initial constitutive 
and mostly non-pathogen-specific defenses offer some level of protection, many 
pathogens are able to overcome these defenses to successfully invade the plant. However 
in certain instances, when genetic factors in both the host and the pathogen are present, 
an additional, pathogen-specific disease resistance pathway is induced. 
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2.1.1 Plant-Pathogen Recognition 
The specific recognition of a pathogen by a plant requires the presence of unique 
factors in both organisms and results in the induction of a distinct signal transduction 
pathway. This leads to the expression of a subset of genes providing a resistance tailored 
to the invading pathogen. These factors were originally identified by Flor in the 1940s 
through his studies of the host/pathogen interaction between flax (Linum ultissimum) and 
flax rust fungi (Melampsora lini). He discovered that disease resistance would only occur 
during an incompatible interaction when the plant possessed a dominant resistance gene 
(R) and the pathogen expressed the complementary dominant avirulence gene (A vr), a 
phenomenon he termed gene-for-gene resistance (Flor, 1971; Hammond-Kosk and Jones, 
2000). However in a compatible interaction, either the R gene, A vr gene or both are 
recessive resulting in a diseased state (Flor, 1971; Hammond-Kosk and Jones, 2000). 
Interestingly, in the instance of a compatible interaction, the Avr gene from the pathogen 
is required for pathogen virulence making it a Vir (virulence) gene (Leach and White, 
1996; White et aI., 2000). 
2.1.2 Systemic Acquired Resistance 
Systemic acquired resistance (SAR) is defined as a broad-spectrum disease 
resistance pathway induced in plants after attack by avirulent pathogens. The response 
results in the induction of a distinct signal transduction pathway at the site of infection 
and in distal cells. SAR is distinguished from other induced defense pathways by the 
spectrum of pathogen protection that is observed and the subset of defense genes whose 
expression is induced (Ward et al., 1991). Chester (1933a and b) was the first to identify 
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the phenomenon of acquired resistance in plants. But it was not until the 1960s when this 
induced immunity was clearly defined and termed SAR. Ross (1961 and 1966) observed 
that tobacco, which would react hypersensitively to tobacco mosaic virus (TMV), would 
also induce resistance in uninfected parts of the plant. This systemic induction of defense 
genes resulted in decreased symptom severity from secondary infection from several 
different pathogens. 
The induction of SAR relies on the accumulation of the metabolite salicylic acid 
(SA) and the expression of a suite of pathogenesis-related (PR) genes through the action 
of the protein NPRI (non-expressor of pathogenesis related gene 1) and TGA 
transcription factors. 
2.1.3 Alternative Defense Pathways and Induced Systemic Resistance 
An alternative systemic inducible defense pathway was identified in Arabidopsis 
and characterized by its SA-independent induction of a different subset of PR genes, 
namely the antimicrobial peptide defensin (PDF1.2) and thionin (Thi2.1). In this induced 
disease resistance pathway, PDFI.2 and Thi2.1 expression is induced by non-host fungal 
pathogens via a signaling pathway that involves jasmonate (JA) and ethylene (Penninckx 
et aI., 1996; Eppel et aI., 1997; Penninckx et aI., 1998). l 
Another inducible defense pathway, known as induced systemic resistance (ISR), 
has also been found that leads to increased resistance in secondary tissue after pathogen 
attack. This pathway, which is also SA-independent, is induced by plant growth-
promoting rhizobacteria and relies on a pathway regulated by JA and ethylene. 
Interestingly, this pathway does not result in the induction of PDFI.2 (Pieterse et aI., 
1996; van Loon et aI., 1998; Pieterse et aI., 1998). 
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The interplay between SA and JA/ethylene in defense response pathways is not 
well understood (Maleck and Dietrich, 1999). Lawton et aL (1994) and Xu et aL (1996) 
found evidence to demonstrate that these signaling molecules work synergistically to 
induce defense responses. However evidence, including the inhibition of JA biosynthesis 
by SA, suggests that these molecules may also work antagonistically (Doares et al., 1995; 
Harms et aI., 1998). The existence of positive and negative interconnections between SA 
and JA/ethylene provides an excellent control mechanism for the plant such that the 
accumulation of specific signaling molecules would not only induce the correct defense 
pathway(s), but would also be able to down-regulate or turn off pathways. While the 
detailed relationships between the induction of disease resistance pathways and their 
signaling molecules is outside the scope of this thesis, reviews by Dong (1998) and 
Glazebrook (2001), and more recently Loake and Grant (2007) and Flors et aL (2008), 
provide excellent insight into the subject. 
2.2 The Role of Salicylic Acid in SAR 
The accumulation of the metabolite salicylic acid (SA) is required for the 
establishment and deployment of SAR. The role of SA in SAR was first described by 
White and colleagues who discovered that tobacco leaves i treated with SA or acetyl 
salicylic acid (aspirin) displayed heightened resistance to TMV and increased PR gene 
expression (White, 1979; Antoniw and White 1980). 
Evidence for an endogenous role of SA in SAR came ten years later from 
analyses of SA levels in pathogen infected tobacco and cucumber plants. Malamy et aL 
(1990) observed that SA levels increased 20- to 50-fold following TMV infection of 
tobacco and these increases coincided with or preceded PR gene expression. 
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Additionally, a lO-fold increase in SA levels was observed in uninoculated leaves that 
coincided with the accumulation of PR transcripts. In the phloem sap of cucumber 
infected with Colletotrichum lagenarium, Pseudomonas syringae or tobacco necrosis 
virus (TNV), a 10- to 100-fold increase in SA was observed prior to the development of 
SAR (Metraux et ai. 1990; Rasmussen et aI., 1991; Smith et al., 1991). 
Evidence for the requirement of SA in SAR came from plants expressing a 
bacterial salicylate hydroxylase gene (nahG) that converted SA into inactive catechol, 
which prevented the activation of SAR. Transgenic tobacco and Arabidopsis expressing 
nahG fail to accumulate high levels of SA after pathogen infection and also fail to 
develop SAR or to express PR genes in uninoculated leaves (Delaney et aI., 1994; 
Vernooij et aI., 1994; Gaffney et al., 1994). 
The SAR pathway has been identified and studied in many dicotyledonous plant 
species where it is activated in response to a wide variety of plant pathogens (Mal amy 
and Klessig, 1992; Ryals et al., 1996; Shah and Klessig, 1999). However the role of SA 
in the SAR defense pathway of monocots such as rice and maize is not as well 
established (Matsuta et aI., 1991; Morris et aI., 1998; Vallelian-Bindschedlir et al., 1998). 
2.2.1 SA Analogs 
To date, SA is the only plant-derived substance that has been demonstrated to be 
an inducer of SAR (White, 1979; Antoniw and White, 1980; Ward et aI., 1991). 
Activation of SAR by SA (Figure 1), provides a very attractive means for an alternative 
form of disease control. In order for a compound to be considered as an activator of SAR, 
it needs to exhibit the following three qualities: (i) the compound or its significant 
metabolites should not exhibit direct antimicrobial activity, (ii) it should induce resistance 
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to the same spectrum of pathogens as in biologically activated SAR, and (iii) it should 
induce the expression of the same marker genes observed in pathogen-activated SAR 
(Kessmann et al., 1995). The chemical 2,6-dichloroisonicotinic acid and its methyl ester 
(both referred to as INA; Figure 1) were the first synthetic compounds shown to activate 
SAR (Metraux et aI, 1991; Vemooij et aI., 1995). However both SA and INA do not 
warrant practical use as plant protection compounds due to low crop tolerance resulting 
from phytotoxicity (Friedrich et aI., 1996). Recently, the synthetic SA analog benzo-
1,2,3- thiadiazole-7-carbothioic acid S-methyl ester (BTH; Figure 1) was demonstrated to 
be a potent activator of SAR (Friedrich et al., 1996; Gorlach et aI., 1996; Lawton et aI., 
1996) and is marketed for use on a limited number of crops by Syngenta. 
2.2.2 Biosynthesis of SA 
Considering the significance of SA in the SAR pathway, a great deal of research 
has focused on the biosynthetic pathway leading to SA. Currently, there are two 
competing pathways proposed for SA biosynthesis. In 1993, Yalpani et al. observed that 
TMV-infected tobacco synthesize SA through a side branch of the phenylpropanoid 
pathway. Production of SA through this pathway (Figure 2) is unclear although it is 
believed to occur via an oxidative (Alibert and Ranjeva, 1911) or non-oxidative, chain 
shortening mechanism (Yazaki et aI., 1991; Schnitlzler et aI., 1992). The first step toward 
SA biosynthesis is the conversion of phenylalanine to trans- cinnamic acid (t-CA) , 
catalyzed by the enzyme phenylalanine ammonia lyase (PAL). When Mauch-Mani and 
Slusarenko (1996) used the PAL inhibitor AIP (2-aminoindan-2-phosphoric acid) as a 
pre-treatment on Arabidopsis to block general phenylpropanoid metabolism, they 
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observed that Arabidopsis, which is normally resistant to Peronospora parasitica was 
now susceptible. Furthermore, Pallas et aI. (1996) discovered that sense suppression of 
the PAL gene prevented both SAR development and PR gene expression in the 
uninoculated leaves of TMV-infected tobacco. Interestingly, Shadle et aI. (2003) did not 
observe a change in resistance to TMV or an increase · in SA levels in tobacco 
overexpressing PAL. 
The final step in the biosynthesis of SA, as illustrated in Figure 2, involves the 
conversion of benzoic acid to SA via a cytochrome P450 monooxygenase called benzoic 
acid 2-hydroxylase (BA2H). Uon et al. (1993) observed that BA2H activity in cell free 
tobacco leaf extracts was lO-fold higher after inoculation with TMV and 6-fold higher 
after infiltration of healthy plants with benzoic acid (Leon et al., 1993; Yalpani et aI., 
1993). 
Interestingly, a second pathway, typically found in mycobacteria, has been 
identified as a potential source of SA in plants (Figure 3). Expression of the bacterial 
enzymes isochorismate synthase (ICS1) and isochorismate pyruvate lyase (IPL1) in 
tobacco and Arabidopsis resulted in an accumulation of SA and an increase in pathogen 
resistance (Mauch et al., 2001; Verb erne et al. 2000). In 1999, Nawrath and Metraux 
J. 
identified the SA-induction deficient mutants sidl and sid2 in Arabidopsis, which are 
unable to accumulate SA after SAR induction. Alleles of sidl and sid2, called eds5 and 
eds16 (enhanced disease susceptibility) respectively, were identified independently with 
an enhanced disease susceptibility phenotype (Glazebrook et aI., 1996; Dewdney et al., 
2000). In 2001, Wildermuth and colleagues cloned SID2IEDS 16 and found that it 
encoded a putative chloroplast-localized ICS whose expression is induced by infection in 
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both local and systemic tissue. Although no function has been assigned to SID1IEDS5, it 
has sequence similarity to a transporter protein which might suggest a role in transport of 
SA or a phenolic precursor outside of the plastid (Nawrath et al.,2002). 
Recently, Catinot et ai. (2008) examined virus induced gene silencing (VIGS) of 
ICS in tobacco and found that SA accumulation was compromised but not completely 
abolished. Combined with the observation that SA still accumulates in sidlleds16, it 
would appear that both the phenylpropanoid and isochorismate pathways may both be 
involved in SA biosynthesis. It has been postulated that SA biosynthesis via the 
phenylpropanoid pathway is responsible for the rapid accumulation of SA at the site of 
infection associated with localized cell death while SA biosynthesis from isochorismate 
is more important for sustained SA biosynthesis during SAR (Wildermuth et aI., 2001; 
Ferrari et aI., 2003). 
2.2.3 The Systemic Signal in SAR 
While pathogen attack at the site of infection can trigger induced disease 
resistance in primary cells, a signal is required to relay this information to distal, 
uninfected parts of the plant. It was initially postulated that the elicitor from the invading 
pathogen diffused from the site of infection to other cel~ throughout the plant to 
transduce the signal via the R-avr interaction. Studies by Dorey et ai. (1997) found this 
not to be the case. The levels of SA increase at the site of infection in distal tissues and in 
phloem sap of cucumber and tobacco prior to PR gene expression (Metraux et aI., 1990; 
Yalpani et aI., 1991; Malarny et aI., 1991).The more popular theory is that SA acts as the 
long distance signal in SAR. In vivo SA-labeling studies using e4C]-benzoic acid 
(MOlders et al., 1996) and eSO]-SA (Shulaev et al., 1995), showed that leaves of TMV-
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infected tobacco and TNV -infected cucumber transport the label from the site of infection 
throughout the plant where it accumulates in uninfected tissues. Despite this evidence, 
two key experiments contradict the role of SA as the long distance signal molecule in 
SAR. When primary cucumber leaves infected with P. syringae were removed six hours 
after inoculation, before SA accumulates in the phloem sap, neither the systemic increase 
in SA nor the expression of PR genes was affected (Rasmussen et al., 1991). Similarly, 
experiments with grafted tobacco plants showed that TMV-inoculated nahG rootstocks, 
which accumulate little SA, were still able to transmit a systemic signal to wild-type 
scions to induce PR gene expression and resistance comparable to ungrafted wild-type 
plants (Vernooij et aI., 1994). Criticism of these studies was that SA accumulation was 
not totally abolished with a low undetectable level of SA likely occurring in the 
cucumber phloem sap while nahG rootstocks still accumulated a small amount of SA. It 
is therefore possible that SA may be the long distance signaling molecule if only small 
amounts are required to induce a response. However in experiments by Willet and Ryals 
(1998), where they were able to control the gradient of free SA produced in TMV-
inoculated leaves of tobacco, they observed that the level of free SA in the inoculated leaf 
is directly proportional to the level of SAR in the upper, uninoculated leaf. This would 
'" suggest that a high accumulation of SA is required to induce SAR to provide pathogen 
protection. 
2.2.3.1 A Lipid Transfer Protein as a Systemic Signal 
In 2002, Maldonado and colleagues identified the Arabidopsis mutant dir 1-1 
(defective in induced resistance) which exhibits wild-type local resistance to avirulent P. 
syringae, but fails to develop SAR or induce PR gene expression in distal tissue. DIR1 
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encodes a putative apoplastic lipid transfer protein and is proposed to interact with a lipid 
derived molecule to promote long-distance signaling. Similarly, Nandi et a1. (2004), 
identified the Arabidopsis mutant sfd1 (suppressor of fatty acid desaturase) which is 
compromised in the accumulation of SA and expression of PR genes in distal tissue but 
local disease resistance is not affected. SFD1 encodes a 'putative dihydroxyacetone 
phosphate reductase, which is postulated to be involved in creating the lipid derived 
molecule that interacts with DIRI (Nandi et al., 2004; Truman et aI., 2007). 
2.2.3.2 Methyl Salicylate as a Systemic Signal 
Methyl salicylate (MeSA), which results from the methylation of the carboxyl 
group in SA (refer to Figure 1), is a common conjugated form of SA observed in several 
plants species (Lee et aI., 1995). In 1997, Du and Klessig identified an SA binding 
protein (SABP2) that has esterase activity and is responsible for converting MeSA to SA 
(Sesker et aI., 1998). Silencing of SABP2 results in the suppression of local resistance to 
TMV and SAR development (Kumar and Klessig, 2003) and its activity is induced 4- to 
5-fold in wild-type plants after treatment with SA (Park et aI., 2007). Forouhar et a1. 
(2005) established that SABP2 possesses specific esterase activity toward MeSA and that 
SA binds the active site of SABP2 with a dissociation co~stant (kd) of 90nM. These 
findings, in combination with competition assays between SA and MeSA, suggest that 
SA is a potent inhibitor of SABP2's MeSA esterase activity providing a mechanism for 
feedback inhibition (Forouhar et al., 2005). Park et a1. (2007) observed that when the SA 
feedback inhibition of SABP2 was compromised, SAR was not established after 
inoculation with TMV. This suggests that if the conversion of MeSA to SA is not 
inhibited by the corresponding increase in SA, MeSA fails to accumulate and act as the 
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mobile signal. Additionally, the esterase activity of SABP2 was only required for the 
development of SAR in systemic tissue. As a complementary experiment, Park et al. 
(2007) performed a grafting experiment where they found that the SA methyl transferase 
responsible for MeSA production from SA (NtSAMT1; Dudareva et aI., 1998) is only 
required in the rootstock of a TMV -infected tobacco graft and not in the systemic tissue 
(scion). 
While the results of Park et al. (2007) are very convincing, they do not disprove 
any of the observations of Maldonado et al. (2002) or Nandi et al. (2004) suggesting a 
lipid derived signal molecule acts as the long distance signal. Conversely, SA 
accumulation to wild-type levels in dir 1-1 mutants and the lack of induction of SAR 
through DIRI overexpression has led to the hypothesis that DIRI and SFDI function in 
cooperation with MeSA as the long distance signal in SAR (Maldonado et aI., 2002; Park 
et aI., 2007). 
2.2.4 SA Modes of Action 
In order to understand how an increase in SA, whether local or systemic, is able to 
control pathogen resistance, it is necessary to understand how SA exerts its control. 
J. 
2.2.4.1 SA, Catalase and Hydrogen Peroxide 
In 1991, Chen and Klessig identified a soluble SA binding protein (SABP) in 
extracts of tobacco leaves. They found that this protein strongly and reversibly bound SA 
and its biologically active analogs but not to structurally similar SA analogs lacking 
biological activity (Chen and Klessig, 1991; Chen et al., 1993). Sequence analysis of the 
SABP cDNA clone revealed high sequence similarity to the antioxidant catalase and in 
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vitro purified SABP showed activity in converting hydrogen peroxide (H20 2) to water 
and oxygen. The addition of SA or its biologically active analogs to this enzyme assay 
resulted in inhibition of activity both in vitro and in vivo (Conrath et al., 1995; Durner 
and Klessig, 1996; Wendehenne et aI., 1998). Aside from tobacco, SA inhibition of 
catalase has also been observed in the leaves of tomato, cucumber and Arabidopsis 
(Sanchez-Casas and Klessig, 1994) and the roots of rice (Chen et al., 1997). 
The mode of inhibition of catalase by SA is quite interesting; it centers on the iron 
in catalase which is Fe(III) in the native form. Fe(III) initially undergoes a two electron 
oxidation in the presence of H20 2 generating the Fe(V) intermediate which then accepts 
two electrons from another molecule of H20 2 resulting in the release of O2 and a return to 
the native Fe(ill) state. This catalytic activity is very rapid. However after the 
intermediate Fe(V) state is formed, catalase can follow another route, the peroxidase 
route, to regenerate the native Fe(ill) state. This involves two sequential one-electron 
reduction steps where SA can act as the electron donor. This results in shunting the 
normally rapid catalase cycle to the peroxidase cycle which is approximately WOO-fold 
slower and effectively inhibits catalase activity (Durner and Klessig 1995 and 1996). 
However, despite the almost twenty years that have passed since the identification 
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of catalase as an SA-binding protein, there is yet to be a consensus on the role of H20 2 as 
a second messenger for SA. This is mainly due to several studies that show that SA acts 
as a second messenger of H20 2 (Bi et aI., 1995; Neuenschwander et aI., 1995; 
Chamnongpol et aI.; 1998). In an attempt to reconcile the conflicting observations, 
interdependence between SA and H202 has been proposed. (Leon et al., 1995). For 
example, Rao et aI. (1997) established that SA requires H20 2 to potentiate lipid 
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peroxidation, induce PR gene expression and establish SAR. Their results also supported 
observations by Neuenschwander et aI. (1995) who determined that H202 requires SA to 
induce PR genes. An alternative hypothesis to explain the SA-H202 relationship is that 
the role of SA as a catalase inhibitor is only important at the site of infection as a means 
to initiate and help maintain the oxidative burst. The dissociation constant (kd) for SA 
binding to catalase is approximately 14~M (Chen and Klessig, 1991) and this 
concentration of SA has only been observed at the site of infection. In distal tissue, the 
concentration of SA is 10- to 100-fold lower suggesting SA's inhibition of catalase could 
not function in this tissue (Enyedi et al., 1992; Neuenschwander et al., 1995). 
The SA inhibition of catalase is an attractive model for the inhibition of SA 
because this would result in an accumulation of H20 2, a molecule known to directly affect 
proteins through post-translational modifications (PTMs). Changes in gene expression 
could be brought about by changing the redox status, and therefore activity, of 
transcription factors (discussed in detail in Section 2.5.1). Links between SA and nitric 
oxide (NO) (Durner et aI., 1998; Dolledonne et aI., 1998; Klessig et aI., 2000) and SA 
and a mitogen activated protein (MAP) kinase (Conrath et aI., 1997; Zhang and Klessig, 
1997; Zhang et al., 1998) have also been observed and offer additional means by which 
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proteins could be post-translationally modified to alter their activity. 
2.3 Proteins Involved in SAR 
Screens of Arabidopsis mutants provided some of the first glimpses into the 
proteins that are involved in the SAR pathway. Several mutants were identified with 
constitutive SAR and are characterized by spontaneous cell death in the absence of 
pathogen challenge (Ryals et aI., 1996). These mutants, such as lsd (lesion simulating 
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disease) and acd (accelerated cell death), display elevated SAR gene expression, high 
concentrations of SA and resistance to normally virulent pathogens (Dietrich et aI., 1994; 
Greenberg et al., 1994; Weymann et al., 1995). An Arabidopsis mutant known as cim 
(constitutive immunity) has also been characterized and found to behave in a similar 
manner to Lsd and acd mutants however it does not display any obvious cell death 
phenotype (Lawton et al., 1993; Ryals et aI., 1996). Although these mutants have 
enhanced diseases resistance, a major drawback is that the gene products of these mutants 
have poorly defined functions and do not provide much information to further our 
understanding of the signaling cascade that leads to SAR. 
2.3.1 Pathogenesis Related Proteins 
Pathogenesis related (PR) genes, whose coordinate expression correlates with the 
onset of SAR after pathogen challenge or treatment with either SA or its analogs, were 
the first genes identified to have a role in SAR. Although the identity of several of the 
proteins encoded by these PR genes has been known since 1987 (reviewed in Ward et al" 
1991) the function of many PR proteins has yet to be identified. Some PR genes have 
been found to encode proteins such as ~-1,3-glucanase and chitinase, however others, 
such as PRJ, the archetypical PR gene for SAR in Arabidop~is, has no known function. 
In 1991, Ward and colleagues. studied the expression of nine classes of P R genes that 
correlated with the onset of SAR in tobacco treated with TMV, SA and INA. They 
observed a maximal expression of these PR genes both locally and systemically at six and 
twelve days after TMV infection, respectively. 
A loss of SAR is often correlated with a loss of PR gene expression however 
overexpression of a PR gene almost never enhances disease resistance. Many groups 
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observed enhanced tolerance against fungal infection when they overexpressed two PR 
genes encoding, ~-1,3-glucanase and chitinase, in model (Broglie et aI., 1991; Zhu et al., 
1994) and crop plants (Grison et aI., 1996). However these groups were often only 
looking at pathogens that were known to be sensitive to chitinase and/or glucanase, while 
in reality, most plant pathogens were not significantly inhibited by the overexpression of 
these PR genes. The primary reason for this may be due to the large suite of PR genes 
that must be expressed to observe SAR (Ward et aI., 1991). 
2.3.2 Non-expressor of Pathogenesis Related Gene 1 (NPR1) 
An Arabidopsis mutant compromised in SAR was identified by Cao et ai. (1994) 
through screening mutants that were non-responsive to inducers of SAR. This mutant, 
named nprl (non-expressor of pathogenesis related genes 1), was also identified 
independently through different genetic strategies by two other groups and is also known 
as niml (non-inducible immunity 1; Delaney et al., 1995) and sail (salicylic acid 
insensitive 1; Shah et aI., 1997). Treatment of npr 1 mutants with either SA or INA fails 
to activate PR gene expression or SAR suggesting that SA and INA signaling require the 
function of the NPR1 protein (Delaney et aI., 1995; Shah et aI., 1997). 
Cloning of the Arabidopsis NPRl gene revealed a n6vel protein containing two 
protein-protein interaction domains. The BTBIPOZ (Broad-Complex, Tramtrack, and 
Bric-a-braclPox virus and Zinc finger) domain is found in the N-terminus while the 
ankyrin repeat domain is located toward the central portion of NPR1 (Cao et al., 1997; 
Aravind and Koonin, 1999). The characterization of several npr 1 mutants revealed a 
single point mutation in either protein-protein interaction domain eliminated NPR1 
function and demonstrated their critical role (Cao et aI., 1994; Delaney et aI., 1995; Shah 
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et al., 1997). Also critical for its function during SAR is the ability of NPR1 to localize to 
the nucleus. An NPR1-GFP fusion protein was detected exclusively in the nucleus after 
SA or INA treatment whereas it was mostly located in the cytoplasm in untreated cells 
(Kinkema et aI., 2000). More recent studies have shown that some NPR1 is localized in 
the nucleus prior to SA treatment (Despres et aI., 2000 and 2003). The significance of 
nuclear localization was demonstrated by Kinkema et ai. (2000) who showed that PR 
gene expression was only observed when NPR1 localized to the nucleus. Additionally, 
simply allowing nuclear localization of NPR1 was not sufficient for PR gene expression. 
Instead, nuclear localization of NPR1 in combination with INA treatment was required 
(Kinkema et aI., 2000). 
NPR1 overexpression in Arabidopsis is able to confer enhanced disease resistance 
without the detrimental side effects of the lsd, acd or cim mutants, providing an ideal 
target for genetic engineering in crop plants (Ryals et aI., 1996; Cao et al., 1998). To this 
end, overexpression of the NPR1 homolog in tomato (Lin et al., 2004) and apple (Malnoy 
et aI., 2007) has been shown to enhance disease resistance. Although NPR1 
overexpression is beneficial for crop protection, the exact mechanism by which NPR1 
exerts its effects is unclear. One key issue with the regulation of PR gene expression by 
l 
NPR1 is the fact that NPR1 does not contain an obvious DNA binding domain. 
2.3.3 TGA Transcription Factors 
TGA transcription factors (TF), named for their recognition of the cognate DNA 
motif TGACG, contain a basic region/leucine zipper motif (bZIP) that is responsible for 
DNA binding and protein dimerization, respectively (Hurst, 1995). In plants, TGA TFs 
have been characterized most extensively in tobacco and Arabidopsis. Jakoby et al. 
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(2002) have identified over 80 bZIP TFs in Arabidopsis, which is approximately four 
times more than the number identified in yeast, worms or humans (Riechmann et aI., 
2002). 
Characterization of a bZIP TF in tobacco, named TGAla, revealed that the bZIP 
domain is necessary and sufficient for sequence specific DNA binding (Katagiri et al., 
1992). Additionally, the basic portion of the bZIP region is also required for nuclear 
localization and constitutes a nuclear localization signal (NLS) (Vanderkrol and Chua, 
1991). TGAla will bind to a cis-element known as activation sequence 1 (as-I) in the 
cauliflower mosaic virus (CaMV) 35S promoter (Lam et aI., 1989). It also binds the cis-
elements found in the ocs (octopine synthase) and nos-I (nopaline synthase) promoter 
regions of Agrobacterium genes (Fromm et aI., 1989; Lam et al., 1990). Interestingly, an 
as-I-like element (discussed further in Section 2.4.2.2) has been identified in the 
promoter of several PR genes suggesting TGAla, as well as other TGA TFs, might act to 
regulate PR gene expression (Strompen et al., 1998). In fact, Strompen et aI. (1998) 
determined that TGAla bound the tobacco PRIa as-I-like element with the same affinity 
as the CaMV as-I element and the same mutations in the P RI a as-I element that affected 
PRIa inducibility also impaired binding of TGAla in vitro. These results suggest that the 
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level of expression of P RI a in tobacco is controlled through the as-I-like element and 
TGAla. Around the same time, Lebel et al. (1998) characterized cis-acting regulatory 
elements in the Arabidopsis PRI promoter that were involved in SA and INA 
inducibility. They identified two regions upstream of the transcription start site, termed 
LS5 and LS7 (linker scanning), whose mutation was found to elevate or abolish the 
induction of PRI, respectively. A closer analysis of the two sequences revealed the 
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presence of the same as-J-like element observed in tobacco PRJa (Lebel et al., 1998; 
Strompen et aI., 1998). Despres et al. (2000) have shown that the Arabidopsis TGA2 TF 
is able to bind both LS5 and LS7 further supporting a role for TGA TFs in the regulation 
of PR gene expression. 
2.3.3.1 TGA TFs and NPRI 
The significance of TGA TFs binding the promoter of PR genes was not realized 
until several groups independently identified that NPR1 interacts with several TGA TFs 
providing NPR1 with means to regulate PR gene expression (Zhang et al., 1999; Despres 
et al., 2000; Zhou et aI., 2000). 
Ten TGA TFs have been identified in Arabidopsis and seven (TGA1 to TGA7) 
have been assayed for their ability to interact with NPRl. There is very little sequence 
similarity between the seven TGA TFs in the N-terminus and varying levels of similarity 
in the rest of the protein, which has resulted in the clustering of the seven TGA TFs into 
three clades: (i) TGA1 and 4, (ii) TGA2, 5 and 6, and (iii) TGA3 and 7. Members within 
a clade possess similar DNA-binding specificities, expression patterns and transactivation 
properties (Zhang et aI., 1999; Despres et al., 2000; Zhou et aI., 2000; Niggeweg et aI., 
2000a and b; Schiermeyer et al., 2003). A multiple alignmem of the seven TGA TFs is 
illustrated in Figure 4. Yeast two-hybrid experiments identified that two clades, 
containing TGA2, 3, 5, 6 and 7, are able to interact with NPR1 while the third clade, 
containing TGA1 and 4, does not (Zhang et aI., 1999; Despres et aI., 2000; Zhou et aI., 
2000). 
Despres et ai. (2000) observed that binding of Arabidopsis TGA2 to either the 
CaMV 35S as-J element or the LS5 or LS7 elements of the PRJ promoter is enhanced in 
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the presence of NPRl. Furthermore, mutations in NPRI which result in a compromised 
ability to induce SAR also abolished interaction with TGA2, 3, 5, 6 and 7 and these 
NPRI mutants also failed to enhance TGA2 binding to the as-J element (Zhang et aI., 
1999; Despres et al., 2000; Zhou et al., 2000). The fact that mutations in NPRI that 
abolish the development of SAR also prevent NPRI-TGA interaction suggests that 
NPRI-mediated DNA binding of TGA TFs is required for the activation of SAR 
associated defense genes. 
In 2002, Fan and Dong provided further evidence to support the above 
observation when they showed that TGA2 and NPRI interact in planta and this 
interaction is enhanced by SA or INA treatment. They also observed, using a modified 
TGA2Gal4 chimeric construct, that a reporter gene under the control of the Gal4 
upstream activating sequence (UAS) was activated in response to SA and this activation 
was abolished in an nprJ mutant (Fan and Dong, 2002). Johnson et al (2003) made 
similar observations when they performed a gel shift assay using the LS7 element and 
leaf nuclear protein extracts from wild-type or npr J mutant plants with or without SA. 
While TGA2 binding to LS7 occurred in the absence of SA, the binding was markedly 
increased after SA treatment while there was no enhancement of binding observed in 
J 
extracts from the nprJ mutant after SA treatment. Johnson et aI. (2003) also observed an 
in planta interaction between NPRI and TGA TFs through chromatin 
immunoprecipitation (ChIP) experiments; TGA2 and TGA3 were found to bind the PRJ 
promoter only in the presence of SA and NPRl. Both of these results underscore the 
importance of NPRI in the SA-inducible binding ofTGA TFs to the as-J-like element. 
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TGA4 
TGA2 
TGAS 
TGA6 
TGA3 
TGA7 
TGAl 
TGA4 
TGA2 
TGAS 
TGA6 
TGA3 
TGA7 
---MNSTS --THFVPPRRVGIYEPVHQFGMWGESFKSNIS----NGTMNTPNHI I IPNNQ 51 
-- - MNTTS--THFVPPRRFEVYEPLNQIGMWEES FKN--- - ---NGDMYTPGSIIIPTNE 48 
-- ------------------------------------------- - MADTSPRTDVSTDD 14 
----- - --------------------------------------- - MGDTSPRTSVST DG 14 
-------- - - -------- - ----------------- - --- ------MADTSSRTDVST DG 14 
MEMMSSSSSTTQVVSFRDMGMYEPFQQLSGWESPFKSDINNITSNQNNNQSSSTTLEVDA 60 
---MMSSSSPTQLASLRDMGIYEPFQQIVGWGNVFKSDIN-- --DHSPNTATSSIIQVDP 53 
KLDNN- -- - - VSEDTSHG--TAGTPHMFDQEASTSRHPDK I QRRLAQNREAARKSRLRKK 104 
KPDS--- - - - LSEDTSHG--TEGTPHKFDQEASTSRHPDKI QRRLAQNREAARKSRLRKK 1 00 
DTDHP----- --- DLGSEGALVNTAASDSSDRSKGKMDQKTLRRLAQNREAARKSRLRKK 66 
DTDHN--- -----NLMFDEGHLGIGASDSSDRSKSKMDQKTLRRLAQNREAARKSRLRKK 66 
DTDHR--- - ----DLGSDRGHMHAAASDSSDRSKDKLDQKTLRRLAQNREAARKSRLRKK 66 
RPEADDNN- RVNYTSVYNNSLEAEPSSNNDQDED-RINDKMKRRLAQNREAARKSRLRKK 118 
RIDDHNNNIKINYDSSHNQIEAEQPSSNDNQDDDGRIHDKMKRRLAQNREAARKSRLRKK 113 
:* ****************** 
AYVQQLETSRLwn IQLEQE~DRARQQGFYVGNG I DTNSLGFSETMNPGlAAFEMEYGHWV 164 
AYVQQ~ETSRLW~ I HLEQE~DRARQQGFYVGNGVDTNALSFSDNMSSGIVAFEMEYGHWV 160 
AYVQQrENSRL~LTQLEQE~QRARQQGVFISGTGD-- --QAH STGGNGALAFDAEHSRWL 122 
AYVQQ~ENSRLKf '. TQLEQELQRARQQGVFISSSGD-- --QAHSTAGDGAMAFDVEYRRWQ 122 
AYVQQ~ENSRLK;LTQLEQELQRARQQGVFISSSGD----QAHSTGGNGALAFDAEHSRWL 122 
AHVQQLEESRLKfLSQLEQELVRARQQGLCVRNSSDTSYLGPAGNI~SG lAAFEMEYTHWL 178 
AYVQQ~EESRLWiSQLEQELEKVKQQG---- - -----HLGPSGSINTGIASFEMEYSHWL 163 
* : ***** ***** : ***** :.:*** * : *: *: : * 
EEQNRQICELRTVLHGHINDIELRSLVENAMKHYFELFRMKSSAAKADVFF~lSGMWRTS 224 
EEQNRQICELRTVLHGQVSDIELRSLVENAMKHYFQLFRMKSAAAKIDVFYVMSGMWKTS 220 
EEKNKQMNELRSALNAHAGDSELRIIVDGVMAHYEELFRIKSNAAKNDVFHLLSGMWKTP 182 
EDKNRQMKE LSSAIDSHATDSELRIIVDGVI AHYEELYRI KGNAAKSDVFHLLSGMWKTP 182 
EEKNRQMNELRSALNAHAGDTELRIIVDGVMAHYEELFR I KSNAAKNDVFHLLSGMWKTP 182 
EEQNRRVSE IRTALQAHIGDIELKMLVDSCLNHYANLFRMKADAAKADVFFLMSG~wRTS 238 
QEQSRRVSELRTALQSHISDIELKMLVESCLNHYANLFQMKSDAAKADVFYLISGMWRTS 223 
: : : .. ::: *: :.: . .. : * ** : : *: . : ** .* . .. * *** ***. ::* ***:*. 
AERFFLWIGGFRPSDLLKVLLPHFDVLTDQQLLDVCNLKQSCQQAEDALTQGMEKLQHTL 28 4 
AERFFLW I GGFRPSELLKVLLPHFDPLTDQQLLDVCNLRQSCQQAEDALSQGMEKLQHTL 280 
AERCFLWLGGFRSSELLKLLANQLEPMT ERQLMG I NNLQQTSQQAEDALSQGMES LQQSL 242 
AERCFLWLGGFRSSELLKLIASQLEPLTEQQSLDINNLQQSSQQAEDALSQGMDNLQQSL 242 
AERCFLWLGGFRSS ELLKLLANQLEPMTERQVMGINSLQQTSQQAEDALSQGMESLQQSL 242 
TERFFQWIGGFRPS ELLNVVMPYVEPLTDQQLLEVRNLQQSSQQAEEALSQGLDKLQQGL 298 
TERFFQW IGGFRPSELLNVVMPYLQPLTDQQILEVRNLQQSSQQAEDALSQG IDKLQQSL 283 
: ** * * : ****.*:**: : : .. . * . . * : : .*:*:. * ***: ** :**: : .** : * 
ADCVAAGQ--LGEGS -- ----YIPQVNSAMDRLEALVSFVNQADHLRHETLQQMYRILTT 336 
AESVAAGK--LGEGS------YIPQMTCAMERLEALVSFVNQADHLRHETLQQMHRILTT 332 
ADTLSSGT--LGSSS SGNVASYMGQMAMAMGKLGTLEGF IRQADNLRLQTLQQMIRVLTT 300 
ADTLSSGT--LGSSSSGNVASYMGQMAMAMGKLGTLEGFIRQADNLRLQTYQQMVRLLTT 300 
ADTLSSGT- - LGSSSSDNVASYMGQMAMAMGQLGTLEGFIRQADNLRLQTLQQMLRVLTT 300 
VESIAIQIKVVESVN----- -HGAPMASAMENLQALESFVNQADHL~QTLQQMSKILTT 352 
AESIVIDA-VIESTH - -----YPTHMAAAI ENLQALEGFVNQADHLRQQTLQQMAKI LTT 336 
* . * . * .* : .***:** .* : : * ** 
TGAl RQAARGLLALGEYFQRLRALSSSWATRHREPT 368 
TGA4 RQAARGLLALGEYFQRLRALSSSWAARQREPT 364 
TGA2 RQSARALLAIHDYFSRLRALSS LWLARPRE-- 330 
TGAS RQSARALLAVHNYTLRLRALSSLWLARPRE-- 33 0 
TGA6 RQSARALLAI HDYSSRLRALSSLWLARPRE-- 330 
TGA3 RQAARGLLALGEYFHRLRALSSLWAARPREHT 384 
TGA7 RQSARGLLALGEYLHRLRALSS LWAARPQEPT 368 
**:**.***: : * ******* * : * :* 
Figure 4. Alignment of Seven Arabidopsis TGA TFs 
Clustal W amino acid alignment of TGAI (NP _851273), TGA2 (NP _001078539), TGA3 
(ABG48390), TGA4 (ABD85167), TGA5 (NP _974745), TGA6 (ABL66771) and TGA7 
(Q937E2). The conserved basic portion of the bZIP domain is boxed in light grey while 
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the conserved leu cines of the leucine zipper are boxed in dark grey. Conserved amino 
acids in all seven TGA TFs are indicated by an asterisks (*), conserved substitutions are 
indicated by two dots (:) and semi-conserved substitutions are indicated by one dot (e). 
The order of TGA TFs is based on their division into different clades. 
SA is believed to enhance the interaction between TGA2 and NPRI leading to 
enhanced binding of the PRJ promoter, but the exact mechanism of SA-mediated 
enhancement is not clear. It is possible that SA either enhances the affinity of NPRI for 
TGA2 or increases the availability of NPRI for TGA2 (Fan and Dong, 2002). The second 
hypothesis is supported by the observation that SA or INA treatment increases the 
distribution of NPRI to the nuclear fraction where TGA2 is found (Kinkema et al., 2000; 
Mou et al., 2003). 
2.3.3.2 Functional analysis of TGA TFs 
Determining the function of TGA TFs during SAR has proven to be a 
complicated task. Although an activity related to interaction with NPRI for several TGA 
TFs is clear, it has been difficult to establish if any of the TGA factors have any NPRl-
independent roles. These difficulties may be due to the redundancy of TGA TFs that 
diminish the values of mutants to describe their putative function. As a result, 
overexpression has been used to examine the effect of TGA90verexpression on SAR in 
Arabidopsis. These plants were significantly more resistant to the normally virulent 
pathogen P. parasitica whereas an overexpressing TGA2 line had no obvious effect. 
Since the TGA5-accumulating line did not express higher levels of PRJ and it was not 
compromised in an nprJ mutant or in Arabidopsis lines expressing nahG, the observed 
resistance might involve an SA- and SAR-independent mechanism (Kim and Delaney, 
2002). Using a different approach, Foley and Singh (2004) examined the effect of 
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decreased expression of either TGA4 or TGA5 in Arabidopsis. They observed that while 
neither had any effect on phenotype, both seemed to affect the responsiveness of an ocs 
(an element bearing sequence similarity to the as-J-like element) element to SA and H20 2 
in roots. TGA4-silenced lines showed enhanced responsiveness of the ocs element to SA 
and H20 2 while TGA5 silenced lines reduced this response. These results would suggest 
TGA5 is possibly involved in at least two defense related signaling pathways, acting as a 
positive activator in both instances, whereas TGA4 may act as a negative regulator (Kim 
and Delaney, 2002; Foley and Singh, 2004). 
Dominant-negative experiments have provided an alternative means to establish 
the function of TGA TFs, however with vastly conflicting results. Dominant-negative 
studies rely on overexpressing a mutant whose gene product adversely affects the normal, 
wild-type gene product. For example, Fan and Dong (2002) created a dominant-negative 
mutant of TGA2 where the DNA binding domain has been removed. This mutant is still 
able to interact with NPRl. Plants expressing this dominant-negative mutant of TGA2 
had a phenotype similar to nprJ mutants (Fan and Dong, 2002). These plants also 
displayed a reduction in PRJ and PR2 expression after INA treatment and infection 
resulted with a normally avirulent pathogen. Furthermore, Zhang et al. (2003) observed 
l 
that INA treatment of a triple TGA2, 5, 6 knock-out Arabidopsis lines did not induce PRJ 
and did not protect this line from a normally avirulent pathogen. Taken together, these 
data suggest that the TGA2, 5, 6 clade positively regulates PRJ gene induction. However, 
the triple knock-out line also accumulated higher basal levels of PRJ compared to wild-
type plants in the absence of INA treatment suggesting a negative regulation by these TFs 
of basal PRJ expression. The role of TGA2 as a negative regulator is also supported by 
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Pontier et al. (2001) who observed that a TGA2 dominant-negative mutant displayed 
enhanced expression of PRJ a by SA in tobacco. 
The as-I-like element, aside from being responsive to SA and INA, also responds 
to environmental cues and stresses. The hormone auxin, for instance, mediates at least 
some of its effect by enhancing the expression of specific genes through the as-I-like 
element through TGA TFs. Pascuzzi et al. (1998) and Johnson et aI. (2001a) showed that 
TGA1a can activate the expression of a reporter gene fused to an as-I-like element after 
treatment with the synthetic auxin 2,4-D (2,4-dichlorophenoxyacetic acid). In vitro 
studies found that TGA1a is able to bind the as-I-like element in the promoter of GNTl 
and GNT35, two tobacco glutathione S-transferase (GST) genes. These results were 
confirmed by ChIP experiments in vivo where binding was only observed after treatment 
with 2,4-D (Johnson et aI., 2001b). Interestingly, although TGA1a was observed to bind 
the tobacco PRIa as-I-like element in vitro, ChIP experiments did not detect TGA1a 
bound to the PRJa promoter before or after 2,4-D treatment (Johnson et aI., 2001b). 
One should be cognizant of the fact that the cis-acting elements being studied in 
most instances are not in the context of the full length promoter they were taken from. 
This means that while a specific type of responsiveness to one TGA factor over another 
l 
might be relevant, it might not reflect the in vivo situation that would occur in the context 
of the full length promoter. 
Using a reverse genetics approach, Kesarwani et aI. (2007) recently provided 
extensive detail concerning the role of TGA TFs during disease resistance. They found 
that TGA1 and 4 play partially redundant roles in regulating basal resistance and have 
only a moderate effect on PR gene expression after INA treatment. They further 
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examined the TGA2, 5 and 6 clade and determined that TGA2 has repressor activity on 
PR gene expression even though it can act as a positive regulator in the tga5-1 tga6-1 null 
mutant background. Also, an activation-tagged mutant of TGA6 was able to increase 
basal as well as induced expression of PRl suggesting a positive role in PR gene 
expression. These data have led to the hypothesis that single TGA TFs have dual 
functions and can act as both positive and negative regulators of SAR (Pontier et aI., 
2001; Kesarwani et aI., 2007). 
2.4 Timing of SAR 
The events that take place during SAR are timed and coordinated to ensure that 
disease resistance pathways are induced early enough and sustained to prevent pathogen 
infection. PR gene expression is usually induced six to eight hours after pathogen 
infection which, on the time scale of induced disease resistance, is considerably rapid 
(Horvath et aI., 1998). However on the time scale of a molecular response to a stimulus, it 
is quite slow. Several studies have examined the inducibility of genes by SA and other 
molecules and this has resulted in the identification and classification of two different 
groups of genes in disease resistance: immediate-early and late genes (Horvath and Chua, 
1996; Horvath et aI., 1998). These two groups are distingfiished by their kinetics of 
induction and by the fact that expression of immediate-early genes is not affected by the 
protein synthesis inhibitor cycloheximide (CHX) while the expression of late genes is 
(Horvath and Chua, 1996). This suggests that expression of immediate-early genes 
involves latent or pre-existing pools of TFs while de novo synthesis is required for the 
induction of late genes (Horvath and Chua, 1996; Horvath et aI., 1998; Uquillas et aI., 
2004). 
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One very interesting feature of both immediate-early and late genes is the 
presence of the as-I-like element in their promoter (Droog et a., 1995; Lebel et aI., 1998; 
Strompen et aI., 1998). As already discussed, TGA TFs bind the as-I-like element of 
several different genes (Despres et aI., 2000; Fan and Dong, 2002; Johnson et aI., 2003). 
While the number of identified immediate-early genes is large, PR genes are the only 
genes identified as late genes and a role for TGA TFs in their expression has already been 
discussed. 
2.4.1 Immediate-Early Genes 
Initially, several glutathione S-transferases (GSTs) were identified as immediate-
early genes in tobacco (Nt103-1 and Ntl03-35; Droog et aI., 1995 and GNT35; Xiang et 
aI., 1996) and Arabidopsis (GSTl; Chen et al., 1996) by their rapid induction after 
pathogen challenge and/or treatment with one or more of SA, INA, H20 2, 2,4-D and 
methyl jasmonate (MeJA). GSTs catalyze the nucleophilic addition of the thiol of 
reduced glutathione (GSH) to a large variety of electrophilic compounds with the main 
goal of detoxifying xenobiotic compounds (Armstrong, 1997). The postulated role of 
GSTs during pathogen infection is to limit tissue damage to neighboring cells (Levine et 
aI., 1994). 
Horvath et aI., (1996) identified a glucosyl transferase, IEGTI (immediate-early-
induced glucosyl transferase) in Arabidopsis whose expression was induced 30 minutes 
after SA treatment, peaked at three hours and then decayed. Treatment with CHX had no 
effect on IEGTl induction or timing, however, the decay of IEGTI was abolished 
suggesting that de novo protein synthesis is required to turn off expression of IEGTI 
(Horvath et aI., 1996). GST6 is another immediate-early gene in Arabidopsis whose 
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expression is rapidly induced by SA treatment (Chen et aI., 1996) and is insensitive to 
CHX (Uquillas et aI., 2004). Interestingly, TGA4 and TGA5 bind the promoter of GST6 
(Chen et al., 1996), however, the expression of GST6 is not compromised in an nprJ 
mutant (Uquillas et al., 2004). This would suggest that TGA-dependent induction of 
GST6 occurs in an NPRI-independent manner. 
EH-J (epoxide hydroxylase 1; Guo et aI., 1998) and PIOX (pathogen-induced 
oxygenase; Sanz et al., 1998) were also identified as immediate-early genes based on 
their responsiveness to SA. Similar to GSTs, EH-l is also believed to play a role in 
protecting cells from oxidative damage during pathogen infection while PIOX has 
homology to cyclooxygenase. In mammalian systems, cyclooxygenases catalyzes the first 
committed step in the formation of prostaglandins and thromboxanes, both of which are 
lipid derived signal molecules involved in the immune response (Sanz et aI., 1998). By 
analogy, PIOX may be involved in the generation of lipid-derived signal molecules that 
activate defense responses in plants (Dempsey et aI., 1999). 
Recently, Blanco et aI. (2005) identified twelve genes in Arabidopsis that were 
induced by SA as early as 30 minutes to around 2 hours and classified these as 
immediate-early genes. They split these genes into two groups based on the proteins they 
I 
encoded. The first group of genes are involved in cell protection (glycosyl transferases 
(GTases) and GSTs) while the second group of genes are involved in signal transduction 
(protein kinases and TFs). The first group of genes was characterized by their rapid 
response to SA (30 minutes), sensitivity to a lower concentration of SA, dose-dependent 
response to increasing concentrations of SA and independence of NPR 1. The second 
group responded less rapidly to SA (2 hours), was insensitive to lower concentrations of 
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SA, showed less of a dose-dependent response and required NPRI. Curiously, the 
dependence of any of these genes on de novo protein synthesis was not tested. When the 
promoters of the two groups of genes were analyzed, it was noted that the as-i-like 
element was over-represented in the first group only, with little to no representation in the 
second group. This would suggest that the expression of the second group of genes is 
mediated in an NPRI-dependent but TGA-independent manner whereas induction of the 
first group is the complete opposite. 
2.4.2 Gene Expression Controlled by the as-l-like Element 
The fact that the as-i-like element occurs in the promoter of genes that are 
regulated so differently in terms of kinetics as well as dependence on de novo protein 
synthesis indicates the regulation by NPRI and TGA TFs complex. 
2.4.2.1 Chemical Signals 
Aside from SA, the induction of many immediate-early genes containing an as-i-
like element also occurs through treatment with INA, 2,4-D, H20 2, and MeJA although 
the timing and degree of induction sometimes varies (Qin et al., 1994; Xiang et aI., 1996; 
Horvath and Chua, 1996). One way a common cis-acting element can be differentially 
l 
regulated is by the dissimilar effects that varying chemicals have on TFs. The spectrum 
of TGA hetero- and homodimers that results from SA treatment is likely drastically 
different from those produced by treatment with 2,4-D or MeJA. For example. the 
expression of a reporter gene containing the upstream activating sequence for Gal4 by a 
TGA2::GaI4 fusion construct was activated by SA but not by 2,4-D or MeJA (Fan and 
Dong, 2(02). 
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2.4.2.2 The Sequence and Arrangement of the as-I-like Element 
The as-i element found in the Cauliflower mosaic virus (CaMV) 35S promoter is 
twenty base pairs in length. It contains two perfect palindromes with a conserved 
sequence separated by four nuc1eotides where the center of each palindrome is separated 
by twelve base pairs (Krawczyk et aI., 2002). The as-i-likeelement identified in plant 
promoters is the same except for the presence of an imperfect palindrome. In the 
promoters of immediate-early genes, the twelve base pair spacing between the 
palindromes is strictly conserved; an increase or decrease in spacing affects the DNA 
binding and transactivation of several tobacco TGA TFs (Krawczyk et al. , 2002). In 
contrast, the twelve base pair spacing in the as-i-like element in the PRi and PRi a 
promoters is not strictly conserved. However in both immediate-early and late genes, the 
sequence of the four nuc1eotides between the two palindromes was found to influence the 
binding affinity of TGA TFs (Krawczyk et al., 2002). Additionally, the nuc1eotides 
flanking the as-i-like element also dictate preference for binding of certain TGA TFs 
over others. There is also the possibility that binding will only occur on one palindrome 
of the as-i-like element as opposed to both. This was observed by Niggeweg et al. 
(2000a) who found that tobacco TGAla and TGA2.2 bound to only a single TGACG 
J< 
motif on the as-i element at low protein concentrations. At higher protein concentrations 
however, simultaneous occupation of both motifs was observed for TGA2.2 but not for 
TGAla. 
The accessibility of the as-i-like element to TGA TFs also affects regulation. 
Butterbrodt et aI. (2006) observed that histone acetylation, which correlates with an 
increase in gene expression through increased DNA accessibility, occurs on the PRia 
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promoter after SA treatment. On the other hand, histone acetylation of a minimal as-l 
element from CaMV 35S was not influenced by SA. 
2.5 Redox Regulation 
Reactive oxygen species (ROS) result from the incomplete reduction of oxygen. 
All organisms have evolved protective mechanisms, both enzymatic and non-enzymatic, 
to minimize ROS-mediated damage of DNA, proteins and lipids. However there are 
instances, such as the immune response in vertebrates and the oxidative burst in plants, 
where ROS accumulate past the point where normal buffering mechanisms are not 
effective (Lamb and Dixon, 1997; Alvarez et al., 1999). While these unmanageable 
increases in ROS are detrimental to cells, organisms have also managed to utilize these 
ROS as signals to regulate gene expression. 
Cysteines are the most sensitive of all amino acids to oxidation and normally exist 
in a reduced state due to the reducing environment of the cytoplasm (Schafer and 
Buettner, 2001). However, under oxidative stress, several different cysteine modifications 
are possible. Research in the past ten years has focused on the redox regulation of 
cysteines in non-plant systems (Toledano et aI., 2004; Shelton et al., 2005) while more 
recent work has identified similar mechanisms in plants (~ et al., 2004a; Fobert and 
Despres, 2005; Michelet et al., 2005; Wang et al., 2006). The most common forms of 
oxidative stress include the superoxide radical (02.-), hydrogen peroxide (H202) and the 
hydroxyl radical (HO·) (D' Autreaux, and Toledano, 2007). The difference in reactivity, 
half-life and lipid solubility of ROS translates into varying effects on biological targets 
(Halliwell and Gutteridge, 1999; D' Autreaux and Toledano, 2007). For instance, HO· has 
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indiscriminant reactivity whereas O2. - has high reactivity with iron-sulfur clusters and 
H20 2 with cysteines (Toledano, 2007). 
The formation of a disulfide bond constitutes one of the most common forms of 
cysteine redox regulation although nitrosylation (S-NO), glutathionylation (S-SG) and 
hydroxylation [S-OH (sulfenic); S-02H (sulfinic); S-03H (sulfonic)] have also been 
observed (Shelton et al., 2005). It was initially believed that most cysteine modifications, 
other than disulfide bonds, were simply transient intermediates, however extensive 
research has provided evidence that most of the above mentioned modifications are stable 
and have biological significance (Kim et al., 2002; Poole et aI., 2004; Giustarini et al., 
2004; Filomeni et aI., 2005). 
Most cysteine modifications are reversible and even interconvertible (i.e. once a 
cysteine has been oxidized to S-OH, it can still form a disulfide bond or become 
glutathionylated; Shelton et aI., 2005) however S-03H is believed to be an irreversible 
modification (Dawson et aI., 1991). Although this might not necessarily be the case given 
that S-02H was initially believed to by an irreversible oxidation until Biteau et al. (2003) 
discovered an ATP-dependent reduction activity for S-02H in Saccharomyces cerevisiae. 
Two cytosolic pathways exist that maintain the reducing environment of the cell: 
J 
thioredoxins (Trx) and glutaredoxins (Grx) (Ritz and Beckwith, 2001; Ortenberg and 
Beckwith, 2003). These two systems operate in a similar manner, via a dithiol 
mechanism, to reduce disulfide bonds (illustrated in Figure 5A and B). Trx uses the 
reducing power of NADPH while Grx employs glutathione (GSH), although ultimately 
the reducing power is derived from NADPH (Qin et al., 2000). Both Trx and Grx share a 
classical active site defined as the CXXC-type (for example CPYC). The N-terminal 
36 
W 
-....l 
A 
B 
c 
o 
NADPH +X' FAD XTrxR(SHlX Trx-S, XProtein(SHl, 
NADP' FADH, TrxR-S, Trx(SHl, Protein-S, 
NADPH +X' GR-S, X 2 GSH X Grx-S, X Protein(SHl, 
NADP' GR(SHl, GSSG Grx(SHl, Protein-S, 
2 GSH 
OR 
TrxR + NADPH + H' 
" .. 
r~ Grx -~5H .5-, "-'-"", CiD=Grx - 5, 5H-, "", ' ~', [&rx }=5 
l or I I (Protein) ~ or ) (pr.otein) ~ or I 
i~ I~~" ,J- / Trx t _ )~ " ' Trx 5 
5H----; '--- \ ~ rcirx L--5H 
\ Protein) ~- or I 
5H-' 1~r-5H 
/ 
(.5
1 
( protein) ~ 
"' \ I 5- ',. '" ' 
, 5G 
, ,,. 
" ,~_._ GSSG 
5 H5\~rote~'~1 G~ J 
I ' 
' -~.-•.. -
H5-r~rotein) 
\. ! 5H 
5G 
5H- , 
(Protein"; 
5H-' 
Figure 5. Enzymatic Reaction ScheIqes for the Thioredoxin and Glutaredoxin Systems , 
(A) Mechanism of NADPH dependent protein disulfide reduction by the thioredoxin system. TrxR - thioredoxin reductase; Trx - thioredoxin; S2 
- oxidized disulfide; (SH)2 - reduced disulfide (Adapted from Meyer et aI., 1999). (B) Mechanism of GSH dependent glutaredoxin reduction of a 
protein disulfide. GR - glutathione reductase; Grx - glutaredoxin; S2 - oxidized disulfide; (SH)2 - reduced disulfide (Adapted from Fernandes and 
Holmgren, 2004). (C) The thioredoxin (Trx) and glutaredoxin (Grx) dithiol mechanism for reducing a protein disulfide. The N-terminal cysteine 
(denoted as S,) is deprotonated by stabilizing neighboring amino acids and attacks the protein disulfide bond. A transient glutaredoxin-protein 
disulfide is formed while the other cysteine from the protein disulfide deprotonates the C-terminal cysteine in the GrxlTrx active site. The C-
terminal Grx/Trx cysteine then attacks the mixed disulfide, liberating a reduced target protein. The reduced forms of Grx and Trx are regenerated 
via 2 molecules of GSH and thioredoxin reductase (TrxR) plus NADPH and H+, respectively (Adapted from Fernandes and Holmgren, 2004). (D) 
The glutaredoxin (Grx) monothiol mechanism for reducing a mixed disulfide with GSH. In this instance, only the deprotonated N-terminal 
cysteine (S') is involved. It attacks the cysteine in glutathione leading to a reduced protein target and the glutaredoxin oxidized by glutathione. A 
second GSH molecule is involved in regenerating the reduced form of Grx (Adapted from Fernandes and Holmgren, 2004). 
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cysteine in the active site has a lower pKa and is the first to attack the protein disulfide 
bond resulting in a mixed disulfide between Trx or Grx and the protein being reduced 
(Figure 5C). The C-terminal cysteine then attacks the mixed disulfide releasing the 
reduced protein and generating an oxidized Trx or Grx, which is regenerated through 
NADPH-dependent thioredoxin or GSH plus glutathione reductase, respectively (Meyer 
et aI., 1999; Fernandes and Holmgren 2004). Grx can additionally reduce mixed 
disulfides between GSH and a protein (Figure 5D) (Fernandes and Holmgren 2004). In 
this monothiol reduction mechanism, only the N-terminal cysteine is present in the active 
site, the CXXS-type (for example CGFS), although a dithiol active site is also able to 
perform a monothiol reduction. The N-terminal cysteine attacks the cysteine of 
glutathione in the mixed disulfide and the reduced Grx is regenerated by one molecule of 
GSH. 
Trx have been extensively studied and characterized in E. coli, yeast and 
mammals whereas Grx are less well characterized. Mammalian systems have one 
mitochondrial Trx and Grx and one cytoplasmic Trx and Grx while Arabidopsis has 26 
Trxs (Meyer et al., 2002) and 31 Grxs (Rouhier et aI., 2004), all with varied localization 
within the cell. Currently, very few plant Grxs have been characterized in terms of their 
l 
expression, localization, targets or biochemical activity (see Table 1 in the Appendix) 
whereas the function of many Trxs has been characterized in various plant subcellular 
compartments (Rouhier et aI. 2005). 
2.5.1 Redox Regulation of Proteins 
The reducing environment of the cytoplasm, which regulates the redox status of 
cysteines, is influenced by the ratio of reduced to oxidized glutathione (GSHlGSSG) as 
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well as the presence of ROS. Changes in the redox status of cysteine residues results in 
modifying the electronic and steric conformation of the amino acid thereby affecting 
protein structure. This in turn will influence their activity, localization, DNA-binding 
affinity, transactivation or repression properties and/or protein-protein interaction. 
OxyR was one of the first TFs to be studied in detail in terms of the redox 
regulation of its activity. OxyR is an E. coli TF that activates the expression of 
antioxidant genes in response to H20 2 (Storz et aI., 1990). In the reduced form, OxyR is 
inactive and does not transactivate. The oxidized form, which has been postulated to 
result from an intramolecular disulfide bond, is capable of activating transcription (Zheng 
et aI., 1998; Choi et aI., 2001). This mode of regulation depicts the classical redox switch 
where the reduced form constitutes the OFF or inactive form and the oxidized form is the 
ON or active form. However a simple redox switch involving a disulfide bond does not 
appear to explain the behavior of OxyR (Storz et aI., 1990; Kullik et al., 1995). Instead, 
Kim et al. (2002) proposed that OxyR is involved in a more intricate sensing mechanism 
for oxidative stress where differential and graded responsiveness is observed. To this end, 
they observed several stable PTMs of a single OxyR cysteine in vivo including S-NO, S-
OH and S-SG. Each of these modified forms of OxyR were still transcriptionally active, 
;.. 
so the redox switch model is still applicable, however the modifications affect structure, 
DNA-binding affinity and promoter activity. This elaborate response to varied oxidative 
stress suggests that OxyR is able to process different signals into distinct transcriptional 
responses (Kim et aI., 2002). 
Yap 1 (Yeast AP-l) is a bZIP TF in S. cerevisiae responsible for regulating genes 
encoding cellular enzymatic and non-enzymatic processes for the oxidative stress defense 
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systems (Jamieson, 1998; Toone and Jones, 1998; Carmel-Harel and Storz, 2000). Yapl 
shuttles in and out of the nucleus under non-stress conditions, however, the nuclear 
export of Yapl is inhibited by H20 2 resulting in its nuclear accumulation and 
transcription of its target genes (Kuge et aI., 2001). Yapl contains a C-terminal nuclear 
export sequence (NES) that contains three cysteines. The presence of an intramolecular 
disulfide bridge in the NES was observed in vivo after H20 2 treatment and corresponded 
with nuclear localization of Yap 1. There is also evidence that sustained nuclear 
localization and maximal transcriptional activation requires redox regulation of cysteines 
at the N-terminus of Yap 1 (Kuge et al., 2001; Paget and Buttner, 2003). 
Aside from E. coli and yeast, there are many mammalian proteins whose DNA-
binding affinity, localization and activity are regulated by redox conditions including p53 
(Jayaraman et aI., 1997), NF-1d3 (Xanthoudakis and Curran, 1992), Pax5 and Pax8 (Tell 
et aI., 1998a and 1998b) and Jun and Fos (Abate et aI., 1990). More recently, plant 
proteins have shown to be regulated by the redox status of cysteines. The R2R3 MYB 
domain proteins in plants comprise one of the largest known families of TFs. Vertebrate 
Myb genes encode proteins with MYB domains formed by three MYB repeats (RIR2R3) 
whereas the majority of plant Myb genes encode proteins with only two MYB repeats 
l 
(R2R3) (Lip sick, 1996; Rosinski and Atchley, 1998; Braun and Grotewold, 1999; Stracke 
et al., 2001). The RIR2R3 MYB domain in vertebrates contains a single cysteine residue 
that is reduced for DNA-binding and transcriptional activity while the R2R3 MYB 
domain in plants contains two cysteines. By studying the maize PI regulatory protein, a 
typical R2R3 MYB domain protein, Heine et al. (2004) discovered that under non-
reducing conditions, these two cysteines form an intramolecular disulfide bond that 
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prevents the R2R3 MYB domain to bind DNA (Heine et aI., 2004). While the exact 
mechanism of PI redox regulation still needs to be elucidated, the redox regulation of the 
MYB domain (vertebrate or plant) provides an interesting example of a redox switch that 
appears to work in reverse. The oxidized protein, which is normally not supported in the 
reducing environment of the cell, is the OFF or inactive form while the reduced protein is 
the ON or active form required for DNA binding and transactivation. 
2.5.2 Redox Regulation of SAR 
The oxidative burst that occurs at the onset of SAR is responsible for an 
accumulation in ROS (Halliwell and Gutteridge, 1999). A change in the ratio of 
GSHlGSSG has also been observed after INA treatment and pathogen challenge in 
Arabidopsis (Mou et al., 2003) which, along with the oxidative burst, constitutes an ideal 
signal for redox responsive proteins. 
In the absence of SA, NPRI is retained in the cytoplasm (Kinkema et aI., 2000) 
and this retention is the result of oligomerization of NPR 1 via intermolecular disulfide 
bonds involving Cys82 and Cys216 (Mou et aI., 2003). Upon SAR induction, NPRI is 
reduced to its monomeric form which subsequently accumulates in the nucleus to induce 
PR gene expression. Inhibiting the reduction of NPRI prevents PR gene expression while 
mutation of either Cys82 or Cys216 leads to constitutive monomerization, nuclear 
localization and PR gene expression (Mou et al., 2003). Interestingly, by incubating 
purified NPRI with increasing ratios of GSHlGSSG, Mou et ai. (2003) observed a shift in 
the oligomeric to monomeric form ofNPRI. 
Yeast two-hybrid screens initially identified TGAI and TGA4 as the only TGA 
TFs that did not interact with NPRI (Zhang et aI., 1999; Despres et al., 2000; Zhou et al., 
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2000) however a plant two-hybrid assay revealed that TGA 1 was able to interact with 
NPRI upon SA treatment (Despres et aI. , 2003). Chimerics of TGAI and TGA2 revealed 
a 30 amino acid region that appeared to be responsible for preventing TGAI 's interaction 
with NPRI. Closer examination of this region identified two cysteines in TGAl, Cys260 
and Cys266. These are conserved in TGA4 but are not present in TGA2 or the other four 
TGA TFs (Despres et aI., 2003). Mutants of TGAI and TGA4, where Cys260 and 
Cys266 were changed to the corresponding amino acids in TGA2, were able to interact 
with NPRI in a yeast two-hybrid assay and the mutant of TGAI was able to interact with 
NPRI in a plant two-hybrid assay whether or not SA was present (Despres et aI., 2003). 
An in vivo labeling assay determined that SA treatment reduced Cys260 and Cys266 
suggesting that SA regulates TGAl's redox status such that interaction with NPRI only 
occurs when these cysteines are reduced (Despres et aI., 2003). Cys260 and Cys266 are 
oxidized in yeast which explains why no interaction with NPRI was observed in the 
original yeast two-hybrid assays (Despres et aI. , 2003; Zhang et aI., 1999; Despres et aI., 
2000; Zhou et aI., 2000). The DNA binding affinity of TGAI is not influenced by its 
redox status, however NPRI only enhances the binding of reduced TGAI to the as-J 
element (Despres et aI., 2003). 
J. 
Recently, Ndamukong et aI., (2007) identified an Arabidopsis glutaredoxin, 
GRX480, that interacts with several TGA TFs and is involved in the suppression of 
PDFJ.2 expression. The expression of GRX480 was found to be SA-inducible and 
dependent on the presence of the TGA2, 5, 6 clade of TFs as well as NPRI (Ndamukong 
et aI., 2007). 
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CHAPTER 3 - The Co-Activator Function of the Arabidopsis 
NPRI Requires the Core of its BTBIPOZ and the Oxidation of 
C-terminal Cysteines 
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3.1 ABSTRACT 
NPR1 is the regulator of systemic acquired resistance (SAR) in Arabidopsis. Current 
models propose that following treatment with the SAR-inducing metabolite salicylic acid 
(SA), Cys82 and Cys216 of NPR1 are reduced, leading to nuclear import. Through an 
unknown mechanism, interaction of nuclear-localized NPR1 with TGA transcription 
factors results in the activation of defense genes, including the SAR marker 
PATHOGENESIS-RELATED J (PRJ), and deployment of SAR. Aside from the fact that 
they interact with each other, there is no biochemical evidence indicating how TGA TFs 
or NPR1 regulate transcription or whether a TGA-NPR1 complex forms on DNA. Here, 
we show by chromatin immunoprecipitation that TGA2 and NPR1 are recruited to the 
PRJ gene independently of each other and of SA-treatment. Consistent with published 
data indicating that a triple knock-out in TGA2/5/6 derepresses PRJ, in vivo plant 
transcription assays revealed that TGA2 is not an autonomous transcriptional activator, 
but is a transcriptional repressor in both untreated and SA-treated cells. However, after 
stimulation with SA, TGA2 is incorporated into a transactivating complex with NPR1 
forming an enhanceosome. Genetic and biochemical data demonstrate that transactivation 
of the TGA2-NPR1 enhanceosome requires the core of th~ NPR1 BTBIPOZ domain 
(residues 80-91) and the oxidation of NPR1 Cys521 and Cys529. These cysteines are 
found in a new type of transactivation domain that we term cysteine-oxidized 
transactivation domain. The data presented further our understanding of the mechanism 
by which TGA2 and NPR1 activate the Arabidopsis PRJ gene. 
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3.2 INTRODUCTION 
Plants, unlike animals, do not possess specialized cells for protection against invading 
pathogens. Instead, every plant cell must be capable of perceiving pathogens and 
mounting effective defense responses if the organism is to successfully protect itself from 
infection. Upon detection of an invading microbe, plant defense responses arise from the 
activation of signal transduction pathways that lead to global transcriptional 
reprogramming (Dangl and Jones 2001; Durrant and Dong 2004). Among the induced 
genes figure pathogenesis-related (PR) genes which are activated both at the site of 
infection and in uninfected parts of the plant in response to the pathogen-induced 
accumulation of salicylic acid (SA) (Ryals et al., 1996). Local and distal SA 
accumulations are mandatory for the deployment of a systemic long-lasting and broad-
spectrum plant disease resistance response called systemic acquired resistance (SAR) 
(Durrant and Dong 2004; Pieterse and Van Loon 2004; Ryals et aI., 1996). Exogenous 
application of SA, or SA analogs, including 2,6-dichloroisonicotinic acid (INA) and 
benzothiadiazole (BTH), termed chemical SAR, also triggers PR gene induction and SAR 
deployment (Ward et aI., 1991). 
The NPRI (non-expressor of pathogenesis related g'ene 1) protein is the key 
regulator of SAR (Cao et aI., 1994; Delaney et al., 1995). In resting cells of wild-type 
Arabidopsis, NPRI is found in both the cytoplasm and the nucleus (Despres et aI., 2000). 
However, in an nprl-l mutant line of Arabidopsis overexpressing an NPRl:GFP fusion 
protein, the NPRI fusion is sequestered in the cytoplasm and only localizes to the nucleus 
after INA treatment (Kinkema et aI., 2000). The cytoplasmic NPRl:GFP fusion protein is 
contained within an oligomer complex held together by intermolecular disulfide bonds 
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(Mou et aI., 2003). Upon INA treatment, Cys82 and Cys216 in NPR1 are presumably 
reduced and NPR 1 :GFP is released from this complex, resulting in accumulation of 
protein monomers inside the nucleus (Mou et aI., 2003). 
Activation of PR genes during SAR, which requires the nuclear localization of 
NPR1 (Kinkema et aI., 2000), is also dependent on a functionally redundant clade of 
three basic leucine zipper TGA transcription factors (TFs), TGA2, TGA5, and TGA6, 
that interact with NPR1 (Despres et aI., 2000; Zhang et aI., 1999). A triple knock-out of 
these TGA genes abolished PRJ induction by INA, indicating that the gene products 
could act as transcriptional activators (Zhang et aI., 2003). This conclusion is supported 
by a report in which a chimeric TGA2-GAL4:DB protein was used to study gene 
regulation and proposed to act as a transcriptional activator (Fan and Dong 2(02). 
However, in a finding that appears to be contradictory to the previous one, Zhang et aI., 
(2003) showed that whether unstimulated or INA-treated, the triply knocked-out plants 
displayed higher levels of PRJ (when compared to levels found in wild-type without 
INA), which could indicate that the proteins of the TGA2-containing clade act as 
repressors of PRJ, presumably by binding to its promoter (Zhang et aI., 2003). 
Furthermore, chromatin immunoprecipitation (ChIP) experiments have demonstrated that 
l 
TGA2 physically interacts with the PRJ promoter in an SA- and NPRl- dependent 
manner (Johnson et aI., 2003), which would also contradict the hypothesis that TGA2 
binds to the PRJ promoter in the absence of SA (Zhang et al., 2003). It is thus not clear 
whether TGA2 is a transcriptional activator or a repressor. PRJ is also positively 
regulated in an SA-dependent, but NPRI-independent fashion by the transcription factor 
AtWhyl (Desveaux et aI., 2004). Furthermore, PRJ is negatively regulated by 
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SUPPRESSOR OF NPRI INDUCIBLEI (SNI1; Li et al., 1999) and ChIP experiments 
have shown an increase in histone H3 acetylation and methylation at the PRJ promoter in 
sniJ mutant plants (Mosher et aI., 2006). These data implicate chromatin structure in the 
regulation of PRJ expression. 
NPRI and TGA TFs (TGAI and TGA2) show a direct physical interaction within 
the nucleus and in vitro (Despres et aI., 2003; Fan and Dong 2002; Subramaniam et al., 
2001). This interaction stimulates the DNA-binding activity of TGA TFs to their cognate 
cis-acting element in vitro (Despres et al., 2000; Despres et aI., 2003) and in vivo (Fan 
and Dong 2002). However, despite the fact that NPRI and TGA2 can form a ternary 
complex on DNA (DNA-TGA2-NPRI complex) in yeast (Weigel et aI., 2005), it is 
unclear whether, when inside a plant nucleus, they will only interact in the nucleoplasm 
or whether they will form such a ternary complex. To date, there is no experimental 
evidence indicating that NPRI is actually recruited to the PRJ gene in vivo. Therefore, 
aside from its DNA-binding enhancement activity on TGA TFs, the biochemical role of 
NPRI in NPRI-TGA complexes, if any, remains speculative. 
NPRI contains two protein-protein interaction motifs: ankyrin repeats (Cao et aI., 
1997; Mosavi et aI., 2004; Ryals et aI., 1997) and a BTBIPOZ (Broad-Complex, 
I 
Tramtrack, and Bric-a-braclPox virus and Zinc finger) domain (Aravind and Koonin 
1999; Bardwell and Treisman 1994). The ankyrin repeats mediate interactions with TGA 
TFs and their mutation abolishes NPRI-TGA complex formation, PR gene expression, 
and SAR (Cao et aI., 1997; Despres et al., 2000; Despres et aI., 2003; Ryals et al., 1997; 
Zhang et al., 1999). The functional requirements of the NPRI BTBIPOZ in disease 
resistance are not yet understood. 
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Here, we demonstrate that TGA2 is not a transcriptional activator in resting or 
SA-treated cells, as it is unable to activate transcription when expressed on its own. We 
show that TGA2 and NPRI can, independently of one another, physically interact with 
the PRJ promoter in both resting and SA-treated cells. We also show that NPRI contains 
an autonomous transactivation domain in its C-terminus and acts as a co-activator in SA-
treated cells where it associates with TGA2 to create a transcriptional activating complex. 
NPRI and TGA2 are sufficient to activate gene expression after stimulation of the cells 
with SA and thus the DNA-TGA2-NPRl ternary complex constitutes an SA-dependent 
enhanceosome. We demonstrate that the co-activator function of NPRI requires the 
presence of the BTBIPOZ core and the oxidation of Cys521 and Cys529, located in the 
transactivation domain of NPRI. Finally, using an in vivo labeling technique capable of 
distinguishing between reduced and oxidized cysteines, we determined that Cys521 and 
Cys529 are oxidized in both resting and SA-treated cells. The data presented here provide 
a mechanistic understanding of transcriptional regulation mediated by the TGA2-NPRl 
complex. Additionally, they help to elucidate the biochemical function of TGA2, a 
repressor of NPRI-mediated de-repression, NPRl, a co-activator, and to unravel the 
existence of a new type of eukaryotic transactivation domain that we term: cysteine-
J. 
oxidized transactivation domain. 
3.3 METHODS AND MATERIALS 
3.3.1 Chemicals 
All consumables were purchased from Sigma CSt. Louis, MO) unless otherwise stated. 
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3.3.2 Bacterial Strains and General Cloning Vectors 
The E. coli strain DH12S (GIBCO-BRL, Grand Island, NY) was used for plasmid 
maintenance and production. Cloning plasmids used were pBC SK( +) (Stratagene, La 
Jolla, CA) and pCR2.1 (Invitrogen, Carlsbad, CA). Large-scale plasmid purification was 
performed using Endo-Free GigaPrep Kits (Qiagen, Mississauga, ON). All constructs 
used were verified by sequencing. 
3.3.3 Plasmid Constructs for Transactivation Assays 
The GAIA DB, from the yeast two-hybrid vector pBI880, the VP J6 TA (provided by 
Brian Miki, Agriculture and Agri-Food Canada, Ottawa, Ontario, Canada), and the 
Renilla luciferase from plasmid pRL-null (Promega, Madison, WI) were amplified by 
PCR using appropriate primers and ligated into the expression vector pBI524 (Datla et 
aI., 1993) containing a modified double Cauliflower mosaic virus 35S promoter with the 
Alfalfa mosaic virus translational enhancer. The coding sequence for all genes tested 
were amplified by PCR using gene specific primers and ligated into pBI524 containing 
GAIA DB or VPJ6 TA in the appropriate reading frame to permit the expression of N-
terminal fusion proteins. The unfused versions (i.e. no DB or TA) were cloned into 
i 
pBI524 lacking the GAL4DB or VP16 TA. The 5X UASGAIA:luciferase reporter 
construct was provided by Masaru Ohme-Takagi National Institute of Advanced 
Industrial Science and Technology (Tsukuba, Japan; Fujimoto et al., 2000). To create the 
PRJ promoter-Iuciferase reporter gene fusion, the -1293 promoter fragment (Lebel et aI., 
1998) was amplified by PCR and used to substitute the 5X UASGAIA fragment in the 
luciferase-nopaline synthase (nos) polyadenylation signal reporter plasmid. To create the 
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LexA activated synthetic promoter, the double stranded binding domain for LexA, 
created as two single stranded oligomers annealed together with appropriate restriction 
enzyme overhangs, was ligated into the 5X UASGAIA:luciferase reporter construct such 
that 2 of the VAS of Gal4 were removed. Spacing between the Gal4 VAS, the LexA 
binding domain and the TAT A box are depicted in Supplemental Figure 1 A and were 
decided based on results from Tiwari et al. (2004). The DNA binding domain of LexA 
was ligated into pBI524 containing VP 16 TA in the appropriate reading frame to permit 
the expression of an N-terminal fusion protein. 
3.3.4 ChIP of NPRI and TGA2 
ChIP was performed as was described previously (Chakravarthy et aI., 2003). Briefly, 2g 
of Arabidopsis thaliana was fixed in a 1 % formaldehyde solution for 30 minutes at room 
temperature (RT) with stirring. The fixed tissue was washed 3X and dried before being 
ground in an equal volume of IP buffer (0.1 % SDS, 1 % Triton X-100, 50mM HEPES pH 
7.9, 150mM NaCI, 1mM EDTA) plus lOX protease inhibitor cocktail (P2714) and 
centrifuged to remove leaf debris. The supernatant (SN) was sonicated (Sonic 
Dismembrator Model 100; Fisher Scientific, Ottawa, ON) at level 10 for 6 x 15 seconds 
of continuous blasts with 15 second rests on ice in between tb shear DNA. The samples 
was then filtered through a PVDF filter (09-720-3, Fisher Scientific, Ottawa, ON) 
adapted to a 3mL syringe pre-packed with glass wool. The specificity of the anti-NPRI 
antibody has been demonstrated (Despres et aI., 2000) and the anti-His antibody for 
TGA2 was from Santa Cruz Biotechnology (sc-803 AC). Antibody-coupled Protein A 
agarose beads (153-6153; Affi-gel Protein A Gel, Bio-Rad, Mississauga, ON) were 
incubated with the fixed tissue overnight at 4°C on a rotating wheel (Roto-torque, Cole-
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palmer instrument company, Montreal, QC). The crosslinking was then reversed and the 
DNA eluted, precipitated and subjected to PCR. The PCR primer pair specific to the PRI 
promoter was as follows: 59-ATGGGTGATCTATTGACTGTTT-39 and 59-
GTAGCTTTGCCATTGTTGAT-39. To confirm that the PCR product generated was 
indeed a fragment of the PRI promoter, it was gel excised, cloned, and sequenced. 
3.3.5 Plant Growth Conditions and Transformation 
Conditions for growth of Arabidopsis thaliana (Columbia) and nprl-3 (Cao et aI., 1997) 
and methods for plant transformation, the selection of transgenic individuals and northern 
blot hybridization were previously described (Liu et aI., 1995). 
3.3.6 Plant Two-Hybrid Assays 
Arabidopsis thaliana (Columbia) leaves were harvested from four week old plants grown 
at 21°C (day) and 18°C (night) with a ten hour photoperiod and placed on a medium 
containing MS salts and micronutrients supplemented with B5 vitamins, 1 % sucrose and 
0.8% agar at a pH of 5.8. Two leaves were transformed per bombardment. Bombardment 
and sample processing were as described by Fujimoto et ai. (2000). Briefly,sample 
preparation for bombardments consisted of one microcentrifuge tube containing enough 
;. 
DNA-gold mixture for 5 bombardments. With continuous vortexing, 44.4J..lL of 60mg/mL 
1.0 micron gold (165 2263, Bio-Rad, Mississauga, ON) was mixed with 13J..lL of DNA 
consisting of the reporter gene, internal standard and the vector(s) for the protein or 
protein pair being tested. DNA was then precipitated onto the gold particles with 42J..lL of 
3M CaCh and 20llL of O.IM spermidine. The DNA-gold mixture was then washed once 
with 70% and 100% EtOH before being resuspended in 48J..lL of 100% EtOH. 8J..lL of 
51 
DNA-gold mixture was pipeted for each bombardment on macrocarriers (165 2335; Bio-
Rad, Mississauga, ON) and allowed to dry. The Model PDS-10001He Biolistic® Particle 
Delivery System (165 2257; Bio-Rad, Mississauga, ON) was used to deliver the DNA-
gold mixture to the Arabidopsis leaves. Rupture disks (1562329; Bio-Rad, Mississauga, 
ON) of 1100psi were used in combination with ultra high purity (5.0) helium at 1500psi. 
When required, filter-sterilized salicylic acid was sprayed on the leaves at a concentration 
of 1mM for the indicated length of time. Leaves were left for a period of 24 hours before 
being assayed. The assay was performed using the Dual-Luciferase® Reporter Assay 
system (PRE 1960; Fisher Scientific, Ottawa, ON) following the manufacturers 
instructions. Fluorescence was measured as photon emission (EG and G Berthold Lumat 
LB9507 Luminometer, Bad Wildbad, Germany) and the value obtained represents the 
value of the reporter gene divided by the value of the internal standard (as relative 
luciferase units). Every bar in each graph represents five bombardments repeated five 
times (n = 25). 
3.3.7 Yeast Two-Hybrid Assays 
Plasmids pBI880 (DB) and pBI881 (TA) (Kohalmi et ai., 1997) in conjunction with the 
yeast strain YPB2 of Saccharomyces cerevisiae were used throughout this study. Yeast 
cells were transformed using S.c. EasyCompTM Transformation Kit (K505001; 
Invitrogen, Carlsbad, CA) and grown on synthetic dextrose using the appropriate amino 
acid drop-out(s). Yeast cells were co-transformed with the modified DB and TA plasmids 
and selected for on synthetic dextrose without leucine or tryptophan for protein-protein 
interaction assays. Either the activity of the lacZ reporter gene was monitored visually by 
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using the X-gal filter assay or ~-galactosidase activity was determined 
spectrophotometric all y. 
3.3.8 Molecular modeling and Wirplot diagram 
The model of the NPRI BTBIPOZ domain was generated through comparative modeling 
by submitting the entire NPR 1 amino acid sequence to the automated approach of the 
3DJIGSAW v.2.0 modeling server (http://www.bmm.icnet.uk/servers/3djigsaw). The 
server's domain fishing module (Contreras-Moreira and Bates, 2002) initially identified 
the presence of a BTB/POZ domain spanning residues 36-190 of NPRI. The crystal 
structure of the PLZF BTBIPOZ domain (PDB accession code: lCS3) was then used as a 
template to construct a preliminary model for the corresponding NPRI domain. To 
alleviate an unrealistic steric interference and generate the final model, a portion of L2 
(residues 96 to 112) was refined using Quanta v.4.1 followed by energy minimization 
with the CHARMM force field v.27.1 (Accelrys, San Diego, CA) (Brooks et al, 1983). 
Images of the models were generated with the POV-Ray module (http://www.povray.org) 
of the Swiss-Pdb Viewer v3.7SP5 (Geux and Peitsch, 1997). The two-dimensional 
secondary structure diagram was generated using the WIRPLOT module of the 
PROCHECK program v.3.4.5 (Laskowski et al, 1993) and l the colors of the resulting 
postscript file were edited using Ghostscript v.5.50 and visualized using GSview v.2.6. 
3.3.9 In vivo determination of the Cys Redox Status of NPRIL1513 
Due to very low amounts of proteins in the biolistics assays, 80 bombardments were 
performed with the il513:TA constructs. After a 24-hr incubation period with or without 
SA, proteins were extracted from Arabidopsis leaves, separated into two aliquots and 
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processed immediately and in parallel. For detection of reduced cysteines, one aliquot 
was treated with 0.2mM of 3-(N-maleimido-propionyl) biocytin (MPB) for one hour in 
the dark at room temperature. Proteins were then precipitated four times with acetone. 
For detection of oxidized cysteines, the second aliquot was first treated with 20mM of N-
ethylmaleimide (NEM) for one hour, precipitated with acetone and then treated with 
20mM dithiothreitol (DIT) for one hour. After another acetone precipitation, proteins 
were treated with 0.2mM of MPB for one hour in the dark at room temperature followed 
by two acetone precipitations. 
3.3.10 1mmunoprecipitation and Detection of Modified Cysteines in NPR1Li513 
The cysteine-labeled proteins were incubated for 16 hours at 4°C with anti-VPl6 
antibody (sc7545 AC, Santa Cruz Biotechnology, CA) coupled to protein A-sepharose 
beads (Bio-Rad, Mississauga, ON). The VP16 does not contain any cysteines. The beads 
were subsequently washed three times in IP buffer and the proteins were eluted by 
boiling in 2X sample buffer (0.12M Tris-CI pH 6.8, 4% SDS, 20% glycerol, 0.05% 
bromophenol blue, 10% 2-mercaptoethanol). The supernatant was electrophoresed on an 
8% sodium dodecyl sulfate polyacrylamide gel. The proteins were transferred to 
nitrocellulose and reacted according to the manufacturer's in~ruction (LI-COR, Lincoln, 
NE) with a strepavidin:Alexa fluor 680 (Molecular Probes, Eugene, OR) conjugate and 
detected by infrared imaging using an Odyssey imager (LI-COR, Lincoln, NE). 
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3.3.11 Statistical Methods 
All pooled data are expressed as averages, and error bars represent SD. When data from 
two independent populations are compared, statistical significance was assessed using a 
two-tailed Student's t test. 
3.4 RESULTS 
3.4.1 Recruitment ofTGA2 to the PR1 Promoter is Both SA- and NPR1-
Independent 
SA-induction of the PRJ gene is positively controlled by a clade of three TGA TFs 
(TGA2, 5 and 6) with redundant functions. In the triple TGA knock-out plants, the levels 
of PRJ transcripts were up to 50-fold higher, when compared to non-stimulated wild-type 
plants (Zhang et aI., 2003). This was interpreted as a loss of TGA factor binding to a 
negative element in the PRJ promoter; however, whether this effect was due to direct 
binding of the TGA TFs to DNA was not addressed. If the interpretation of Zhang et al. 
(2003) is correct, their results would contradict those of Johnson et ai. (2003), who 
demonstrated using ChIPs that recruitment of TGA2 to the PRJ promoter is both SA- and 
NPRI-dependent. These ChIPs were performed on endogenous TGA2 using an anti-
TGA2 antibody raised against the N-terminus. However, sin~e ChIPs can generate false 
negatives when epitopes are inaccessible, we sought to determine whether the apparent 
lack of interaction between TGA2 and the PRJ promoter in resting cells observed by 
Johnson et ai. (2003) is due to the absence of antibody recognition, to masking of the 
epitope or to the absence of TGA2. 
As a means of generating an alternative epitope, the TGA2 coding region was 
ligated to a 6-histidine tag (His) and the resulting fusion (TGA2:His), under the control of 
55 
the CaMV35S promoter, was introduced into the tga2/5/6 knock-out plants. Figure lA is 
a diagram of the PRJ gene which shows the position of the PCR primers used for all the 
ChIP experiments. Figure IB shows that a PCR product is present in the lanes 
corresponding to immunoprecipitations performed with the anti-His antibody (lanes 3 and 
7), indicating that TGA2:His interacted with PRJ in both untreated and SA-treated cells. 
hnmunoprecipitation with pre-immune serum (PI) did not lead to a detectable band (lanes 
2 and 6). ChIP performed with the anti-His antibody on the untransformed tga2/5/6 
mutant plant also did not lead to a detectable band (data not shown). The right section of 
panel B shows the results for a northern blot analysis of PRJ indicating that TGA2:His 
restored PRJ inducibility in the tga2/5/6 mutant in an SA-dependent fashion and that 
expression of PRJ is not constitutive in these plants. 
The above results indicate that the lack of interaction previously reported by 
Johnson et aI. (2003) in the absence of SA might have been due to the masking, under 
certain conditions, of the N-terminal TGA2 epitope chosen by these authors. Therefore, it 
became relevant to test whether the same phenomenon was responsible for the lack of 
interaction reported between TGA2 and PRJ in the nprJ background (Johnson et aI., 
2003). To do so, TGA2:His, under the control of the CaMV35S promoter, was introduced 
l 
in the nprl-3 mutant background and ChIPs were performed using the anti-His antibody. 
Results of Figure 1 C show the presence of a PCR product in the lanes corresponding to 
immunoprecipitations performed with the anti-His antibody (lanes 3 and 7). This 
indicates that, in the absence of NPRl, TGA2:His interacted with PRJ in both untreated 
and SA-treated cells. Immunoprecipitation with PI did not lead to a detectable band 
(lanes 2 and 6). ChIP performed with the anti-His antibody on the untransformed nprJ-3 
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Figure 1. NPRI Is a Co-Activator Required for Transcriptional Activation by a 
TGA2-NPRI Complex in SA-Treated Cells Only.NPRl Is 1: Co-Activator Required 
for Transcriptional Activation by a TGA2-NPRI Complex in SA-Treated Cells 
RNA 
(A) Graphic representation of the PRJ gene. The straight arrows and the numbers indicate 
the position of the PCR primers used for ChIP experiments. LS5 and LS7 are two DNA 
regions containing the TGA factors cognate binding sequence TGACG (Lebel et aI., 
1998). 
(B) Chromatin hnmunoprecipitations of TGA2:His expressed in tga2/5/6 knock-out 
plants. The right section of this panel is a northern blot illustrating that the TGA2:His 
protein complemented the tga2/5/6 mutation and restored PRJ inducibility. 
(C) Chromatin Immunoprecipitations of TGA2:His expressed in nprJ-3 mutant (nprl-3) 
Arabidopsis plants. The right section of this panel is a northern blot illustrating that the 
TGA2:His protein expressed in the nprJ-3 mutation did not bring about expression of 
PRJ whether tissues were treated or not with SA. Northern blot from wild-type plants 
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(WT) treated with SA is shown for comparison. For (B) and (C), ChIPs were conducted 
with anti-His antibodies conjugated to agarose beads. 
(D) Chromatin Immunoprecipitations of NPR1 from wild-type (NPR1) and nprJ-3 
mutant (nprl-3). The right section ofthis panel is a northern blot illustrating that the PRJ 
gene is not expressed in the npr J-3 mutant and expression in the wild-type plant (WT) is 
dependent upon SA treatment. 
(E) Chromatin Immunoprecipitations of NPR1 from the tga2/5/6 knock-out Arabidopsis 
plants. The right section of this panel is a northern blot illustrating that the PRJ gene is 
not expressed in the tga2/5/6 mutant whether or not tissues have been treated with SA. A 
northern blot from wild-type plants (WT) treated with SA is shown for comparison. For 
(D) and (E), ChIPs were conducted with anti-NPR1 antibodies for which the specificity 
has been demonstrated previously (Despres ate aI., 2000). 
In (B), (C), (D), and (E) tissues were untreated (No SA) or treated for 6 hr with 1mM SA. 
PI indicates that ChIP was performed with pre-immune serum. PCR was conducted with 
PRJ promoter-specific primers. The arrow indicates the location of the PCR products. 
The NPRl-3 protein is a deletion version of NPR1 (Cao et aI., 1997), which has lost the 
antigenic region used to raise the anti-NPR1 antibodies used in this study. The inputs 
represent 2% of the immunoprecipitated material (50-fold dilution). 3X or 5X indicate 
that the PCR reaction was performed with 3 or 5 times the amount of immunoprecipitated 
material, respectively, to demonstrate that the PCR reaction was in the linear range. In 
lanes 13 and 14 of panel (D), 1110 of the amount of immunoprecipitated material used in 
lanes 6 and 12, respectively, was used to perform the PCR to demonstrate that the PCR 
reaction was in the linear range. The right sections of these panels are northern blots 
using PRJ probes. RNA stained with ethidium bromide is shown for loading comparison. 
(F) Histograms illustrating the fact that TGA2 tethered to DNA through Gal4 DB fused 
to the N-terminal (TGA2:DB) or C-terminal (TGA2:DB-Ct) does not activate 
transcription, while a chimeric transcription activator composed of the Ga14 DB fused to 
the transactivation domain of viral protein 16 (Ga14 DB:VP16 TA) does. Gal4 DB 
represents the baseline level of transcription. 
(G) Histograms illustrating the transcription activation of NPRI tethered to DNA through 
Gal4 DB (NPRl:DB). NPR1 indicates the absence of fusion. (-) indicates that only the 
reporter and internal standard vectors have been bombarded into the tissues; no effector 
has been introduced. 
(H) Histograms illustrating the effect of NPRI on the Aranscriptional activity of 
TGA2:DB. NPRI indicates that the protein is expressed without a fusion. 
(I) Histograms illustrating the fact that TGA2 tethered to DNA through Gal4 DB 
(TGA2:DB) interacts very poorly with NPRl :TA in the absence of SA-treatment. 
In (F), (G), (H), and (I) Arabidopsis leaves were left untreated (white bars) or were 
treated for 24 hr with ImM salicylic acid (grey bars). The constructs were transfected 
along with the 5X UAsGAlA:Firefly luciferase reporter and the CaMV35S:Renilla 
luciferase internal standard vectors. Data are reported as Relative Luciferase Units. The 
fold-activation represents the Relative Luciferase Units (RLU) obtained with the given 
protein or protein pair divided by the RLU obtained with the unfused Gal4 DB construct 
alone (baseline transcription). Values consist of n = 25 samples and represent averages ± 
1 SD. Every bar represents five bombardments repeated five times (n = 25). 
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(J) Histogram illustrating the effect of NPR1, and niml-2 on the transcriptional activity 
of the TGA2-NPR1 complex. All proteins were native (without fusion), with the 
exception of NPR1:TA (NPR1 fused to the viral protein 16 transactivation domain), 
which was used to assess the level of interaction between NPR1 and TGA2 in the context 
of the PRJ promoter. The reporter system was the Arabidopsis PRJ promoter fused to the 
firefly luciferase. The CaMV35S promoter:Renilla luciferase fusion was used as an 
internal standard. (-) indicates that no effector were bombarded along with the reporter 
and internal standard vectors. Cruciferin is an Arabidopsis storage protein used here to 
illustrate the background level of this system when expressing an unrelated protein. Gal4 
DB served the same purpose. Arabidopsis leaves were left untreated (white bars) or were 
treated for 24 hr with 1mM salicylic acid (grey bars). Data are reported as Relative 
Luciferase Units. Values consist of n = 25 samples and represent averages ± 1 SD. Every 
bar represents five bombardments repeated five times (n = 25). 
mutant plant did not lead to a detectable band (data not shown). As indicated by northern 
blot analysis (right section of panel C), expression of TGA2:His in the nprl-3 mutant 
background did not lead to expression of PRJ, whether or not cells were subjected to SA-
treatment. 
3.4.2 Recruitment of NPRJ to the PRJ Promoter is both SA- and TGA2/5/6-
Independent 
Since no experimental evidence exists to indicate that NPR 1 can be recruited to 
the PRJ promoter, it is unclear whether NPR1 is capable of forming a complex with 
TGA2 on DNA to modulate transcription. To address this question, we performed ChIP 
experiments with wild-type and nprJ-3 mutant Arabidopsis plants, before and after SA-
treatment (Figure 1D). The npr J-3 mutant was chosen as a negative control since this 
allele carries a premature stop codon (Cao et aI., 1997), which removes the amino acid 
region used to raise the anti-NPR1 antibody (Despres et al., 2000). The specificity of the 
anti-NPR1 antibody has been demonstrated previously (Despres et al., 2000) and can also 
be witnessed in Figure 2C, where a band corresponding to NPR1 was detected in the 
wild-type plant (lane 1) but not in the nprJ-3 mutant plant (lane 2). With the exception of 
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input lanes (lanes 1 and 7), ChIP performed on the nprJ-3 lines did not yield a band, 
regardless of whether cells were treated with SA or whether the immunoprecipitation 
antibodies were from PI or raised against NPRl. Conversely, ChIP performed on wild-
type plants indicated that NPR1 interacted with PRJ in both untreated cells and cells 
treated with SA (lanes 6 and 12). Immunoprecipitation with PI did not lead to a 
detectable band (lanes 5 and 11). Northern blot analysis (right section of panel D) 
confirmed that PRJ was not expressed in the nprJ-3 mutant nor was it induced in the 
wild-type plant prior to SA treatment. 
Intuitively, knowing that NPR1 and TGA2 can interact with each other and 
because NPRI does not contain a known DNA-binding domain, one could expect the 
recruitment of NPR1 to the PRJ promoter to be dependent on TGA2. To test this 
hypothesis, we performed ChIP experiments on the tga2/5/6 mutant plant using the anti-
NPR1 antibody. The presence of a PCR product in the lanes corresponding to 
immunoprecipitations performed with the anti-NPR1 antibody (Figure IE, lanes 3 and 7) 
indicate that NPRI continues to interact with PRJ in the absence of TGA2/5/6, in both 
untreated and SA-treated cells. Immunoprecipitation with PI did not lead to a detectable 
band (lanes 2 and 6). Note that formaldehyde, the cross-linker used in the ChIP 
J. 
experiments, can cross-link protein to DNA but also protein to protein (Buck and Lieb, 
2004). Hence, recruitment of NPRI to the PRJ promoter does not indicate that NPRI 
binds directly to DNA. The northern blot shown in the right section of panel E confirmed 
that PRJ was not expressed in the tga2/5/6 mutant whether or not cells were subjected to 
an SA-treatment. 
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3.4.3 NPRI Is a Co-Activator Required for Transcriptional Activation by a 
TGA2-NPRI Complex in SA-Treated Cells Only 
PRI is positively regulated by NPRI (Cao et al., 1997; Ryals et al., 1997) and by 
TGA2/5/6 (Zhang et al. 2003). This prompted us to test whether TGA2 can act as a 
transcriptional activator. To do so, TGA2:DB (N-terminal fusion) and TGA2:DB-Ct (C-
terminal fusion) were assayed using an in vivo plant transcription assay (Figure IF). The 
baseline level of transcription was determined by transfecting leaves with Gal4 DB (not 
fused to any other protein or protein domain) along with a reporter construct consisting of 
a firefly luciferase gene under the control of 5 copies of the Gal4 upstream activating 
sequences (UAS) fused to a minimal promoter. Transfection with TGA2:DB or 
TGA2:DB-Ct did not result in reporter gene activation beyond the baseline level, 
regardless of whether cells were treated with SA or not. The same result was obtained 
with TGA2 that was not fused to Gal4 DB or any other foreign protein domain (TGA2). 
Transfection with Ga14 DB fused to a strong transactivation domain (Gal4 DB:VPI6 TA) 
led to SA-independent expression of the reporter gene well above the baseline (Figure IF, 
white versus grey bars). These results demonstrate that the reporter gene can indeed be 
activated under our experimental conditions and indicate that TGA2 is not a 
l 
transcriptional activator, whether or not cells are stimulated with SA. Indeed, we have 
found that TGA2 is capable of repressing an activated reporter gene prior to and after SA 
treatment (Supplemental Figure 1). In this system, we used a 3X Ga14:1X LexA:minimal 
promoter:Firefly luciferase reporter gene which acts as an activated system where 
repression can be tested. The LexA binding domain present in the promoter is bound by 
the LexA protein fused to the VP16 transactivation domain and results in reporter gene 
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expression (Supplemental Figure 1, Gal4DB + LexAVP16 white and grey bars). The 
empty Gal4DB binds the 3X VAS in this instance but has no affect on reporter gene 
expression. However, when TGA2 is fused to the Gal4DB in the presence of LexAVPI6, 
reporter gene activation is decreased (Supplemental Figure 1, compare Gal4DB + 
LexAVP16 to TGA2:DB + LexAVPI6, white and grey bars, p<O.05), indicating that 
TGA2 is not a transcriptional activator but a repressor. 
Knowing that NPRI can be recruited to a promoter in vivo (Figure ID and E), we 
tested if NPRI can activate transcription when tethered to DNA. To accomplish this, 
NPRI was fused to Gal4 DB (NPR1:DB) and assayed using the in vivo plant transcription 
assay (Figure IG). In untreated cells (white bars), NPR1:DB did not lead to gene 
activation beyond the baseline level. However, after SA treatment (grey bars), NPR1:DB 
activated transcription 2.2-fold above the baseline level. Expression of NPRI without 
fusion to Gal4 DB (NPR1) did not lead to gene activation that was significantly different 
from the baseline level (p<O.05), indicating that transactivation by NPR1:DB observed 
with SA was dependent on the recruitment of NPRI to the promoter. The results indicate 
that NPRI could potentially act as a transcriptional co-activator if recruited to a promoter 
via a DNA-binding protein, such as TGA2. 
We next addressed whether NPRI could modulate the transcriptional properties of 
TGA2. When TGA2:DB was co-expressed with NPRI (not fused to any foreign 
transactivation or DNA-binding domain), expression of the reporter gene in untreated 
cells did not increase beyond the baseline (Figure IH, white bars). However, transcription 
rose 2.6-fold above the baseline level after SA treatment (Figure IH, grey bars). Since 
neither TGA2:DB nor NPRI activate transcription of the reporter gene on their own 
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(Figure IF and IG) and NPRI stimulates transcription when tethered to DNA (Figure IG, 
NPRl:DB), results from Figure IH suggest that the transcriptional activation observed 
when NPRI (unfused) is co-expressed with TGA2:DB is likely due to NPRI being 
tethered, or recruited, to the DNA through TGA2:DB. Physical interaction between 
TGA2 and NPRI at the reporter gene promoter and in the presence of SA was 
demonstrated using plant two-hybrid assays (Figure 11, TGA2:DB + NPRl:TA). 
Together, these observations are consistent with the formation of a ternary complex 
between DNA, TGA2:DB and NPRl, with NPRI acting as a co-activator ofTGA2 on the 
Gal4-based promoter. 
U sing plant two-hybrid assays (Figure 11), we showed that, in the absence of SA 
(white bars), NPRI fused to VP16 TA (NPRl:TA) also interacted with TGA2:DB 
(significant difference p<0.05 between TGA2:DB and TGA2:DB + NPRl:TA), but very 
poorly. A similar conclusion was reached based on data from a protein fragment 
complementation assay (Subramaniam et aI., 2001). Thus, in addition to the fact that 
NPRl:DB (tethered to DNA) does not transactivate in the absence of SA, the very weak 
interaction between NPRl:TA and TGA2:DB in unstimulated cells may also account for 
the lack of transcriptional stimulation by NPRI. We also confirmed that, in the absence 
l 
of SA, NPRl:TA is competent to interact with other proteins as demonstrated by its 
interaction with a mutant version of TGAI (Figure 11, TGAlm:DB), which was 
previously shown to interact with NPRI in the presence and absence of SA-treatment 
(Despres et aI., 2003). 
Next, we tested the transactivation properties of NPRI and TGA2 in the context 
of the PRJ promoter. DNA coding for native (unfused) proteins were delivered by 
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biolistics as in Figure 1 F-U, except that the reporter consisted of the luciferase gene 
under the control of the PRJ promoter (Figure lJ). Relatively low levels of luciferase 
activity were detected following transfection of this reporter gene without effector 
plasmids (-). Since only 20 to 100 cells are effectively transfected under our transient 
assay conditions and because of the very low endogenous amount of NPRI and TGA2 
protein, modulation of the transiently delivered PRJ reporter gene by SA is below 
baseline level. Transfection of two unrelated effectors, Gal4 DB, which does not bind 
PRJ (there is no Gal4 binding site in the PRJ promoter), and the seed storage protein 
Cruciferin, increased reporter gene expression, which most likely represents the 
unspecific effect of expressing a protein in this system. Thus, expression levels observed 
with these proteins represent the baseline of this system. Whether cells were treated (grey 
bars) or not (white bars) with SA, NPRlied to activation of the PRJ promoter beyond the 
baseline level. TGA2, on the other hand, had no effect on the baseline activity of the 
promoter. However, in untreated cells (white bars), when NPRI was co-expressed with 
TGA2, transcription values were brought back down to the baseline level, indicating that 
TGA2 repressed the NPRI-dependent activation of PRJ. As observed with NPRl, the 
protein niml-2, a variant of NPRI with a mutation in an ankyrin repeat that does not 
f 
interact with TGA2 (Despres et aI., 2000; Ryals et al., 1997), also activated the PRJ 
promoter in the absence of TGA2 in untreated and SA-treated cells. This suggests that the 
ankyrin repeats are unlikely to be involved in the recruitment of NPRI to the PRJ 
promoter. Furthermore, since niml-2 does not interact with TGA2, this result is also 
consistent with a TGA2-independent recruitment of NPRI to the PRJ promoter, as was 
observed with ChIPs (Figure IE). Co-expression of niml-2 with TGA2 also restored 
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transcription values to the baseline level. Co-expression of TGA2 and NPR1 in SA-
treated tissues (grey bars) led to activation of PRJ beyond the baseline and significantly 
beyond what was observed with NPR1 alone (p<0.05), confirming that NPR1 acts as a 
TGA2-co-activator on the PRJ promoter. Also, co-expression of TGA2 with NPR1:TA 
established that the two proteins interact on the PRJ promoter; only in the presence of SA 
(grey bars), since values observed with TGA2 + NPR1:TA were significantly higher than 
those obtained with TGA2 + NPR1 (p<0.05) or NPR1:TA alone (p<0.05). Our results 
indicate that, in untreated cells, TGA2 represses the NPR1-dependent activation of PRJ, 
without the two proteins interacting with each other. However, after SA-treatment, the 
two proteins interact to form a ternary complex with PRJ DNA in which NPR1 acts as a 
TGA2-co-acti vator. 
3.4.4 The BTBIPOZ Domain of NPRJ Is Required for PRJ Activation by SA 
To determine the functional importance of the NPR1 BTBIPOZ domain, we 
generated a series of rational mutants based on information available from other model 
systems. Of the four known structural classes of BTB domains (BTB Zinc Finger, Skp1, 
ElonginC, and T1), NPR1 is most similar to those associated with zinc fingers, the so-
called long-form (Stogios et aI., 2005). We thus performed a small scale multiple 
alignment (Figure 2A) of long-form BTB/POZ domains including the one from human 
promyelocytic leukemia zinc finger (PLZF), the archetypical BTBIPOZ domain (see 
Aravind and Koonin, 1999 for a more exhaustive alignment of 79 BTBIPOZ domains 
including that of NPR1). Also shown is a representation of the secondary structure of the 
PLZF BTB/POZ derived from its crystal structure (Ahmad et al., 1998; PDB accession 
code: 1buo). 
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Figure 2. The BTBIPOZ Domain of NPRI Is Required for PRI Induction 
(A) Multiple-alignment of selected BTB/POZ domains. Residues blocked in black are 
conserved among all sequences. Numbers refer to the amino acid position in NPRI. 
Straight arrows and coils indicate the position of beta strands and helices in the PLZF 
crystal structure, respectively. a and TJ indicates a- and 310- helices, respectively and ~ 
refers to ~-strands. The bent arrow indicates the position where the NPRI-deletion 
proteins begin. The horizontal brackets below the amino acid sequence of a2 and a3 
indicate the residues that have been mutated to alanine in the "Alanine-Substitution" 
mutant. C150 bears a C to Y mutation in the nprl -2 mutant, which abolishes interaction 
with TGA2, PR gene activation, and deployment of SAR (Cao et al., 1997; Despres et aI., 
2000; Zhang et al., 1999). NPRl, PLZF, POZ3, and ZF5 are from Genbank accession 
numbers GI:1773295, GI:486933, GI:2291257, and GI:1399185, respectively. The inset 
represents directed yeast two-hybrid assays using the filter test and the outcome of the 
experiments. niml-2 is a mutant version of NPRI that bears a histidine-to-tyrosine 
replacement in one of the ankyrin repeats (Ryals et aI., 1997)/ which abolishes interaction 
with TGA factors (Despres et al., 2000 and 2003). Y (yes), indicates an interaction while 
N (no), indicates an absence of interaction (white color after 24 hr incubation with X-
GAL). 
(B) Northern blot analysis using NPRJ or PRJ probes. RNA stained with ethidium 
bromide is shown for loading comparison. Lane 1 contains RNA from wild-type 
Arabidopsis and lane 2 from the nprl-3 mutant. The remaining lanes contain RNA from 
nprJ-3 lines expressing the following constructs; wild-type NPRI (Lanes 3 and 4), the 
"Alanine-Subsitution" mutant (Lanes 5 and 6), and the deletion mutants ~11O (Lanes 7 
and 8), ~66 (Lanes 9 and 10), ~44 (Lanes 11 and 12), and ~22 (Lanes 13 and 14). Results 
from two independent transgenic lines are shown per construct. Specific line numbers 
follow the construct name. 
66 
(C-D) Top Panel. Immunoblot analysis of proteins from wild-type Arabidopsis (WT), the 
nprl-3 mutant (NPRl-3), and the nprl-3 background lines expressing NPR1, the 
"Alanine-Substitution" mutant and ~110 as described in (B). An anti-NPR1 antibody 
(Despres et aI., 2000) was used. Bottom Panel. Ponceau staining of the membranes 
shown in the top panel. In panel (D), the open arrow indicates the position of the full-
length NPR1 protein (66 kD), while the black arrow indicates that of the truncated 
protein ~11O (54.4 kD). The asterisk points to a protein interacting non-specifically with 
the antibody. 
Since the N-terminal region of the NPR1 BTB/POZ is longer than that of PLZF, we used 
the protein secondary structure prediction PSIPRED (Jones, 1999) and identified a 
potential ~-strand formed by residues 19-22 (FV AT). Deletion of this putative structure 
generated the ~22 mutant (Figure 2A). The next deletion, corresponding to the ~44 
mutant, removed ~1, which has been shown to partially destabilize the PLZF dimer 
(Ahmad et aI., 1998). Deletion mutant ~66 removed all the structural determinants (~1, 
aI, and D65) mandatory for BTB/POZ homodimerization (Ahmad et aI., 1998). The a2 
and a3 helices are buried within the BTBIPOZ and constitute the monomer core of the 
domain (Ahmad et al., 1998). Alanine-substitution of the core in PLZF results in 
disruption of the BTBIPOZ fold (Melnick et aI., 2000). The core region is well conserved 
in NPR1, and of note, the sequence "RSSFF", residues 87-91 of NPR1, is identical to the 
corresponding region in POZ3, and the sequence "HRCVL" .fesidues 80-84, identical to 
the corresponding region in ZF5. Thus, to permit functional testing of the NPR1 
BTBIPOZ core without deleting other elements, the conserved residues in a2 and a3 
were substituted with alanines (Figure 2A, Alanine-Substitution brackets). Finally, since 
~2, ~3, and ~4 form a tertiary structure, an N-terminal deletion aimed at removing the 
core of the BTBIPOZ was created after ~4 but before the next structural element (~11O 
deletion mutant). The five NPR1 variants mutated in the BTB/POZ (~22, ~44, ~66, 
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~110, and the alanine-substitution), all interacted with TGA2 in yeast two-hybrid assays 
(Figure 2A inset). Quantitative yeast two-hybrid assays confirmed that the five NPRI 
mutants interacted with TGA2 however, none of the mutants interacted with TGA2 as 
well as full-length wild-type NPRI (Supplemental Figure 2). 
In order to assess the biological significance of the NPRI BTBIPOZ in controlling 
PRl expression, we created and tested five cDNA constructs encoding the proteins 
depicted in Figure 2A. These were introduced, under the control of the CaMV35S 
promoter, into the nprl-3 genetic background (Figure 2B). As a control, nprl-3 plants 
were transformed with the full-length, wild-type NPRl coding region fused to the 
CaMV35S promoter (NPRl, lanes 3 and 4). Wild-type Arabidopsis (WT) accumulated 
PRl transcripts when treated with 0.5mM SA for 16 hr (lane 1), while nprl-3 plants 
(NPRI-3) did not (lane 2). PRl gene expression was restored in 21 of the 25 independent 
transgenic nprl-3 lines expressing NPRI (lanes 3 and 4, and data not shown), in all 23 
lines expressing ~22 (lanes 13 and 14, and data not shown), in 35 of 38 lines expressing 
~44 (lanes 11 and 12, and data not shown), in 18 of 24 lines expressing ~66 (lanes 9 and 
10 and, data not shown), but in none of the 31 and 40 independent lines expressing the 
alanine-substituted BTB/POZ (lanes 5 and 6, and data not shown) or ~110 (lanes 7 and 8, 
l 
and data not shown), respectively. Figure 2C and D indicate that the ~110 and alanine-
substitution proteins were expressed in these lines. PRl transcripts were not detected in 
any ofthe lines tested in the absence of SA (data not shown). 
Altogether, the results of Figure 2 indicate that although alanine-substitution and 
~110 can interact with TGA2 (Figure 2A, inset and Supplemental Figure 2), their 
expression cannot complement the nprl-3 mutation. This demonstrates that the 
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interaction of NPR1 with TGA2 is in itself not sufficient for biological activity and that 
the core of the NPR1 BTBIPOZ, in the context of the full-length NPR1, is required for 
PRJ induction. 
3.4.5 The NPRI BTBIPOZ Core Is Required for the TGA2-Co-Activator 
Function of NPRI in SA-Treated Cells 
To establish a link between the complementation of PRJ expression and the 
transactivation of the TGA2-NPR1 complex, we determined whether the deletions and 
the alanine-substitution of the NPR1 BTB/POZ affected the capacity of this protein to act 
as a TGA2-co-activator. Deletion of the first 22, 44, or 66 amino acids of NPR1 did not 
substantially affect the capacity of NPR1 to convert TGA2:DB into an activator after 
treatment with SA (Figure 3A). However, deleting the first 110 amino acids or 
substituting the BTB/POZ core with alanines abolished transactivation of the co-
expressed TGA2:DB (Figure 3A). The niml-2 protein, which does not interact with 
TGA2, served as a negative control. In the absence of SA-treatment, none of the mutants 
significantly altered transactivation of TGA2:DB compared to results obtained with full-
length NPR1 (Figure 1F) and, accordingly, data are not shown. We also tested the 
alanine-substitution and ~110 proteins for their capacity to interact with TGA2 in the 
". 
plant two-hybrid system (Figure 3B), which evaluates interaction in the context of the 
promoter. The data indicate that alanine-substitution and ~110 fused to VP16 TA 
interacted with TGA2:DB with no significant differences in the level of interaction 
(p<O.05) when compared to ~22, ~44 and ~66. However, the interaction of these five 
mutant proteins with TGA2 was significantly lower than that observed with wild-type 
NPR1 (p<O.05). These results are consistent with those obtained with quantitative yeast 
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Figure 3. The Core of the NPRI BTBIPOZ Is Required for the TGA2-Dependent 
Co-Activator Function of NPRI in SA-Treated Cells 
(A) Histogram illustrating the effect of NPR1 and the mutants described in Figure 2, on 
the transcriptional activity of the TGA2-NPR1 complex tethered to DNA through Gal4 
DB fused to TGA2. Results obtained with TGA2:DB alone (-) are also shown. 
(B) Histogram illustrating the interaction of NPR1 and the mutants described in (A) fused 
to the VP16 transactivation domain with TGA2 fused to the Gal4 DB. Results obtained 
with Gal4 DB alone (Ga14 DB), Gal4 DB coexpressed with NPR1:TA (Ga14 DB + 
NPR1:TA), and TGA2:DB alone (-) are also shown. For (A) and (B) conditions were 
identical to those described in Figure 1. Data are reported agtl Relative Luciferase Units. 
Values consist of n = 25 samples and represent averages ± 1 SD. Every bar represents 
five bombardments repeated five times (n = 25). 
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two-hybrid assays (Supplemental Figure 2). Together, the findings shown in Figure 3 
indicate that amino acids located between residues 66 and 110 of NPR 1, more precisely 
residues 80 to 84 and/or 87 to 91, which constitute the core of the BTBIPOZ, are required 
for the TGA2-co-activator function of NPRI. 
3.4.6 NPRI Harbors a Cryptic Transactivation Domain in its Last 80 Amino 
Acids 
Given that the core of the NPRI BTBIPOZ is required for transactivation of the 
TGA2-NPRI complex, we sought to determine whether this domain harbors autonomous 
transcriptional regulatory regions. To identify these potential regulatory regions, the 
NPRI BTB/POZ (amino acids 1 to 190) was fused to Gal4 DB (POZ:DB) and assayed 
using the in vivo plant transcription assay (Figure 4A). In the absence (white bars) or 
presence (grey bars) of SA-treatment, POZ:DB and variants, in which the first 22,66, and 
110 amino acids were deleted (LU2POZ:DB, ~66POZ:DB, ~110POZ:DB) or in which 
the core of the BTBIPOZ was replaced with alanines (A-SubPOZ:DB), did not stimulate 
transcription beyond the baseline level (GaI4:DB). One of the most salient features of this 
experiment was the uncovering of a cryptic transactivation domain, revealed when the 
BTBIPOZ was shortened by 44 amino acids at the N-terminus (~44POZ:DB), suggesting 
J' 
that a repressing element is located between amino acids 22 and 44. However, in SA-
treated cells, ~44POZ:DB did not transactivate (Figure 4A; ~44POZ:DB, grey versus 
white bars), indicating that the cryptic trans activation domain does not function when 
cells are induced with SA. Taken together, the results of Figure 4A indicate that the 
BTBIPOZ domain cannot account for the transactivation properties of the full-length 
NPRI tethered to DNA through the Gal4 DB. 
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Figure 4. NPRI Harbors an Autonomous Transactivation Domain in the last 80 
Residues 
(A) Histogram illustrating the transcriptional activity of the NPR1 BTBIPOZ domain, the 
deletion mutants of the BTB/POZ, and the Alanine-Substitution mutant tethered to DNA 
through Gal4 DB. The deletion and the Alanine-Substitution mutants were created 
starting with the NPR1 BTB/POZ domain. BTBPOZ region represents the first 190 
amino acids of NPR 1. 
(B) Schematic representation of NPR1 and the deletions analyzed in panel (C). The 
numbers preceded by L\ indicate the starting amino acid for the particular deletion mutant. 
NLS indicates the nuclear localization signal. Ankyrin represents the region containing 
the ankyrin repeats as defined by Pfam and SMART. Diagram is drawn to scale. 
(C) Histogram illustrating the transcriptional activity of the NPR1 deletion mutants 
described in (B), tethered to DNA through Gal4 DB. For (A) and (C) conditions were 
identical to those described in Figure 1. Data are reported as Relative Luciferase Units. 
Values consist of n = 25 samples and represent averages ± 1 SD. Every bar represents 
five bombardments repeated five times (n = 25). 
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Having determined that the BTB/POZ domain does not harbor an autonomous 
transactivation domain active in SA-stimulated cells (Figure 4A), we set out to identify 
such domains in the C-terminal portion of NPRI. We created additional N-terminal 
deletions of NPRI (Figure 4B); one at amino acid 373, which occurs right after the 
ankyrin repeats as predicted by Pfam (Finn et al., 2006) and SMART (Letunic et al., 
2006); one after residue 463, which is the end point of sequence similarity with 
Drosophila Ankyrin 2 (Genbank accession number: AANI2046.1); one at position 513, 
which corresponds to the beginning of the last stretch of negatively charged and 
hydrophobic residues, a known transactivation domain signature (Cress and Triezenberg 
1991); and finally, one right before the nuclear localization signal (Kinkema et aI., 2000), 
at amino acid 533. These constructs were fused to Gal4 DB and assayed using the in vivo 
plant transcription assay (Figure 4C). In unstimulated cells (Figure 4C, white bars), 
deletion of the first 373 or 463 amino acids of NPRI (~373:DB and ~463:DB), did not 
show gene activation beyond the baseline level. However, further deletion to residue 513 
(~513:DB) , resulted in gene activation 2.2-fold above the baseline level, indicating that a 
repressing region had been deleted, thus exposing a cryptic transactivation domain. 
Extending the deletion to position 533 (~533:DB) reduced gene activity to the baseline 
l 
level, emphasizing the importance of residues 513 to 533 for transactivation. 
In SA-stimulated cells (Figure 4C, grey bars), deletion of the first 373, 463, or 
513 amino acids of NPRI (~373:DB, ~463:DB, or ~513:DB) resulted in gene activation 
1.6-fold above the baseline level. Extending the deletion to position 533 (~533:DB), 
reduced gene activity to the baseline level, again indicating the importance of residues 
513 to 533 for transactivation. The results of Figure 4C demonstrate that, in addition to 
73 
amino acids 22-44 in the BTBIPOZ, NPRI possesses a second repression region, located 
between position 463 and 513 that is also active in unstimulated cells only. Furthermore, 
a transactivation domain, active in uninduced as well as in SA-stimulated cell, requires 
residues located between position 513 and 533. 
3.4.7 Oxidation of NPR1 Cysteines 521 and 529 Is Requiredfor the Activity of 
the Transactivation Domain in SA-Treated Cells only 
Inspection of the region containing the C-terminal transactivation domain of 
NPRI reveals that it contains two cysteine residues (Figure 5A), at position 521 (Cys521) 
and 529 (Cys529). Since cysteines are susceptible to redox modifications and redox 
modifications can affect protein function, we first set out to determine whether Cys521 
and Cys529 were required for the transactivation of the last 80 amino acids of NPRI 
tethered to DNA (~513:DB). Cys521 and Cys529 (the only two NPRI cysteines found in 
~513:DB) were individually mutated to a serine, an amino acid similar to cysteine in size 
and structure, but not reactive to redox modifications. Hence, serine can mimic the 
reduced form of cysteine and preserve the capacity for hydrogen bonding. 
The constructs bearing a mutated cysteine were fused to Gal4 DB and assayed 
using the in vivo plant transcription assay (Figure 5B). In resp-ng cells (Figure 5B, white 
bars), mutation of the cysteine at positions 521 (~513C521S:DB) or 529 
(~513C529S:DB) had no effect on gene activation, with levels similar to ~513:DB (no 
difference, p>0.05), indicating that redox modulation of Cys521 and Cys529 does not 
playa role in transactivation under non-induced conditions. However, in SA-treated 
tissue (Figure 5B, grey bars), ~513C521S:DB and ~513C529S:DB did not lead to gene 
activation beyond the baseline level and values were significantly different from 
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Figure 5. Oxidation of Cys521 and Cys529 Correlates with Transcriptional 
Activation of the PRJ Gene by the TGA2-NPRl Complex. 
(A) Sequence of amino acids located between position 513 and 540. 
(B) Histogram illustrating the transcriptional activity of the ~513 deletion mutant of 
NPRl and the effect of mutating Cys521 or Cys529, within the context of the ~513 
protein. Proteins were tethered to DNA through Gal4 DB. 
(C) Blot analysis ofNPRl~513 immunoprecipitate used to assess the in vivo redox status 
of residues Cys521 and Cys529 present in cells of Arabidopsis leaves treated for 24 hr 
with SA (SA) or left untreated (No SA). Red indicates immunoprecipitates from proteins 
labeled for reduced Cys residues, while Ox indicates immunoprecipitates from proteins 
labeled for oxidized Cys (see Experimental Procedures). 
(D) Histogram illustrating the transcriptional activity of the full-length NPRI and the 
effect of mutating Cys521 or simultaneously Cys521 and Cys529, within the context of 
the full-length NPRI. Proteins were tethered to DNA through Gal4 DB. 
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(E) Histogram illustrating the interaction of NPRl, the Cys521, or the Cys521 and 
Cys529 mutants described in (D), with TGA2 fused to the VP16 transactivation domain. 
niml-2, which does not interact with TGA2, was also expressed with TGA2:DB as a 
negative control. NPRl, niml-2 and the mutants described in (D) were all fused to the 
Gal4 DB. NPRl:DB was also expressed along with the VP16 transactivation domain 
(NPRl:DB + TA) as another negative control. 
(F) Histograms illustrating the effect of NPRI the Cys521, or the Cys521 and Cys529 
mutants described in (D) on the transcriptional activity of TGA2:DB. All proteins, except 
TGA2:DB were expressed without a fusion. 
(G) Histogram illustrating the interaction of NPRl, the Cys521, or the Cys521 and 
Cys529 mutants described in (D) all fused to the VP16 transactivation domain, with 
TGA2 fused to the Gal4 DB. 
For (B), (D), (E), (F) and (G) conditions were identical to those described in Figure 1. 
Data are reported as Relative Luciferase Units. Values consist of n = 25 samples and 
represent averages ± 1 SD. Every bar represents five bombardments repeated five times 
(n = 25). 
(H) Histogram illustrating the effect of NPRl, niml-2, and the Cys521, or the Cys521 
and Cys529 mutants, on the transcriptional activity of the TGA2-NPR1 complex. All 
proteins were native (without fusion). The reporter system was the Arabidopsis PR1 
promoter fused to luciferase. The CaMV 35S promoter:Renilla luciferase fusion was used 
as an internal standard. (-) indicates that no effector were bombarded along with the 
reporter and internal standard vectors. Arabidopsis leaves were left untreated (white bars) 
or were treated for 24 hr with 1mM salicylic acid (grey bars). Data are reported as 
Relative Luciferase Units. Values consist of = 25 samples and represent averages ± 1 
SD. Every bar represents five bombardments repeated five times (n = 25). 
(I) Northern blot analysis using NPR1 or PR1 probes. RNA stained with ethidium 
bromide is shown for loading comparison. Lane 1 contains RNA from wild-type 
Arabidopsis and lane 2 from the npr 1-3 mutant. Lanes 3 and 4 contain RNA from two 
independent npr 1-3 transgenic lines expressing NPR 1 bearing cysteine-to-serine 
mutations at position 521 and 529. Specific line numbers follow the construct name. PR1 
20 hand PR1 100h represent a 20-hour and 100-hour autoradiography, respectively. All 
lanes are from the same gel and blot. 
(J) Top Panel. Immunoblot analysis of proteins from wild-type Arabidopsis (WT), the 
nprl-3 mutant (NPRl-3), and the nprl-3 background liues expressing the mutant 
described in (I). An anti-NPR1 antibody (Despres et aI., 2000) was used. Bottom Panel. 
Ponceau staining of the membranes shown in the top panel. 
~513 :DB (p<0.05). These results indicate that, in the context of the last 80 amino acids of 
NPR1, Cys521 and Cys529 are required for transactivation only after SA-treatment. To 
establish the redox status of Cys521 and Cys529, we performed a labeling assay that 
distinguishes between protein sulfhydryls (reduced Cys residues) and disulfides (oxidized 
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Cys residues) (see Despres et al., 2003 for a flow chart and description of the method). 
The results (Figure SC) indicate that cysteine residues in the last 80 amino acids of NPRI 
are predominantly oxidized (Ox), whether or not the cells have been treated with SA. 
We next tested the effect of their mutations in the context of the full-length NPRI 
tethered to DNA by the Gal4 DB (Figure SD). In unstimulated cells (white bars), 
NPR1:DB did not lead to transactivation beyond baseline levels whether or not the 
cysteines were mutated. However, after SA-treatment, in contrast to what is observed 
with NPR1:DB, mutations of these cysteines abolished transactivation and values were 
significantly different from wild-type NPR1:DB (p<O.OS). Plant two-hybrid experiments 
confirmed that CS21S:DB and CS29S:DB were expressed and retained the capacity to 
interact with TGA2 to an extent comparable to wild-type NPRI :DB (Figure SE). These 
results suggest that the TGA2-co-activator function of NPRI may require CysS21 and 
CysS29. 
3.4.8 Transcriptional Activation of the PR1 gene and TGA2-Co-Activator 
Function of NPR1 Require Cysteines 521 and 529 of NPR1 
Finally, we sought to determine whether mutating CysS21 and CysS29 would 
affect the TGA2-co-acti vator function of NPR 1. We first tested the role of these cysteines 
J-
in the context of the Ga14 promoter and observed that mutation of CysS21 or the double 
mutation CysS21/CysS29 abolished the ability of the TGA2-NPRl complex to 
transactivate (Figure SF). Plant two-hybrid experiments confirmed that constructs CS21S 
and CS21 S/CS29S retained the ability to interact with TGA2 to an extent comparable to 
wild-type NPRI (Figure SG) in the configuration where TGA2 is fused to the Gal4 DB. 
Next, we tested the role of these cysteines in the context of the PRJ promoter. DNA 
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coding for native (unfused) proteins were delivered by biolistics along with the luciferase 
reporter gene under the control of the PRJ promoter (Figure 5R). As observed with 
NPR1, proteins C521S and C521S/C529S activated the PRJ promoter in the absence of 
TGA2 whether or not cells were treated with SA, indicating that these residues of NPR1 
are not required for recruitment to the promoter. Under induced (grey bars) and non-
induced (white bars) conditions, mutation of these cysteines did not bring about 
transactivation of the complex with TGA2 as values were not significantly different from 
those obtained with TGA2 alone (p>O.05). After SA treatment (grey bars), the ability of 
the TGA2-NPR1 complex to activate the PR1 promoter above TGA2 alone or NPR1 
alone (with and without mutated cysteines) is abolished when Cys521 is mutated alone or 
in the presence of the Cys529 mutation (Figure 5R, compare TGA2 + NPR1 to TGA2 + 
C521S and TGA2 + C521S/C529S, p<O.05). 
To further confirm the biological significance of Cys521 and Cys529 of NPR1 in 
controlling PRJ expression, an NPR1 construct harboring the double mutation at 
cysteines 521 and 529 was introduced, under the control of the CaMV35S promoter, into 
the nprJ-3 genetic background (Figure 51; Cys5211529m). Wild-type Arabidopsis (WT) 
expressed PRJ transcript when treated with O.5rnM SA for 16 hr (lane 1), while nprJ-3 
l 
plants (NPR1-3) did not (lane 2). PRJ gene induction was not restored in any of the 19 
independent transgenic nprJ-3 lines expressing the NPR1 double mutant Cys5211529m 
(lanes 3 and 4, and data not shown). Figure 5J indicates that protein Cys5211529m was 
expressed at levels similar to those observed with NPRI. None of the lines tested 
expressed PRJ in the absence of SA (data not shown). 
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3.5 DISCUSSION 
Our study has demonstrated that TGA2 is not a transcriptional activator whether 
cells are resting or SA-treated. Furthermore, our data argue that, upon SA-treatment, PRJ 
is up-regulated by a transactivation complex composed of at least TGA2 and NPRI. First, 
ChIP in wild-type Arabidopsis confirmed that NPRI is recruited to the PRJ promoter in 
" both non-treated and SA-treated cells. Second, despite the fact that TGA2 is not a 
transactivator, NPRI associates with TGA2 in SA-stimulated cells to form a 
transcriptional activating complex, both on a heterologous (5X Gal4 VAS) and a native 
(PRJ) promoter. Third, genetic complementation analyses of rationally designed site-
directed and deletion mutants of the NPRI BTBIPOZ establish a role for the core of this 
domain in activating PRJ. This finding is important because it establishes a direct 
correlation between complementation of PRJ expression and transactivation on the 
heterologous promoter of a complex containing TGA2 and these NPRI BTB/POZ 
mutants. Fourth, a cysteine-oxidized transactivation domain in the C-terminus of NPRI is 
also required for the activation of PRJ by the TGA2-NPRl complex. This emphasizes 
again the correlation between transactivation of the TGA2-NPRl complex and the 
activation of PRJ. We thus conclude that, in SA-treated cells, NPRI is a TGA2-co-f.. 
activator essential for PRJ induction. 
3.5.1 TGA2 Is Required/or Transcriptional Repression 0/ PRI in Uninduced 
Cells 
The observation that, under uninduced and INA-induced conditions, the triply 
knocked-out tga2/5/6 mutant displayed levels of PRJ expression 50-fold higher than in 
the wild-type suggested that TGA2, and members of its clade, could act as transcriptional 
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repressors (Zhang et al., 2003), which implied that they can bind the PRJ promoter 
independently of treatment with SA. Our ChIP results, using TGA2 fused to a six-
histidine-tag (Figure IB and C), indeed indicate that recruitment of TGA2 to the PRJ 
promoter is both SA- and NPRI-independent and thus suggest that the de-repression of 
PRJ observed by Zhang et al. (2003) in the tga2/5/6 knock-out plant is due to the lack of 
direct binding of these TGA TFs to PRJ. However, this contradicts a report in which 
ChIP indicated that binding of TGA2 to PRJ is both NPRl- and SA-dependent (Johnson 
et al., 2003). Since the N-terrninal region of TGA2 used by Johnson et al. (2003) to raise 
the anti-TGA2 antibody contains 28% of serine and threonine, two phosphorylatable 
amino acids, it is plausible that phosphorylation of a number of these residues could 
contribute to a decrease in the antibody-antigen interaction. To reconcile these apparently 
incongruous results, we propose that the data of Johnson et al. (2003) together with ours 
suggest that the N-terrninal region of TGA2 is either inaccessible to the antibody or that 
the epitope is post-translation ally modified when cells are unstimulated or in the absence 
of NPRI. 
In an in vivo transcription system based on the PRJ promoter (Figure 11), we 
demonstrated that, in uninduced cells, TGA2 represses transcription of the PRJ promoter 
l 
activated only by expression of NPRI (Figure 11 white bars; NPRI compared to TGA2 + 
NPRl). However, TGA2 was unable to repress the baseline level of PRJ expression as 
defined by expression of the unrelated proteins Gal4 DB and Cruciferin (Figure 11). 
Therefore, in the context of PRJ and in uninduced cells, TGA2 may only serve to repress 
the activating effect resulting from the recruitment of NPRI to the promoter. TGA2:DB 
can also repress transcription from a LexA:VP16-activated synthetic promoter 
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(Supplemental Figure 1). These data further emphasize the fact that TGA2 is not a 
transcriptional activator on its own. The repressing effect of TGA2 observed on the PRJ 
promoter activated by NPRI is likely independent of an interaction between TGA2 and 
NPR 1, since there is no detectable interaction between these two proteins in the context 
of the PRJ promoter (Figure 11 white bars; TGA2 compared to TGA2 + NPRl:TA). This 
is further substantiated by the observation that the activating effect resulting from the 
recruitment of niml-2 (an NPRI mutant version that does not interact with TGA2) to 
PRJ, is also repressed by TGA2 (Figure 11 white bars; niml-2 compared to TGA2 + 
niml-2). 
As determined by northern blot analysis, overexpression of TGA2:His did not 
lead to constitutive expression of PRJ in plants used for ChIP experiments (Figure 1). 
These results are consistent with those reported for native TGA2 (Kim and Delaney, 
2002) and a TGA2:Gal4 DB chimeric protein (Fan and Dong, 2002). In contrast, a 
chemically-inducible TGA2:GFP fusion was shown to lead to the accumulation of PRJ 
transcripts in the absence of BTH treatment (Kang and Klessig, 2005). These results are 
difficult to explain in light of results presented in Supplemental Figure 1, demonstrating 
that TGA2 is a transcriptional repressor. It is possible that the chemically-inducible 
". 
nature of the trans gene used by Kang and Klessig (2005) resulted in the accumulation of 
vastly higher amounts of proteins than achieved in our study or those of Fang and Dong 
(2002) and Kim and Delaney (2002), leading to unspecific effects. Another possibility, 
not tested by Kang and Klessig (2005), is that the particular TGA2:GFP fusion they 
created fortuitously generated a transactivation domain leading to SA-independent 
activation of PRJ. Finally, these authors did not assess whether the TGA2:GFP fusion is 
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recruited to PRJ in planta. Therefore, the possibility that this fusion exerted its effect on 
PRJ through an indirect mechanism cannot be ruled out. 
3.5.2 NPRlls a Transcriptional Co-Activator in SA-Stimulated Cells 
When tethered to DNA through the Gal4 DB, NPRI activates transcription only 
after cells have been stimulated with SA. However, the finding that expression of NPRI 
without fusion to the Gal4 DB does not lead to transcriptional modulation indicates that 
recruitment to the promoter is required for transcriptional activation. In the absence of a 
fusion to the Gal4 DB, NPRI can be recruited to the heterologous Gal4 promoter via 
TGA2:DB. This recruitment leads to transactivation of the TGA2-NPRI complex in SA-
treated cells (Figure IH), thus defining NPRI as a co-activator. Remarkably, the TGA2-
NPRI complex is sufficient to activate the heterologous (Figure IH) and PRJ promoter 
(Figure lJ) in an SA-dependent fashion. Therefore, the complex behaves as an SA-
regulated enhanceosome exposing a unique activating interface (Thanos and Maniatis 
1995; Merika and Thanos 2(01). Transactivation of the TGA2-NPRI enhanceosome 
requires the core of the NPRI BTB/POZ domain, since deletion beyond it (~11O) or its 
mutation (alanine-substitution), abolishes the function of the enhanceosome both on a 
transiently-delivered heterologous promoter (Figure 3A) mid on the endogenous PRJ 
gene (Figure 2B). Transactivation of the TGA2-NPRI enhanceosome is also dependent 
on the oxidation of Cys521 and Cys529 of NPRI (Figure 5). 
Although NPRI behaves as a transcriptional activator in SA-treated cells when 
tethered to DNA on the Gal4-based promoter, this may not be the case when NPRI is 
recruited to the PRJ promoter. First, addition of a strong transactivation domain (VPI6) 
to NPRI (NPR1:TA) did not lead to further activation of the transiently-delivered PRJ 
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promoter when compared to unfused NPR1 transfected alone (Figure 11). Second, 
mutation of Cys521/Cys529, which abolishes the transactivation properties of NPR1, 
activated PRJ to the same extent as the wild-type NPR1 (Figure 5H). These results could 
suggest that in the architectural context of the PRJ promoter, the PRJ-activating effect of 
NPR1 observed over the baseline level, may be de-repression as opposed to activation; 
that is to say the effect may be due to chromatin structure modification instead of an 
active recruitment of the basal transcription machinery by NPRl. The discrepancy 
between the results observed on the Gal4-based and PRJ promoters could arise from 
dissimilarity in the architecture of the two promoters. It could also arise from 
dissimilarity in the architecture of protein complexes due to allosteric effects of DNA 
(Lefstin and Yamamoto 1998), since in one case NPR1 interacts with DNA through a 
heterologous DB, while in the other, NPR1 is recruited to PRJ through an unidentified 
DB or through an unknown DNA-binding protein, itself recruited to PRJ. Therefore, 
although ChIPs demonstrated that NPR1 is recruited to PRJ in both resting and SA-
treated cells (Figure 1D and E), its role on the uninduced PRJ is unclear. However, it 
seems reasonable to think that NPR1 interacts with PRJ as a ready-to-go latent co-
activator. This is consistent with the fact that overexpression of NPR1 does not lead to 
" constitutive PRJ expression; transcription still requires activation by SA (Cao et aI., 
1998). The nature of this switch remains elusive. 
It has been proposed that the role of NPR1, in a wild-type plant, is to inactivate 
the repressing effect of SNIl on PR genes (Li et aI., 1999). As such, in the snil nprJ-J 
double mutant, PR gene expression is restored and is inducible. This also led to the 
proposal that the induction of PR genes requires the activation of TGA TFs in an SA-
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dependent, but NPRI-independent fashion. However, it is clear from the results presented 
here that TGA2, the prototype of the TGA2/5/6 clade, does not display any autonomous 
transactivation properties whether or not cells are treated with SA, but requires an -
association with NPRI to display such activities. Furthermore, the trans activating 
capacity of the TGA2-NPRl complex is dependent upon the functionality of a 
transactivation domain found in the C-terminus of NPRI. Thus, in the case of the PRJ 
gene, it is unlikely that the role of NPRI is simply to inactivate SNIl. Instead, we 
propose that the snil mutation, in the sniJ-npr J double mutant background, might 
activate pathways that regulate PRJ in an NPRl- and TGA2/5/6-independent fashion. 
Indeed, it has been shown that PRJ is regulated in an SA-dependent, but NPRl-
independent fashion by transcription factor AtWhyl (Desveaux et aI., 2004). In resting 
cells, AtWhyl is held inactive by an inhibitor, which prevents it from binding to DNA. 
Upon SA-treatment, AtWhyl is released from the effects of this inhibitor, which allows it 
to be recruited to its cognate DNA (Desveaux et aI., 2004). It is thus possible that SNIl 
plays a role in the AtWhyl-dependent pathway leading to PRJ induction as opposed to 
the TGA2-NPRl-dependent pathway. However, in the absence of ChIP data indicating 
that SNIl or AtWhyl are themselves recruited to the PRJ promoter, it is unclear whether 
their effects on the PRJ promoter are direct or indirect. Furthermore, in the absence of 
data indicating that SNIl can physically interact with TGA2 or NPRl, it is very difficult 
to place, with any confidence, this protein in a model of PRJ regulation. 
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3.5.3 Cysteine-Oxidized Transactivation Domain: A New Type of 
Transactivation Domain 
Cysteine residues in eukaryotic transcription factors have been demonstrated to be 
the target of redox regulation. In most cases cysteines affect DNA-binding activity, which 
is abolished when these are oxidized (Abate et al., 1990; Lando et aI., 2000; Toledano 
and Leonard 1991). However, in a few instances, oxidation has been shown to control 
homodimerization (Benezra 1994) and to inhibit nuclear export (Kuge et aI., 2001). 
When one eliminates cases where effects on transactivation are due to modulation of 
DNA-binding activity (as opposed to modulation of transactivation per se), there is only 
one example in the literature where a transactivation domain is controlled by cysteine 
redox. However, in this instance, oxidation abolished transactivation (Morel and Barouki 
2000). It thus appears that NPRI is a rare example of a transactivation domain positively 
regulated by oxidized cysteines (Cys521 and Cys529). Remarkably, despite the fact that 
Cys521 and Cys529 are oxidized regardless of whether cells are exposed to SA (Figure 
5C), these cysteines only modulate transactivation in SA-stimulated cells (Figure 5B). 
This suggests that different factors mediating contact between the NPRI transactivation 
domain and the basal transcriptional machinery operate in non-induced and SA-
l 
stimulated cells. 
The results reported in this paper constitute a significant advancement of our 
knowledge on plant disease resistance by elucidating the molecular function of TGA2 as 
a transcriptional repressor of NPRI-dependent de-repression of PR-l. Additionally, we 
identified NPRI as a co-activator of TGA2 and established the existence of an SA-
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regulated enhanceosome composed of at least TGA2 and NPRl. Figure 6 presents a 
model that summarizes the results reported in this paper on the regulation of P R -1. 
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Figure 6. Working Model for Regulation of PRJ by the TGA2-NPRI Enhanceosome 
(A) In an nprJ mutant plant such as nprJ-3, there is no NPRI-dependent de-repression of 
PRJ and there is no incorporation of TGA2 into a TGA2-NPRI enhanceosome. PRJ is 
repressed. Since NPRI is recruited to PRJ independently from TGA2 and since NPRI 
does not contain a known DNA binding domain, we postulate that in a wild-type plant 
NPRI is recruited through an unknown protein (Protein X) binding to an unknown DNA 
element (Site X). Although TGA3 has been shown to be recruited to PRJ, its interaction 
with the promoter is both NPRl- and SA-dependent (Johnson e al., 2003). Therefore, it is 
unlikely that NPRI would be recruited by TGA3 or that TGA3 is the postulated Protein 
X. Another possible scenario to explain the recruitment of NPRI to PRJ is that NPRI 
interacts directly with DNA using an unidentified DNA-binding domain. Further 
experimentation is required to distinguish between these two possibilities. 
(B) In the tga2/5/6 triple knock-out (Zhang et aI., 2003), NPRI is recruited to the PRJ 
promoter, which becomes de-repressed. In these plants, the 'OOA2-NPRI enhanceosome 
is not recruited to the PRJ promoter, due to the absence of TGA2, TGA5, and TGA6. 
(C) In a wild-type plant unstimulated with SA, both NPRI and TGA2 are recruited to the 
PRJ promoter independent of each other. However, under resting condition, NPRI and 
TGA2 do not interact with each other. Again here, NPRI is postulated to be recruited 
through an unknown protein (Protein X). 
(D) In the presence of SA, NPRI forms an enhanceosome with TGA2. Transactivation of 
the complex requires the oxidation of Cys521 and Cys529, which are found within the 
confines of a transactivation domain (TAD) in the C-terminus of NPRI. The BTBIPOZ 
domain of NPRI is hypothesized to interact with TGA2. NPRI is postulated to be 
transferred from the unknown Protein X to TGA2. However, it is possible that NPRl, 
Protein X, and TGA2 all interact at the same time. The question mark illustrates this fact. 
The exact nature of the enhanceosome remains undetermined, but it contains at the very 
least NPRI and TGA2. 
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3.6 SUPPLEMENTAL FIGURES 
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Supplemental Figure 1. TGA2 Represses a LexA:VP16-activated Synthetic 
Promoter. 
(A) Graphic representation of the synthetic 3X Ga14:1X LexA.:minimal promoter:Firefly 
Luciferase reporter gene. The upward arrow indicate the position of the TAT A box 
relative to the RNA start site. 60bp and 30bp indicate the spacing in base pairs between 
the most downstream Gal4 element and the LexA element and between the LexA element 
and the TATA box, respectively. Not shown is an omega translational enhancer in the 
transcribed region of the Luciferase gene. 
(B) Histograms illustrating the fact that TGA2 tethered to DNA through Gal4 DB 
(TGA2:DB) represses transcription of a LexA DB fused to t~~ transactivation domain of 
viral protein 16 (LexA:VP16). Arabidopsis leaves were left untreated (white bars) or 
were treated for 24 hr with ImM salicylic acid (grey bars). The constructs were 
transfected along with the 3X UAsGAlA:1X LexA. DNA element:minimal promoter:Firefly 
luciferase reporter and the CaMV35S:Renilla luciferase internal standard vectors. Data 
are reported as Relative Luciferase Units. Values consist of n=25 samples and represent 
averages ± 1 SD. Every bar represents five bombardments repeated five times (n = 25). 
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Supplemental Figure 2. The BTBIPOZ Mutants of NPRI Interact with TGA2 in 
Yeast Two-Hybrid Assays. 
Quantitative yeast two-hybrid assays illustrating the interaction between TGA2 produced 
as a Gal4DB fusion (TGA2:DB) co-expressed with NPRl, niml-2, NPRI lacking the 
first 22, 44, 66, or 110 amino acids (~22, ~44, ~66, ~110, respectively), or NPRI 
mutated in the core of the BTBIPOZ domain (A-Sub) expressed as Gal4TA fusions 
(:TA). TGA2:DB co-expressed with Gal4TA and Gal4DB co-expressed with NPRl:TA 
served as negative controls. Values represent averages ± 1 SD. 
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CHAPTER 4 - The glutathionylation activity of the novel 
glutaredoxin GRX480 regulates the redox status and activity of 
the Arabidopsis transcription factor TGAI 
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4.1 ABSTRACT 
The protein NPRI (non-expressor of pathogenesis related gene 1) is the key modulator of 
systemic acquired resistance (SAR). It is induced by the metabolite SA (salicylic acid) and 
acts through a class of TGA transcription factors to induce a subset of PR (pathogenesis 
related) genes resulting in disease resistance. The interaction between TGAI and NPRI was 
previously found to rely on the reduced state of two cysteines, Cys260 and Cys266, in 
TGAl. As a complement to these results, we found that the ability of TGAI to activate 
transcription correlates with the oxidation of Cys260 and Cys266, with differential 
contribution of each cysteine to transactivation. These data suggests that TGAI activity is 
regulated by a novel redox switch in a mutually exclusive manner such that trans activation 
and interaction with NPRI do not occur at the same time. Through a yeast two-hybrid 
screen, TGAI was found to interact with the novel Arabidopsis glutaredoxin GRX480. 
Glutaredoxins, which are small oxidoreductases, are part of the thioredoxin superfamily and 
are capable of reducing disulfide bonds. Although GRX480 has all the attributes required 
for reduction of a disulfide bond, its preference for binding reduced over glutathionylated 
TGAI and lack of activity in a classical glutaredoxin assay suggest it does not have 
glutaredoxin activity. Instead, we determined that GRX480 is able to glutathionylate TGAI 
at Cys260 using GSSG as a substrate. This activity, in the presence of the TGAI-NPRI 
complex, was found to abolish transactivation, likely through abrogating the interaction 
between TGAI and NPRI by oxidizing TGAl. This data further defines a role for GRX480 
in disease resistance and is the first instance where a protein target and biochemical activity 
has been defined. 
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4.2 INTRODUCTION 
Systemic acquired resistance (SAR) is a broad-range disease resistance pathway 
induced in Arabidopsis after attack by avirulent pathogens. Induction of this defense 
pathway leads to resistance throughout the plant and can be maintained for weeks to 
months after induction (Ward et al., 1991; Ryals et al., 1996). SAR is characterized by 
the expression of a subset of pathogenesis related (PR) genes and the corresponding 
accumulation of PR proteins (Ward et aI., 1991). Salicylic acid (SA) is a key metabolite 
that accumulates during SAR and is required for the successful deployment of this 
pathway (Metraux et al. 1990; Malamy et al., 1990). Exogenous treatment with SA leads 
to the induction of SAR and expression of PR genes (Ward et aI., 1991), while transgenic 
Arabidopsis plants deficient in SA accumulation fail in their ability to mount SAR and to 
accumulate PR gene transcripts (Delaney et aI., 1994; Vernooij et aI., 1994; Gaffney et 
al., 1994). The SAR signaling cascade also involves the protein NPRI (non-expressor of 
pathogenesis related gene 1), which acts downstream of SA (Cao et al., 1994; Delaney et 
al., 1995; Shah et aI., 1997). Arabidopsis nprl mutants are still able to accumulate SA; 
however, they are non-responsive to it and are unable to accumulate PR transcripts or 
mount SAR (Delaney et aI., 1995; Shah et aI., 1997). " 
Analysis of the NPRI protein revealed the presence of two protein-protein 
interaction domains: the BTBIPOZ (Broad-Complex, Tramtrack, and Bric-a-braclPox 
virus and Zinc finger) domain and ankyrin repeats (Cao et aI., 1997; Aravind and Koonin, 
1999). Several of the npr 1 mutants bear single amino acid mutations in either of the 
protein-protein interaction domains suggesting that NPRI modulates SAR through 
interaction with other proteins. NPRI localizes to the cytoplasm and the nucleus in 
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unchallenged Arabidopsis (Despres et al., 2000 and 2003) while treatment with SA or its 
analog INA (2,6-dichloroisonicotinic acid) results in nuclear localization which is 
required for PR gene expression (Kinkema et al., 2000; Mou et aI., 2003). 
NPR1 is able to interact differentially with members of the TGA bZIP (basic 
domainlleucines zipper) family of transcription factors (Zhang et aI., 1999; Despres et aI., 
2000; Zhou et aI., 2000). TGA transcription factors, named for their recognition of the 
cognate DNA motif TGACG, are known to bind the as-J-like element, which is a 
common cis-element found in the promoter of many PR and SAR-related genes 
(Strompen et aI., 1998; Despres et aI., 2000). NPR1-TGA interaction has been observed 
in the nucleus after SAR induction and NPR 1 is able to enhance TGA binding to the as-J 
element in response to SA (Despres et aI., 2000 and 2003). 
Of the ten Arabidopsis TGA TFs, only seven have been examined with respect to 
their ability to interact with NPR1 in yeast. Although the initial yeast two-hybrid assays 
revealed that TGA1 and 4 were not able to interact with NPR1, Despres et al. (2003) 
showed that TGA1 is able to interact with NPR1 in a plant two-hybrid assay after SA 
treatment. Examination of a series of TGA1 mutants where segments of TGA1 had been 
swapped for TGA2 led to the identification of two unique cysteines in TGA1 (Cys260 
J: 
and Cys266, also conserved in TGA4) that, when mutated to the corresponding amino 
acids in TGA2, allowed TGA1 to interact with NPR1 in yeast. Furthermore, the 
identification of the redox status of Cys260 and Cys266 in yeast and Arabidopsis 
revealed that TGA1 is redox regulated and interaction with NPR1 only occurs when 
Cys260 and Cys266 are reduced (Despres et al., 2003). 
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Two pathways exist in plants, mammals, yeast and E. coli to regulate the redox 
status of proteins: the thioredoxin and glutaredoxin pathways (Meyer et aI., 1991). While 
these proteins do not share sequence similarity, they do have similar folding (Eklund et 
aI., 1984) to generate a prominent redox active site that reveals partially overlapping 
functions for reducing disulfide bonds (Meyer et aI., 1999). Glutaredoxins, unlike 
thioredoxins, employ glutathione (GSH) to reduce disulfide bonds, a unique feature that 
allows them to reduce mixed disulfides between GSH and a protein. Arabidopsis has 26 
thioredoxins and 31 glutaredoxins and either pathway could potentially be involved in 
modulating the redox status of TGAI (Meyer et al., 2002; Rouhier et al., 2004). In 
support of this, an Arabidopsis glutaredoxin has been found to interact with TGA2 and 
this interaction appears to be involved in the negative regulation of PDF1.2 expression, a 
jasmonic acid-responsive defense related gene involved in an induced defense pathway 
different from SAR (Ndamuong et al., 2007). 
TGA 1 possesses all the structural determinants required for interaction with 
NPR1, however a redox switch appears to regulate this interaction. The interaction 
between TGAI and NPR1, which results from the SA-dependent reduction of Cys260 
and Cys266 in TGA1, implies a role for TGAI in SAR. Here we report a mutually 
I 
exclusive behavior of TGAI linked to its redox status: oxidation of Cys260 and Cys266 
results in TGA1' s ability to transactivate but not interact with NPRI while reduction of 
these two cysteines results in a loss of transactivation ability but competence to interact 
with NPRI. A bipartite transactivation domain was identified in TGAI that is not 
involved in the transactivation ability of the TGAI-NPRI complex. Instead, a novel 
transactivation domain in NPRI is responsible for the transactivation of the complex 
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suggesting the transactivation domain of TGAI serves another role, likely independent of 
NPRl. In an attempt to understand TGAl's redox regulation, we performed a yeast two-
hybrid screen and identified that TGAI interacts with GRX480, the same glutaredoxin 
that interacts with TGA2 (Ndamukong et aI., 2007). This interaction also occurs in a 
plant two-hybrid system and depends on the presence of ·Cys260 and Cys266. The 
expression of GRX480 is induced by SA and the enzyme displays none of the behavior of 
a classical glutaredoxin, but instead was found to have activity glutathionylating TGAl. 
Furthermore, we show that GRX480 is involved in shutting down the TGAI-NPRI 
complex, most likely through the glutathionylation of TGAI. The data presented here not 
only suggest two unique roles for TGAI regulated by a novel redox switch, it also 
provides a mechanism, through the action of GRX480, for the partial regulation of 
TGAl's redox status. Additionally, we are the first group to identify a protein target and 
biochemical activity for a novel plant glutaredoxin. 
4.3 METHODS AND MATERIALS 
4.3.1 Chemicals 
All consumables were purchased from Sigma (St. Louis, MO) unless otherwise stated. 
l 
4.3.2 Bacterial Strains and General Cloning Vectors 
The E. coli strain DH12S (GffiCO-BRL, Grand Island, NY) was used for plasmid 
maintenance and production. Cloning plasmids used were pBC SK( +) (Stratagene, La 
Jolla, CA) and pCR2.1 (Invitrogen, Carlsbad, CA). Large-scale plasmid purification was 
performed using Endo-Free GigaPrep Kits (Qiagen, Mississauga, ON). All constructs 
used were verified by DNA sequencing. 
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4.3.3 Plasmid Constructs for Transactivation Assays and Plant Two-Hybrid 
Assays 
The GAL4 DB, from the yeast two-hybrid vector pBI880, the VP16 TA (provided by 
Brian Miki, Agriculture and Agri-Food Canada, Ottawa, Ontario, Canada), and the 
Renilla luciferase from plasmid pRL-null (Promega, Madison, WI) were amplified by 
PCR using appropriate primers and ligated into the expression vector pBI524 (Datla et 
aI., 1993) containing a modified double Cauliflower mosaic virus 35S promoter with the 
Alfalfa mosaic virus translational enhancer. The coding sequence for all genes tested was 
amplified by PCR using gene-specific primers and ligated into pBI524 containing GAL4 
DB or VP 16 TA in the appropriate reading frame to permit the expression of N-terminal 
fusion proteins. The unfused versions (i.e. no DB or T A) were cloned into pBI524 
lacking the GAL4DB or VP16 TA. The 5X UASGAL4:luciferase reporter construct was 
provided by Masaru Ohme-Takagi National Institute of Advanced Industrial Science and 
Technology (Tsukuba, Japan; Fujimoto et aI., 2000). 
4.3.4 Yeast Two-Hybrid Assays 
Plasmids pBI880 (DB) and pBI881 (TA) (Kohalmi et aI., 1997) in conjunction with the 
yeast strain YPB2 of Saccharomyces cerevisiae were used t~roughout this study. Yeast 
cells were transformed using S.c. EasyCompTM Transformation Kit (K505001; 
Invitrogen, Carlsbad, CA) and grown on synthetic dextrose using the appropriate amino 
acid drop-out(s). For transactivation assays, where ~-galactosidase activity was 
determined, the desired constructs fused to the Gal4 DNA binding domain were 
transformed into the yeast and selected for on synthetic dextrose without leucine. For 
protein-protein interaction assays, where the activity of the lacZ reporter gene was 
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monitored visually by using the X-gal filter assay, yeast cells were co-transformed with 
the DB and T A plasmids and selected for on synthetic dextrose without leucine or 
tryptophan. 
4.3.5 Plant Two-Hybrid Assays 
Arabidopsis thaliana (Columbia) leaves were harvested from four week old plants grown 
at 21°C (day) and 18°C (night) with a ten hour photoperiod and placed on a medium 
containing MS salts and micronutrients supplemented with B5 vitamins, 1 % sucrose and 
0.8% agar at a pH of 5.8. Two leaves were transformed per bombardment. Bombardment 
and sample processing were as described by Fujimoto et al. (2000). Briefly, sample 
preparation for bombardments consisted of one microcentrifuge tube containing 48JlL 
DNA-gold mixture (enough for 5 bombardments). With continuous vortexing, 44.4JlL of 
60mg/mL 1.0 micron gold (165 2263, Bio-Rad, Mississauga, ON) was mixed with 13JlL 
of DNA consisting of the reporter gene, internal standard and the vector(s) for the protein 
or protein pair being tested. DNA was then precipitated onto the gold particles with 42JlL 
of 3M CaCh and 20JlL of 0.1M spermidine. The DNA-gold mixture was then washed 
once with 70% and 100% EtOH before being resuspended in 48JlL of 100% EtOH. 8JlL 
J 
of DNA-gold mixture was pipeted for each bombardment on macrocarriers (165 2335; 
Bio-Rad, Mississauga, ON) and allowed to dry. The Model PDS-1000/He Biolistic® 
Particle Delivery System (165 2257; Bio-Rad, Mississauga, ON) was used to deliver the 
DNA-gold mixture to the Arabidopsis leaves. Rupture disks (156 2329; Bio-Rad, 
Mississauga, ON) of 1l00psi were used in combination with ultra high purity (5.0) 
helium at 1500psi. When required, filter-sterilized salicylic acid was sprayed on the 
leaves at a concentration of 1mM for the indicated length of time. Leaves were left for a 
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period of 24 hours before being assayed. The assay was performed using the Dual-
Luciferase® Reporter Assay system (PRE 1960; Fisher Scientific, Ottawa, ON) 
following the manufacturers instructions. Fluorescence was measured as photon emission 
(EG and G Berthold Lumat LB9507 Luminometer, Bad Wildbad, Germany) and the 
value obtained represents the value of the reporter gene divided by the value of the 
internal standard (as relative luciferase units). Every bar in each graph represents five 
bombardments repeated five times (n = 25). 
4.3.6 In Vivo Determination of Cysteine Redox Status 
Proteins extracted from yeast cells, E. coli or Arabidopsis leaves were separated into two 
aliquots and processed immediately and in parallel. For detection of reduced cysteines, 
one aliquot was treated with 0.2rnM of 3-(N-maleimido-propionyl) biocytin (MPB) for 
one hour in the dark at room temperature. Proteins were then precipitated four times with 
acetone. For detection of oxidized cysteines, the second aliquot was first treated with 
20rnM of N-ethylmaleimide (NEM) for one hour at room temperature (RT), precipitated 
with acetone and then treated with 20rnM dithiothreitol (DTT) for one hour at RT. After 
another acetone precipitation, proteins were treated with 0.2rnM of MPB for one hour in 
the dark at RT followed by two acetone precipitations. Cys-teine labeled proteins were 
then subjected to an immunoprecipitation to purify TGA1 or GRX480. 
4.3.7 Immunoprecipitation and Detection of Modified Cysteines 
The cysteine-labeled proteins were incubated for 16 hours at 4°C with the anti -TGA 1 
antibody (for TGA1C172N/C266S/C287S) or Anti-His H-15 antibody (for GRX480) 
coupled to protein A-sepharose beads (153-6153; Affi-gel Protein A Gel, Bio-Rad, 
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Mississauga, ON). The beads were subsequently washed three times in IP buffer (0.1 % 
SDS, 1% Triton X-lOO, SOmM HEPES pH 7.9, lS0mM NaCI, ImM EDTA) and the 
proteins were eluted by boiling in 2X sample buffer (0.12M Tris-CI pH 6.8, 4% SDS, 
20% glycerol, O.OS% bromophenol blue, 10% 2-mercaptoethanol). The supernatant was 
electrophoresed on a 10% (TGAl) or 12% (GRX480) sodium dodecyl sulfate 
polyacrylamide gel. The proteins were transferred to nitrocellulose and reacted according 
to the manufacturer's instruction (LI-COR, Lincoln, NE) with a strepavidin:Alexa fluor 
680 (Molecular Probes, Eugene, OR) conjugate and detected by infrared imaging using 
an Odyssey imager (LI-COR, Lincoln, NE). The anti-TGAI antibody was raised in 
rabbits against the immunizing peptide "CEDTSHGTAGTPHMFDQEAST" and affinity 
purified by Alpha Diagnostics International (San Antonio, TX). The specificity of the 
anti-TGAI antibody has been demonstrated previously (Despres et aI., 2003). The His-
probe (HIS) (sc803) was purchased from Santa Cruz Biotechnology, Santa Cruz, CA. 
4.3.8 In vivo determination of the Cys Redox Status of 
TGAI C172NIC266SIC287S 
SOmL culture of yeast transformed with TGA1C172N/C266S/C287S:TA (Gal4) was used 
to determine the redox status of Cys260. For Arabidopsis, due to very low amounts of 
i 
proteins in the biolistics assays, 80 bombardments were performed with the 
TGAIC172N/C266S/C287S:TA (VP16) construct. After a 24-hr incubation period 
without SA, proteins were extracted from Arabidopsis leaves or from the overnight SOmL 
yeast culture, separated into two aliquots and processed immediately and in parallel as 
described above in Sections 4.3.6 and 4.3 .7. Neither TA domain contains cysteines. 
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4.3.9 Protein Expression 
The E. coli BL21 derivative strain DE3(+) containing pLys S was used for expression of 
TGAl, TGAICI72N/C266S/C287S, GRX030 and GRX480. All genes were amplified by 
PCR and cloned in-frame in pET41a(+) to create N-terminal fusions (with an N-terminal 
6X HIS tag). SmL of an overnight culture, grown at 37°C shaking at 200rpm, was used to 
inoculate SOOmL (TGAl, TGAIC172N/C266S/C287S and GRX030) while S x SmL 
overnight cultures were used to inoculate S x SOOmL cultures for GRX480. All cultures 
were grown at 37°C shaking at 200rpm until they reached an OD600 .of 0.4-0.6 at which 
point they were induced with ImM IPTG (lsopropyl-~-D-thiogalactopyranoside; 
IPTGOOl.S BioShop, Mississauga, ON) and grown for an additional 2 hours at 37°C 
shaking at 200rpm. Bacterial pellets were collected by centrifugation at 4°C, 3S00rpm for 
IS minutes (Sorvall-RC-SC-Plus; Mandel Scientific Company, Ontario, CA). Pellets 
were washed once with mQH20 and stored at -20°C. 
4.3.10 Protein Extraction 
Approximately Ig of TGAl, TGAIC172N/C266S/C287S and GRX030 pellet and 
approximately 6g of GRX480 pellet was used in each purification. TGAl, 
TGAIC172N/C266S/C287S and GRX030 pellets were resutpended in 2mL of binding 
buffer (40mM imidazole, 20mM NaH2P04, IS0mM NaCl, pH 7.S) and sonicated (Sonic 
Dismembrator Model 100; Fisher Scientific, Ottawa, ON) on level S for S x 10 second 
bursts with 30 second rests on ice in between. GRX480 pellets (each approximately Ig) 
were resuspended individually in 4mL of binding buffer and ground in approximately Ig 
of aluminum oxide Type A-S (A2039) before being combined. All samples were 
centrifuged at maximum speed, 4°C for IS minutes and the supernatant (SN) was 
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collected and filtered through a 13mm 0.22)..lm PVDF syringe filter (09-720-3, Fisher 
Scientific, Ottawa, ON) and used immediately in HIS purification. 
4.3.11 FPLC-Adapted HIS Purification 
A HisTrap HP ImL column (17-S247-01, GE Healthcare Bio~Sciences, Baie d'Urfe, QC) 
was adapted to the AKTA Explorer FPLC (GE Healthcare Bio-Sciences, Baie d'Urfe, 
QC) operated with UNICORN Version 3.00.10 software. The total SN from the protein 
extraction was loaded onto the column after a SmL equilibration of the His Trap column 
with binding buffer. The column was then washed with SmL binding buffer followed by 
elution buffer (1M imidazole, 20mM NaH2P04, IS0mM NaCl, pH 7.S) which was 
collected in 12 x SOO)..lL fractions. Fractions 4 and S were shown to contain the purest 
fraction of protein in all cases by immunoblot (Figure 1 in the Appendix) and were used 
in subsequent experiments. 
4.3.12 GSSG Treatment of TGA1 
A desired amount of HIS purified TGAI (that had been reduced with 20mM DTT before 
being applied to the HIS column for purification) was subjected to glutathionylation by 
treatment with lOmM GSSG (prepared in a solution of lqptM Tris-CI pH 8.0). The 
mixture was incubated at 37°C, shaking in a benchtop shaker at 1100 rpm (Thermomixer 
R, Eppendorf, Mississauga, ON) for 1 hour in the dark. Samples were subsequently 
electrophoresed or subjected to DNA-based pull-downs. 
4.3.13 MAWI TOF Mass Spectroscopy 
30)..lL of TGAI fraction 4 untreated or glutathionylated were electrophoresed on a 10 % 
SDS-polyacrylamide gel. The gel was reversibly stained with Colloidal Brilliant Blue G 
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(B2025) for 2 hours prior to being fixed for 1 hour (7% glacial acetic acid in 40% (v/v) 
MeOH). The gel was de stained by a 30 second rinse with 10% glacial acetic acid in 25% 
(v/v) MeOH and further destained for 2 hours with 25% MeOH. The desired bands were 
excised and placed in pre-washed (50% acetonitrile (ACN)/O.l % trifloroacetic acid 
(TFA)) 1.5mL micro centrifuge (MC) tubes. The gel slices were destained 2X with 
destaining solution (lOOmM N~HC03/50% ACN) in a benchtop shaker at 37°C, 
1400rpm. After removing the final SN, the gel slices were dehydrated for 10 minutes at 
RT in WOuL ACN. The ACN was removed and the gel slices were dried in a SPD 
SpeedVac (SPDlllV; Thermo Savant, Calgary, AB). The gel slices, when applicable, 
were then reduced with WmM DTT in 25mM NH4HC03 for 1 hour in a 56°C water bath. 
The SN was discarded and the gel slice allowed to cool before the gel slice was 
submerged in 55mM iodoacetimide in 25mM NH4HC03 for 45 minutes in the dark at RT 
with occasional vortexing. The SN was removed and the gel slice was washed 2 x 10 
minutes with WOIlL of 25mM NH4HC03 shaking at RT at 1400rpm. The SN was 
removed and the gel slices were dried in a speed vac. A 20llg/mL solution of Trypsin 
Gold (V5280, Fisher Scientific, Ottawa, ON) in digestion buffer (40mM NH4HC03110% 
ACN) was used to cover the gel slice and left to sit at RT for 1 hour. Enough digestion 
J 
buffer was then added to cover the gel slice and the mixture was left to shake in the 
benchtop shaper at 1l00rpm and 37°C overnight. The SN was removed and 150llL of 
mQH20 was incubated with the gel slice, shaking at 1400rpm, RT for 10 minutes. The 
SN was kept and stored in a pre-washed 1.5mL MC tube, followed by 2 x 60 minute 
extractions of the gel slices with 50llL extraction buffer (50% ACN/5% TF A) shaking at 
RT, 1400rpm. The two extractions plus the water were pooled and dried through a speed 
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vac. The dried peptides were them purified using Cl8 ZipTips (TN-224; Millipore, 
Billerica, MA) according to the manufacturers instructions. I/lL of the eluted peptides 
were combined with I/lL of matrix (a saturated solution of a-cyano-4-hydroxycinnamic 
acid (70990) in a 50/50 ACNIH20 + 0.1 %TFA) and I/lL of this mixture was spotted on a 
S261100 AnchorChipTM target (Bruker Daltonics, Billerica,MA) and allowed to dry. 
Mass spectra were obtained using Autoflex II TOFITOF (Bruker Daltonics, Billerica, 
MA) in positive mode and 9% laser power. Spectra were optimized and mass list 
obtained using FlexAnalysis Version 3.0 (Bruker Daltonics, Billerica, MA). The TGAI 
peptide mass fingerprint was confirmed by a significant match in the Mascot database 
(http://www.matrixscience.com). 
4.3.14 HED Assay 
Adapted from Holmgren and A.slund (1995). Fraction 4 of GRX480 and GRX030 
purified from the HIS column were tested for glutaredoxin activity. A reference cuvette 
as well as both reaction cuvettes contained 0.5mL 100mM Tris-CI pH 8.0, 2/lL 250mM 
GSH (in 100mM Tris-CI pH 8.0), 2/lL 100mM NADPH (in 100mM Tris-CI pH 8.0), 2/lL 
0.5M EDTA, I/lL 50mg/mL BSA, 1.1/lL glutathione reductase and 2J.lL 0.1672M HED 
l 
(~-hydroxyethylene disulfide; in 100mM Tris-CI pH 8.0). This was left to sit for 2-5 
minutes to allow for the formation of the mixed disulfide between GSH and RED. 
Immediately before starting the assay measurements, 5 pmol of GRX480 or GRX030 
were added to the reaction cuvettes while nothing was added to the reference cuvette. A 
decrease in absorbance was measured at 340nm using a UV /Visible spectrophotometer 
(Ultrospec 3100 pro; Fisher Scientific, Ottawa, ON) every 15 seconds over a 5 minutes 
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period where the reference absorbance was automatically subtracted from the absorbance 
of the reactions. One unit of activity is defined as the consumption of IJ..lmol of NADPH 
per minute per mg of protein calculated from the expression: 
[(~A340 x V)/(min x 6.2)]/mg protein 
Where V is the cuvette volume in mL and 6.2 is the millimolar extinction coefficient for 
NADPH (Holmgren and Aslund, 1995). 
4.3.15 DNA-Coupled Pull-down 
SOOJ..lL of Streptavidin-iron oxide particles from Streptomyces avidini (S241S) were 
dispensed in a l.5mL MC tube and the magnetic particles were pulled to the side of the 
tube, for 1 minute or until the SN was cleared, with the MPC-E-l magnet (Dynal, Oslo, 
Norway). The SN was discarded and the particles were resuspended by pipeting in SOOJ..lL 
binding buffer 1 (20mM HEPES pH 7.9, 2M NaCl) containing 2J..lL (lOOpmol) of 
biotinylated probe. The probe consists of LSS and biotinylated LS7 DNA, two as-J-like 
elements in the Arabidopsis PRJ promoter (Lebel et aI., 1998) known to bind TGA TFs 
(Despres et aI., 2000). The double stranded DNA probe, consisting of the following two 
40-mers: S' CCACATCTATGACGTAAGTAAAATAGTGACGTAGAGAAAC 3', 
f. 
S' GTTTCTCTACGTCACTATTTTACTTACGTCATAGATGTGG-Biotin 3', was 
created by resuspending each oligomer to a final concentration of 100pmol/J..lL in TEN 
buffer (lOmM Tris-Cl pH7.S, ImM EDTA, IS0mM NaCl). Equimolar amounts of each 
oligomer were annealed to create a SOpmol/J..lL solution. Particles and probe were 
incubated on a rotating wheel (Roto-torque, Cole-palmer instrument company, Montreal, 
QC) for 30 minutes at RT to allow for the streptavidin-biotin interaction to occur. The 
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particles were magnetically separated as above and the cleared SN discarded. The 
particles with the bound probe were washed 3X with binding buffer 2 (20mM HEPES pH 
7.9, 200mM NaCl) where each wash consisted of magnetically collecting the particles, 
removing the cleared SN and gently resuspending the particles. Fractions 4 and 5 of 
TGAI were combined and then split evenly into aliquots according to the number of pull-
downs being performed. Some aliquots were glutathionylated (Section 4.3.13) and the 
fractions that were not were left untreated but subjected to shaking at 37°C in the dark for 
1 hour. The aliquots of TGAI were topped off to 500J..1L with binding buffer 2 containing 
100mM EDT A and used to resuspend the particles with bound probe. This mixture was 
incubated for 30 minutes at RT rotating on the wheel. The cleared SN was removed and 
the particles were washed twice as described above. Combined fractions 4 and 5 of 
GRX4S0 were divided into aliquots according to the number of pull-downs being 
performed. They were topped off to 500J..1L with binding buffer 2 and applied to the 
DNA-probe-TGAI mixture and incubated on the wheel for 30 minutes at RT. The cleared 
SN was removed and the particles were washed twice as described above. The protein 
complex samples were eluted with 45uL IX sample buffer (0.06M Tris-CI pH 6.S, 2% 
SDS, 10% glycerol, 0.025% bromophenol blue, 5% 2-merca~toethanol) heated at 100°C 
for 5 minutes. The particles were pelleted and the SN was collected. The protein complex 
samples were electrophoresed on a 12% SDS-polyacrylamide gel and processed as 
described in Section 4.3.S. His-probe (HI5) (scS03, Santa Cruz Biotechnology, Santa 
Cruz, CA) primary antibody was used in the western detection at 111000 and goat anti-
rabbit:Alexa fluor 6S0 (A-21076; Molecular Probes, Eugene, OR) at 1115000 was used as 
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the secondary antibody in coordination with infrared imaging using the Odyssey imager 
(LI-COR, Lincoln, NE). 
4.3.16 Glutathionylation Assay 
This assay took place using the DNA-coupled pull-down method with some alterations. 
In this instance, only TGAIC172N/C266S/C287S was coupled to the DNA-particles. 
Activity of GRX480 and GRX030 was determined by incubating each of these enzymes 
with the DNA-coupled TGAICl72N/C266S/C287S with 5mM GSH (in lOmM Tris-CI, 
pH 8.0), 5mM GSSG (in lOmM Tris-CI, pH 8.0) or neither. Additionally, DNA-coupled 
TGAICl72N/C266S/C287S was also incubated with either 5mM GSH or 5mM GSSG 
alone. These mixtures were incubated for 30 minutes on the wheel at RT in the dark. The 
cleared SN was removed and the particles were washed as described. To detect reduced 
cysteines, the DNA-coupled TGAICl72N/C266S/C287S was treated with 0.2 mM of 
MPB for I hr at R T in the dark. The cleared SN was removed and the particles were 
washed as described. TGAIC172N/C266S/C287S samples were eluted with 45uL IX 
sample buffer by heating at 100°C for 5 minutes. The particles were pelleted and the SN 
was collected. The protein complex samples were electrophoresed on a 10% SDS-
polyacrylamide gel and processed as described in Section 4.3!8 using a strepavidin:Alexa 
fluor 680 (S-32358~ Molecular Probes, Eugene, OR). The loading control was determined 
by incubating with His-probe (HI5) primary antibody and detecting with IR Dye800 
conjugated donkey anti-rabbit secondary antibody. The intensity of the bands was 
determined using the Odyssey Software, Version 1.0.58 (LI-COR, Lincoln, NE) and the 
relative intensity was determined by dividing the intensity of the reduced cysteines by the 
intensity of the loading control. TGAICl72N/C266S/C287S and GRX030 were reduced 
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before purification and equal pmol amounts of GRX030 and GRX480 were incubated 
with each reaction. 
4.3.17 p-Galactosidase Activity 
The transactivation ability of the TGAI and the various mutants was determined from 
yeast expressing ~-galactosidase under the control of the Gal4 UAS. Single colonies were 
selected and grown for -8 hours at which point the OD6OO was determined using a 
UV/Visible spectrophotometer and aliquots of each culture were taken to induce 
overnight cultures to get the desired cell density after 16 hours of growth shaking at 30°C 
according to: 
Inoculation volume = Desired cell density x Culture Voll:lme 
Current cell density i# of generatIons) 
Where the Desired cell density is 0.6 at OD600, 2 hrs is required to obtain each 
successive generation and the current cell density was determined by measuring the 
absorbance at OD600. For each construct, two colonies were tested each time at two 
different time points. Yeast cells were pelleted by centrifugation at 2500rpm, RT for 15 
minutes. Pellets were resuspended in 100uL Z-buffer (60AmM Na2HP04-7H20, 39.1mM 
NaH2P04-H20, lOmM KCI, OA5mM MgS04) and subjected to 3 freeze thaw cycles (2 J 
minutes in liquid nitrogen followed by 5 minutes in 42°C water bath) and 5 x 30 seconds 
vortexing with glass beads (acid-washed; G8772) with 30 second rests on ice in between. 
Cell debris was pelleted and the SN was divided into 4 equal aliquots. Each aliquot was 
topped off to 700J.1L with Z buffer + 0.27% 2-mercaptoethanol. Aliquots were pre-
warmed in 30°C water bath for 10 minutes at which point 160J,.lL of ONPG (ortho-
nitrophenol-p-D-galactoside) was added at 4mg/mL in Z buffer to half the aliquots while 
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160J..lL of mQH20 was added to the other half. Half of the water and ONPG aliquots for 
each construct were incubated for 30 minutes while the remainder were incubated for 60 
minutes at 30°C. After the desired time, the reactions were removed from the water bath 
and stopped by the addition of 400J.,lL of 1M Na2C03. ~-galactosidase cleaves the clear 
and colorless ONPG to the yellow substrate ONP (ortho-nitrophenol) and, as such, the 
'< 00 of each aliquot was determined at 420nm using a UV Nisible spectrophotometer. ~-
galactosidase activity was determined as: 
t x V x 00600 
Where t represents the length of time incubated at 30°C and V x 00600 represents the 
volume and cell density of each culture used in each activity measurement. 
4.3.18 Expression o!GRX480 and PR1 
Quantitative PCR was performed on cONA from Arabidopsis leaves that were either 
untreated or treated with 1mM SA for 1 or 8 hours. Reactions were performed in 
duplicate using gene specific primers for PRJ and GRX480. Expression was analyzed by 
running a sample on an agarose gel where the intensity of PCR bands was determined by 
densitometry. The amount of UbiquitinlO transcript was also determined using gene 
J 
specific primers and used to normalize the level of PRJ and GRX480 expression since it 
is a constitutively expressed gene. 
4.3.19 Statistical Methods 
All pooled data are expressed as means and error bars represent SO. When data from two 
independent populations are compared, statistical significance was assessed using a two-
tailed Student's t-test. 
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4.4 RESULTS 
4.4.1 Transactivation of TGAI Inversely Correlates with its Ability to Interact 
with NPRI and is Regulated by the Redox Status of Cysteines 260 and 266. 
Using an in vivo labeling assay, Despres et al. (2003) observed that interaction of 
TGA1 with NPR1 only occurs when Cys260 and Cys266 are reduced. When expressed in 
yeast, the TGA1 cysteines occur in an oxidized state and when incubated with NPR1, no 
TGA1-NPR1 interaction is observed However when these two cysteines are mutated, to 
mimic a reduced state, interaction with NPR1 occurs. 
Varying lengths of exposure to SA did not result in completely or predominantly 
oxidized TGAI in a transient plant transcription assay (data not shown) making this 
system inadequate for studying TGA1 transactivation. As a result, we examined the 
ability of TGA1 to activate transcription in yeast where we observed that TGA1 is 
capable of auto-activation when fused to a DNA binding domain. The coding sequence of 
wild-type (Wt) TGA1 and TGA1C260N/C266S were ligated into the yeast vector pBI880 
(Kohalmi et aI., 1997) which contains the Gal4 DNA binding (DB) domain. Yeast cells 
were transformed with either construct and transactivation was assessed using the X-Gal 
filter test, which monitors the activation of the lacZ reporter gene. Transcriptional 
activation by TGA1 was only observed when Cys260 and C~s266 were oxidized (Table 
1, compare Wt TGA1 and TGAIC260N/C266S in yeast). Also shown in Table 1 is data 
from Despres et al. (2003) showing transactivation of TGA1 in Arabidopsis leaves is only 
observed when some Cys260 and Cys266 are oxidized. Taken together with the NPR1 
interaction results (Despres et al., 2003), these data suggest a mutually exclusive 
regulation of TGA1 such that transactivation of TGA1 is only observed when Cys260 
and Cys266 are oxidized and interaction with NPR1 only occurs when these cysteines are 
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Table 1. The Redox Status of TGAI Dictates Whether TGAI Transactivates or 
Interacts with NPRI 
Protein and Interaction % Reduced % Oxidized 
Treatment with NPR1 Transactivation Cysteine (SH)C Cysteine (S-S)C 
Yeast WtTGA1, NT 
Yeast TGA 1 C260N/C266S, NT 
Arabidopsis 
WtTGA1, NT leavesa 
Arabidopsis Wt TGA 1, +SA(24) leavesa 
NT = No treatment 
N/A = Not applicable 
NOa 
YEsa 
Slight 
YES 
+SA(24) = Treatment with ImM SA for 24 hours 
YESb oa 100a 
NOb N/A N/A 
Slight -50 -50 
NO 100 0 
a Results observed by Despres et aI. (2003). In the case of Arabidopsis leaves, all data had been observed 
previously. 
b Activation of LacZ reporter gene was monitored by X-gal filter assay from colonies grown on medium 
lacking leucine and tryptophan. YES cOlTesponds to the development of blue colour after approximately I 
hour at 30°C while NO corresponds to white colour observed after 16 hours at 30"C 
C Reduced and oxidized cysteines in TGA 1 were determined using a labeling assay which distinguishes 
between sulfhydryls (SH) and disulfides (S-S) (Despres et aI., 2003). Percentages were based on qualitative 
observation. 
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reduced (Despres et al., 2003). 
4.4.2 Arabidopsis TGAI Possesses a Bipartite Transactivation Domain 
Given that the oxidation of Cys260 and Cys266 is involved in regulating the 
ability of TGAI to transactivate, we were interested in determining if other components 
of TGAI were involved in transactivation. The coding region of TGAl and all TGAI 
mutants (Figure lA) were ligated into the yeast vector pBI880 (Kohalmi et aI., 1997) as 
described above. Each of these constructs, along with an empty pBI880 (GaI4DB; no 
fusion) were introduced into yeast where transactivation was examined through the 
expression of ~-galactosidase. 
Figure lB illustrates that the Gal4 fusion of the Cys260/Cys266 double mutant 
has a drastic affect on TGAl's ability to activate reporter gene expression (compare 
TGAl:DB to TGAlC260N/C266S:DB, p<O.OOl) as expected from the results of Despres 
et aI. (2003). 
Next we examined the individual effect of Cys260 and Cys266 on TGAI 's ability 
to activate transcription as well as the influence of the other two cysteines, Cys 172 and 
Cys287, in TGAI. Individual cysteine mutants ofTGAl (Figure lA) were created by site 
directed mutagenesis and their ability to activate transcription was compared to wild type 
J 
TGAI. Figure lB illustrates that mutation of either Cys172 or Cys287 do not affect the 
ability ofTGAl to transactivate (Figure lB, compare TGAl:DB to TGAlC172N:DB and 
TGAlC287S:DB, p>0.05) while the Cys260 mutation significantly reduces TGAl's 
ability to transactivate. The Cys266 mutation also compromised reporter gene expression 
(Figure lB compare TGAl:DB to TGAlC266S, p<O.Ol; compare TGAlC266S:DB to 
TGAlC172N:DB or TGAlC287:DB, p<0.05), but not to the extent of Cys260 mutation 
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Figure 1. TGAI has a Bipartite Transactivation Domain 
(A) Schematic representation of the TGAI mutants that are fused to the Gal4DB in (B), 
(C) and (D). The amino acid length and position are indicated along the top. The bZIP 
domain is shaded in grey while each of the four cysteines (C) in TGAI and their 
corresponding mutation (asparagine (N) or serine (S» are indicated. The bZIP domain 
starts at amino acid 84 and the N-terminal deletion mutant (i1NTGAl) deletes up to 
amino acid 83. 
(B) Histogram illustrating the effect of individual cysteine mutations on the ability of 
TGAI to activate transcription when tethered to DNA througlythe Ga14DB in yeast. 
(C) Histogram illustrating that the ability of TGAI to activate transcription in yeast 
depends on the presence of Cys260 and Cys266 when tethered to DNA through the 
Gal4DB while Cys172 and Cys287 are not required to active transcription. 
(D) Histogram illustrating that the first 83 amino acids of TGAI are also required for the 
transcriptional activity of TGAI in yeast indicating that TGAI has a bipartite 
transactivation domain involving Cys260/Cys266 and the N-terminus. Inset represents 
the histogram illustrated in (D) without TGAl:DB included. 
In (B), (C), and (D) yeast were also transfected with an empty Gal4DB with no fusion to 
establish basal transactivation. Values were divided by the transcriptional activity of the 
empty GaI4DB. This assay was assessed by the ability to activate ~-galactosidase under 
the control of the Ga14 upstream activating sequence (UAS). Data are recorded as ~­
galactosidase activity where activity is defined as one nm of ONP (the product of the ~-
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galactosidase cleavage of ortho-nitrophenol-~-D-galactopyranoside; ONPG) produced 
per minute at 30°C. Each bar represents the average of six independent assays ± SD. 
suggesting that its role in transactivation may be indirect. This is supported by the 
observation that the Cys260lCys266 double mutant significantly reduces reporter gene 
expression below that of the single Cys260 mutant (compare TGAIC260N/C266S:DB to 
TGAIC260N:DB, p<O.05). Interestingly, none of the individual cysteine mutations nor 
the double mutant completely abolish TGAI's ability to transactivate (compare Ga14DB 
to TGAIC260N/C266S and TGAIC260N:DB, p<O.OI). 
We were interested in determining if Cys260, on its own, would be sufficient for 
TGAI's ability to activate transcription. Expression of a Ga14DB fusion of a TGAI 
mutant where all cysteines, except Cys260, were mutated 
(TGAICI72N/C266S/C287S:DB, Figure IA) resulted in reporter gene expression well 
above baseline (p<O.OI) but still significantly lower compared to wild-type TGAI (Figure 
IC, p<O.OI). Considering that Cys266 appears to contribute to TGAI's ability to 
transactivate, we examined a TGAI mutant where Cys260 and Cys266 were maintained 
and Cys172 and Cys287 were mutated (TGAICI72N/C287S; Figure IA). As is 
illustrated in Figure IC, Cys266, in the presence of Cys260, restores TGAI's 
l 
transactivation back to wild-type levels (compare TGAI:DB to TGAICI72N/C287S, 
p=O.5) suggesting that Cys260 and Cys266 are necessary for the transactivation ability of 
TGAI. 
Given that the mutation of Cys260 and Cys266 do not completely abolish the 
ability of TGAI to transactivate, another element in TGAI must be required. Early work 
obtained in planta by Neuhaus et al. (1994) and Pascuzzi et al. (1998) determined that the 
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N-terrninal domain of tobacco TGAla, the Arabidopsis TGAl homolog, is responsible 
for its transactivation ability. We deleted the first 83 amino acids of TGAl 
(mTGA1:DB) and observed a significant decrease in reporter gene activation (Figure 
1D, compare to TGA1:DB, p<0.01). However it was not sufficient to abolish TGA1's 
transactivation ability (Figure 1D (inset), compare Gal4DB to mTGA1:DB, p<O.01), 
presumably because Cys260 and Cys266 are still present (Figure 1D). In an attempt to 
completely abolish the transactivation ability of TGA1, we combined the N-terrninal 
deletion of TGA1 with the Cys260lCys266 mutation (Figure lA; 
mTGA1C260N/C266S:DB). The transactivation ability of this mutant was assessed and 
found to completely abolish TGA1 's ability to transactivate since the level of reporter 
gene activation was no different from baseline (Figure 1 D (inset), compare Gal4DB to 
mTGAlC260N/C266S:DB, p=0.1). 
These results indicate that the N-terminal 83 amino acids and Cys260 and Cys266 
are necessary and sufficient for the transactivation ability of TGA 1. 
4.4.3 The TGAI-NPRI Complex is Capable of Transactivating and does not 
Require the Transactivation Domain of TGAI 
Once the transactivation domain of TGA1 was identifi~d, we were interested in its 
role in the TGAl-NPRl complex (Despres et aI., 2003). Although interaction with NPR1 
occurs prior to SA treatment, we examined interaction following 24 hours SA treatment 
when Cys260 and Cys266 in TGAl are in the reduced state (Despres et aI., 2003). TGA1 
and TGA1 transactivation domain mutants were fused to the Gal4 DB while NPR1 was 
fused to the transactivation domain (TA) of viral particle 16 (VPl6) or expressed without 
a DB or TA domain (Figure 2A). 
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Figure 2. The TGAI-NPRI Complex is Capable of Activating Transcription 
Irrespective of the Transactivation Domain in TGAI 
(A) Schematic representation of the constructs used for transactivation and interaction 
with NPRI in (C) through to (E). Boxed in white are the promoters. CaMV 35S indicates 
the double CaMV35S:AMV promoter. 5X UASGAIA indicates a promoter composed of a 
multimerized (5 elements) Gal4 VAS fused to a minimal TATA box and the Q 
translational enhancer from the tobacco mosaic virus. Boxed in different shades of grey 
are the coding sequences. Gal4DB indicates the Gal4 DNA binding domain where the 
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Gal4DB was fused to wild-type TGAI (TGA1:DB) or one of three TGAI mutants 
(TGAIC260N/C266S:DB, ~TGA1:DB and ~TGAIC260N/C266S:DB). VP16 
indicates the constitutive transactivation domain of viral particle 16 where the VP16 
transactivation domain was fused to wild-type NPRI (NPR1:TA) or the NPRI mutant 
NPRIC521S/C529S where cysteines (C) 521 and 529 have been mutated to serines (S) 
(NPRIC521S/C529S:TA). NPRI and the mutant were also expressed in a vector without 
a Gal4DB or VP16 fusion (NPRI and NPRIC521S/C529S). DB - DNA binding domain, 
TA - transactivation domain. All constructs possess a 3' terminator signal of the gene for 
nopaline synthase (not shown). The 35S:Renilla construct is an internal reference to 
nonnalize transfection efficiency. 
(B) (i) Schematic representation of a classical two-hybrid depicting how the interacting 
proteins TGAI and NPR1, fused to their respective Gal4DB and VP16 TA domains, 
interact on the UASGAIA to result in reporter gene expression. lllustrated in (ii) is the same 
scenario without the VP16 fusion to NPRI (i.e. no artificial transactivation domain is 
being used). In this case, reporter gene activation results from the transcriptional 
activation ability of the TGAI-NPRI complex. Not shown in (i) or (ii) is the contact of 
the complex with the basal transcriptional machinery which is bound to the TAT A box. 
(C) Histogram illustrating the transcriptional activity of the TGAI-NPRI complex in the 
absence of an artificial transactivation domain fused to NPRI where TGAI is tethered to 
DNA through the Gal4DB. 
(D) Histogram illustrating that none of the TGAI transactivation domain mutants are able 
to activate transcription when tethered to DNA through the GaI4DB. Additionally, none 
of these mutants transfected in the presence of NPRI without the VP16 fusion affects the 
ability of the complex to activate reporter gene expression compared to wild-type TGAI. 
(E) Histogram illustrating that interaction between the DB-fused TGAI transactivation 
domain mutants and NPRl:TA is not compromised by the mutations in TGAI. 
(F) Histogram illustrating the ability of the TGAI-NPRI complex to activate 
transcription is the result of the novel transactivation domain in NPRI which consists of 
cysteines 521 and 529. TGAI is tethered to DNA through the Gal4DB and is able to 
interact with NPR1:TA and NPRIC521S/C529S:TA. However the ability of TGAl:DB 
in a complex with NPRIC521S/C529S to activate transcription is abolished. 
In (C), (D), (E) and (F), Arabidopsis leaves were treated for 24 hours with ImM salicylic 
acid (SA). The constructs were transfected along with the 5X UASGAIA:firefly luciferase 
reporter and the CaMV35S:Renilla internal standard. Relitive luciferase units were 
obtained by dividing the value obtained for the reporter gene by the value obtained for 
the internal standard. Arabidopsis leaves were also transfected with an empty Gal4DB in 
the presence of the reporter and internal standard and represents the baseline level of 
transcriptional activation. Data are reported as relative luciferase units where the 
transcriptional activation of each protein or protein pair is divided by the level of 
transcription from the empty GaI4DB. Values consist of n = 25 samples and represent 
averages ± SD. Every bar represents five bombardments repeated five times. 
In the classical two-hybrid experiment, fusion to the DB domain is required to 
tether the interacting proteins to DNA while the TA domain is required for 
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transactivation of the interacting protein complex and reporter gene expression (Figure 
2B(i)). However certain proteins, like TGAI and NPRI (Rochon et al., 2006), contain 
their own transactivation domain, suggesting transactivation of the TGA 1-NPR 1 complex 
could occur in the absence of the artificial TA domain (Figure 2B(ii)). 
The histogram in Figure 2C illustrates that the co-transfection of TGA1:DB and 
NPRI into Arabidopsis leaves treated with ImM SA for 24 hours is able to activate 
reporter gene expression well above baseline despite the removal of the artificial TA 
domain (compare Gal4DB or TGA1:DB to TGA1:DB + NPR1, p<O.Ol). Reporter gene 
expression does drop relative to NPRI fused to an artificial TA domain (compare 
TGA1:DB + NPR1:TA to TGA1:DB + NPR1, p<0.05) however this can be attributed to 
a difference in the strength of the transactivation domains. 
To determine whether TGAI or NPRI is responsible for the transactivation ability 
of the complex, we repeated the above plant two-hybrid experiment using the three 
TGAI transactivation domain mutants expressed as N-terminal Gal4DB fusions: 
TGA1 C260N/C266S:DB, LrnTGA1:DB and ~NTGAIC260N/C266S:DB. We first 
confirmed that none of the TGAI transactivation domain mutants were capable of auto-
activation when fused to the DB (compare Gal4DB to the three TGAI transactivation 
l 
domain mutants, p>0.05). Examining the transactivation ability of the TGAI-NPRI 
complex in the context of the TGAI transactivation domain mutants reveals that reporter 
gene expression is no different than wild-type TGAI in the presence of NPRI (Figure 
2D, p=O.l). The ability of TGAI to interact with NPR1:TA is also not compromised by 
the TGAI transactivation domain mutants (Figure 2E, compare all to TGA1:DB + 
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NPRl:TA, p=O.l). This implies that the ability of the TGAI-NPRI complex to 
transactivate is not dependent on the transactivation domain of TGAl. 
The transactivation domain of NPRI consists of Cys521 and Cys529 where 
mutation of either or both cysteines to a serine abolishes the ability of NPR 1 to 
transactivate in a plant transcription assay when fused to the Gal4DB (Rochon et al., 
2006). Wild-type NPRI and NPRI where Cys521 and Cys529 are mutated to serine were 
fused to the VP16 TA domain (NPRl:TA and NPRIC521S/C529S:TA) or fused to an 
empty vector without a DB or TA domain fusion (NPRI and NPRIC521S/C529S) and 
transfected with TGAI :DB into Arabidopsis leaves. Figure 2F illustrates that the 
mutation of Cys521 and Cys529 in NPRI abolishes the ability of the TGAI-NPRI 
complex to transactivate (compare TGAl:DB + NPRI to TGAl:DB + 
NPRIC521S/C529S, p<O.Ol). The fact that the interaction between TGAI and NPRI is 
not affected by the mutation of Cys521 and Cys529 (compare TGAl:DB + NPRl:TA to 
TGAl:DB + NPRIC521S/C529S:TA, p=O.l) implies that the transactivation domain of 
NPRI is directly responsible for the transactivation of the TGAI-NPRI complex. 
4.4.4 TGAllnteracts with a Novel Glutaredoxin in Plants and is Dependent on 
the Presence of Cys260 and Cys266 
J" 
Given that the transactivation domain of TGAI does not playa role in the 
transactivation of the TGAI-NPRI complex, the transcriptional activation ability of 
TGAI may be required elsewhere. In an attempt to identify proteins that interact with 
TGAl, a yeast two-hybrid screen of an Arabidopsis cDNA library was performed using 
TGA2:DB as bait (data not shown). Using this screen, we identified that TGA2 interacts 
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with GRX480, a previously identified glutaredoxin (Ndamukong et al., 2007) with an 
atypical active site. 
In the case of TGA1, a directed yeast two-hybrid assay was performed using the 
classical Arabidopsis glutaredoxin GRX030 (At5g63030) and the novel glutaredoxin 
GRX480 (Atlg28480). The coding region of the two glutaredoxins were cloned into the 
yeast vector pBI880 (Kohalmi et aI., 1997) while the coding region of TGAl was cloned 
into the yeast Gal4TA vector pBI881 (Kohalmi et aI., 1997). Interaction was assessed 
through blue/white selection using an X-gal filter test. Table 2 indicates that an 
interaction (indicated as YES) was only observed between TGAI and the novel 
glutaredoxin GRX480. 
In order to begin to understand the TGAI-GRX480 interaction, we examined the 
nature of this complex in Arabidopsis leaves. TGAl was fused to the Gal4 DB 
(TGAI :DB) and co-transfected into Arabidopsis leaves with either GRX030 or GRX480 
fused to the VP16 TA (GRX030:TA or GRX480:TA). Reporter gene expression was 
monitored after 24 hours in the absence and presence of 1mM SA. The histogram in 
Figure 3A illustrates that TGA1:DB is able to interact with the novel glutaredoxin 
GRX480:TA before SA treatment (white bars; compare to Gal4DB, p<O.OI) and this 
j 
interaction is significantly enhanced after exposure to SA (grey bars). On the other hand, 
interaction between TGA1:DB and GRX030:TA, the classical glutaredoxin, is not 
observed regardless of SA's presence (compare to Gal4DB, p>0.05 before and after SA). 
In view of the fact that Cys260 and Cys266 are involved in regulating the ability 
of TGAI to transactivate or interact with NPR1, we were interested in determining if 
interaction with GRX480 was affected by the absence of either or both cysteines. Fusions 
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Table 2. TGAI Interacts with the Novel Glutaredoxin GRX480 but not the Classical 
Glutaredoxin GRX030. 
Baita Active PreyC Interactiond Siteb 
Grx030:DB CGYC TGA1:TA NO (Classical) 
Grx480:DB CCMC TGA1:TA YES (Novel) 
GRX030 (AtSg63030) and GRX480 (Atlg28480) 
a The bait indicates a Gal4 DNA binding domain fusion (DB) 
bThe Active site represents the active site of the glutaredoxin 
(classical and novel are defined in the text) 
C The prey indicates a Gal4 transcriptional activation domain 
fusion (TA) 
d Activation of LacZ reporter gene was monitored by X-gal 
filter assay from colonies grown on medium lacking leucine 
and tryptophan. YES corresponds to the development of blue 
colour after approximately 1 hour at 30nC while NO 
corresponds to white colour observed after 16 hours at 30"C 
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Figure 3. Interaction between TGAI and the Novel Glutaredoxin GRX480 in 
Arabidopsis Leaves Differentially Depends on Cys260 and Cys266 
(A) Histogram illustrating that TGAI tethered to DNA through the Gal4DB (TGAl:DB) 
and the novel Arabidopsis glutaredoxin GRX480 expressed as a VP16 TA fusion 
(GRX480:TA) interact to activate transcription. Interaction between TGAl:DB and the 
classical Arabidopsis glutaredoxin (GRX030:TA) is not observed. Interaction between 
TGAl:DB and NPR1:TA is used as a positive control while TGA1 :DB alone is used as a 
negative control. 
(B) Histogram illustrating that the mutation of either Cys260, Cys266 or both in TGA1 
tethered to DNA through the Gal4DB (TGA1C260N:DB, TGA1C266S:DB and 
TGA1C260N/C266S:DB respectively) have different affects on the ability of TGA1 to 
interact withGRX480. 
In (A) and (B), Arabidopsis leaves were untreated (white b¥s) or treated for 24 hours 
(grey bars) with 1mM salicylic acid (SA). The constructs were transfected along with the 
5X UASIALA:fuefly luciferase reporter and the CaMV35S:Renilla internal standard. 
Relative luciferase units were obtained by dividing the value obtained for the reporter 
gene by the value obtained for the internal standard. Arabidopsis leaves were also 
transfected with an empty Gal4DB in the presence of the reporter and internal standard 
and represents the baseline level of transcriptional activation. Data are reported as 
relative luciferase units where the transcriptional activation of each protein or protein pair 
is divided by the level of transcription from the empty Gal4DB. Values consist of n = 25 
samples and represent averages ± SD. Every bar represents five bombardments repeated 
five times. 
(C) Blot analysis of a TGA1C172N/C266S/C287S immunoprecipitate expressed in yeast 
and Arabidopsis leaves (untreated) to assess the in vivo redox status of Cys260. In both 
instances, the protein was expressed as a transactivation domain fusion (GaI4TA in the 
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case of yeast and VP16 TA in the case of Arabidopsis leaves) since neither domain 
contains any cysteines. Ox represents immunoprecipitates from proteins labeled for 
oxidized cysteine residues (lane 1) while Red indicates immunoprecipitates from proteins 
labeled for reduced cysteine residues (lane 2). The ponceau (yeast) and anti-TGA1 
(Arabidopsis leaves) establish the loading control in each instance. 
to the Gal4DB and VP16 TA were performed as described above and reporter gene 
expression was monitored after 24 hours in the absence (white bars) and presence (grey 
bars) of 1mM SA (Figure 3B). Mutation of both cysteines in TGA1 abolishes the ability 
of GRX480 to interact with TGA1 only after SA treatment (grey bars, compare 
TGA1:DB + GRX480 to TGA1C260N/C266S:DB + GRX480, p<O.Ol) as interaction 
before SA treatment was no different (white bars, p=O.l) (Figure 3B). Interaction 
between TGA1 with Cys260 mutated and GRX480 mimicked the double cysteine mutant 
before and after SA treatment (grey and white bars, compare TGA1C260N/C266S:DB + 
GRX480 to TGA1C260N:DB + GRX480, p>O.05). Interestingly, mutation of Cys266 in 
TGA1 had no affect on interaction with GRX480:TA after SA treatment (grey bars, 
compare TGA1:DB + GRX480:TA to TGA1C266S:DB + GRX480:TA, p=O.l), however 
interaction occurred in the absence of SA treatment and was no different from the 
interaction between wild-type TGA1:DB and GRX480:TA after SA treatment (compare 
TGA1:DB + GRX480:TA (grey bars) to TGA1C266S:DB 1iGRX480:TA (white bars), 
p=O.l) (Figure 3B). Additionally, the interaction of TGA1C266S:DB with GRX480:TA 
was no different from the level of interaction observed after SA treatment (compare grey 
and white bars TGA1C266S:DB + GRX480:TA, p=O.l). These results indicate that 
interaction between TGA1 and GRX480 differentially depends on the presence and redox 
status of Cys260 and Cys266. 
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4.4.5 Cys260 Remains Oxidized in the Absence of Cys266 
Considering the importance of Cys260 in regulating TGA1's ability to 
transactivate and interact with GRX480, we examined the redox status of a TGA1 mutant 
where all cysteines, except Cys260, were mutated. This TGA1 mutant, 
TGA1C172N/C266S/C287S, was fused to either the Gal4TA or VP16 TA and transfected 
into yeast or plant, respectively and the redox status of Cys260 was determined using a 
labeling assay described and illustrated in Despres et al. (2003). In plants, the redox 
status was only assessed before SA treatment since all the cysteines in TGA1 are reduced 
after SA treatment. Figure 3C illustrates that Cys260 is predominately oxidized (Ox) in 
yeast (lane 1, Streptavidin) while very little reduced (Red) Cys260 is observed (lane 2, 
Streptavidin) despite approximately equal protein loading (compare yeast lanes 1 and 2, 
Ponceau). In Arabidopsis leaves, a noticeable amount of Cys260 remains oxidized (lane 
1, Streptavidin) considering only 50% of TGA1 is oxidized in the absence of SA (Table 
1). While the amount of reduced Cys260 is higher in Arabidopsis leaves (lane 2, 
Streptavidin) and the protein loading is approximately equal (compare lanes 1 and 2, 
Anti-TGA1), the observation of any oxidized Cys260, combined with the predominantly 
oxidized Cys260 in yeast, suggests that Cys260 is oxidized Jin the absence of Cys266. 
Given that glutaredoxins are also able to reduce mixed disulfides with glutathione, it 
seems reasonable to suggest that the observed oxidized Cys260 results from a disulfide 
bond with glutathione. 
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4.4.6 GRX480 only Interacts with the Reducedform ofTGAI 
In an attempt to address the possibility that GRX480 binds TGAI to reduce a 
mixed disulfide, we performed a pull-down between E. coli purified GRX480 and 
reduced and oxidized forms of TGAI. HIS-tagged purified fractions of TGAI were 
combined and split in half, one half was treated with lOmM GSSG to glutathionylate 
TGAI (TGA10x) while the other half was left untreated (TGAI Red). Magnetic beads 
tagged with streptavidin provide a solid support for the pull-down and were incubated 
with a DNA probe specifically recognized by TGA TFs fused to biotin (Lebel et aI., 
1998; Despres et al., 2000). Once the probe is coupled to the beads in two separate pull-
downs, oxidized and reduced TGAI are coupled to the DNA. The mixture of beads-
DNA-TGAlox or -TGAI Red is then incubated with equal aliquots of HIS purified 
GRX480. As a control, mixtures of beads-DNA-TGAlox or -TGAI Red were also 
incubated with an E. coli extract not expressing GRX480. The pull-downs were eluted 
and electrophoresed on a 12% SDS-polyacrylamide gel where a 10% input of GRX480 
(lane 1, Figure 4A) was included as a point of reference. Figure 4A illustrates that the 
reduced but not oxidized form of TGAI (lanes 2 and 3, respectively, open arrow) was 
able to pull-down GRX480 (solid arrow). This pull-down is ~pecific since incubation of 
either reduced or oxidized TGAI with an E. coli extract (lanes 4 and 5, respectively) did 
not result in any binding. 
This result was unexpected as GRX480 was hypothesized to bind the 
glutathionylated form of TGAI to reduce it. In order to ensure that glutathionylation of 
TGAI was in fact occurring, we subjected a fraction of glutathionylated TGAI and 
untreated TGAI to MALDI TOF mass spectroscopy. After being electrophoresed, 
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Figure 4. GRX480 only Interacts with the Reduced form of TGAI 
(A) Immunoblot of a DNA-based pull-down between E. coli expressed, HIS column-
purified TGA10x or TGA1 Red and GRX480. The TGA1 HIS purified fractions were 
collected and divided, one half was treated with lOmM GSSG to glutathionylate the 
cysteines in TGA1 (TGA10x) while the other half was left untreated (TGA1Red). In 
separate reactions, TGA10x and TGA1Red were coupled to a DNA-bead mixture which 
contained LS5 and LS7, two DNA regions containing the TGA factors cognate binding 
sequence TGACG (Lebel et aI., 1998). Equal amounts of GRX480 or an E. coli extract 
were incubated with TGA10x and TGA1 Red. Protein complexes were then eluted from the 
DNA beads and electrophoresed on a 12% SDS-polyacrylamide gel. Detection was 
accomplished using an anti-HIS primary antibody, a secondary antibody coupled to a 
fluor and infrared imaging using the Odyssey imager. Lane 1 is the GRX480 input and 
represents 10% of the amount of GRX480 incubated with TGA1Red or TGA10x in lanes 2 
and 3, respectively. Lanes 4 and 5 are the negative controls where TGA1 Red and TGA1 0x 
coupled to DNA-beads were incubated with an E. coli extract, respectively. The solid 
arrow indicates the band that corresponds to GRX480 while the open arrow indicates the 
band that corresponds to TGA1 (either oxidized or reduced). 
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(B) MALDI TOF mass spectra of untreated (top panel in (i) and (li)) and GSSG treated 
(bottom panel in (i) and (ii)) trypsin-digested TGAI from E. coli. The spectra in (i) 
represent the entire mlz range for TGA 1 while the spectra in (ii) are a close up of the 
boxed in region in (i) around the Cys260 peptide. The peak corresponding to the peptide 
containing Cys260, V 43 to ~3, is indicated by the open arrow (expected mlz = 2480.32, 
observed mlz = 2482.074) in the top panel in (i) and (ii). The solid arrow in the bottom 
panel of (ii) indicates the peptide that contains Cys260 has been glutathionylated 
(expected mlz = 2729.30, observed mlz = 2729.692). The intensity of each peptide is 
represented along the y-axis in arbitrary units (a.u.) and the charge-to-mass ration of the 
peptides (mli ) is represented along the x-axis. 
(C) Blot analysis of GRX480 immunoprecipitate from E. coli to assess the in vivo redox 
status of all cysteine residues. Ox represents immunoprecipitates from proteins labeled 
for oxidized cysteine residues (lane 1) while Red indicates immunoprecipitates from 
proteins labeled for reduced cysteine residues (lane 2). The unlabeled sample (lane 3) 
represents 25% of the amount in lanes 1 and 2 but was not treated for either Ox or Red 
labeling and acts as a negative control. The anti-HIS detection acts as a loading control in 
each lane. 
The reduced and glutathionylated forms of TGAI were subjected to an in-gel tryptic 
digest and then analyzed in the positive mode by the Autoflex II TOFITOF mass 
spectrometer (Bruker Daltonics). Figure 4B(i) illustrates the mass spectra obtained for 
reduced (untreated; top panel) and glutathionylated (GSSG treated; bottom panel) TGAI. 
The peptide containing Cys260, which is indicated in the top panel (open arrow; expected 
mlz = 2480.32, observed mlz = 2482.074), is no longer present in the glutathionylated 
TGAI sample (bottom panel). Closer examination of an enlarged version of the spectra, 
around the Cys260 peptide (Figure 4B(ii)), reveals that theJloss of this peptide in the 
glutathionylated TGAI sample (bottom panel) corresponds with the appearance of a 
peptide with an mlz value equivalent to the Cys260 peptide modified by glutathione 
(solid arrow; expected mlz = 2729.30, observed mlz = 2729.692). This indicates that 
glutathionylation of TGAI produces the desired results. As an interesting side note, we 
observed that the peptide containing Cys287 (expected mlz = 3044.46, observed mlz= 
3044.820, not highlighted in Figure 4B) is unchanged after the GSSG treatment of TGAI 
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suggesting the reactivity of this cysteine to glutathione is very low or non-existent. The 
peptides corresponding to Cys 172 (expected m/z = 818.42) and Cys266 (expected m/z = 
1823.79) did not ionize in untreated or GSSG treated samples. The mass list of the 
peptide fingerprints for untreated and GSSG treated TGAI are included in the Appendix 
in Table 2 and 3, respectively. 
The nature of GRX480 purified from E. coli is another factor that might account 
for the unexpected result in Figure 4A. Since GRX480 is a foreign protein being 
expressed in E. coli, it may be non-specifically oxidized or glutathionylated which might 
affect its activity. In order to establish the redox status of GRX480 isolated from E. coli, 
we performed the same labeling assay described for Cys260 in TGAI (Figure 3C) to 
distinguish oxidized and reduced cysteines. Oxidized (Ox) and reduced (Red) labeled 
fractions were electrophoresed along with a sample of untreated GRX480. Figure 4C 
reveals that the cysteines in GRX480 are completely reduced (lane 2, Streptavidin). The 
minor signal observed in the Ox sample (lane 1, Streptavidin) is qualitatively no different 
from the signal observed in the unlabeled sample (lane 3, Streptavidin) suggesting that 
there are no oxidized cysteines in GRX480. The loading control, which is based on 
detection using an anti-HIS antibody, reveals that the loading is biased toward the Ox 
J 
sample (compare lanes 1 and 2, Anti-HIS). 
Therefore, the proper glutathionylation of TGAI and lack of modification of 
GRX480 suggest that the observation that only reduced TGAI is able to pull-down 
GRX480 is authentic. 
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4.4.7 GRX480 does not have Classical Glutaredoxin Activity 
Since GRX480 only binds reduced TGA1, we questioned whether it had 
enzymatic activity. In order to test this hypothesis, we used a classical assay, known as 
the HED assay, to assess the ability of GRX480 to reduce a mixed disulfide (Holmgren 
and Aslund, 1995). In the HED assay, which is outlined in Figure 5, the substrate HED 
(B-hydroxyethylene disulfide or XSSX) is reacted with reduced glutathione (GSH) to 
form the mixed disulfide GSSX. This mixed disulfide is then reduced, by the 
glutaredoxin being studied, in the presence of GSH to generate the reduced substrate 
(XSH) and oxidized glutathione (GSSG). The GSSG is then consumed by glutathione 
reductase in an NADPH dependent manner, generating GSH and NADP+ as products. 
The overall reaction is monitored as a decrease in absorbance at 340nm, due to the loss of 
NADPH. Comparing the classical Arabidopsis glutaredoxin GRX030 with GRX480 in 
the HED assay (Table 3) reveals that only the classical glutaredoxin has activity reducing 
a mixed disulfide. 
Glutaredoxins have a GSH binding site that has been identified by NMR 
(Bushweller et aI., 1994) and site-directed mutagenesis (Nikkola et aI., 1991). In the 
glutaredoxin catalytic cycle, GSH binds to oxidized glutared6xin and reduces it, making 
the enzyme available for further reduction reactions (Fernandes and Holmgren, 2004). 
Considering the novel active site in GRX480, other features of the enzyme might also be 
slightly altered, including the GSH binding site, which might impede the reducing ability 
of GRX480. A multiple alignment of several glutaredoxins from various organisms is 
shown in Figure 6 in the region of the GSH binding site where the critical active site 
glycine, highlighted in grey, is conserved in GRX480 (Nikkola et aI., 1991; Xing and 
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GSH + XSSX ~ GSSX + XSH 
GSH + GSSX Glut.redoxin) GSSG + XSH 
GSSG + NADPH + H+ GSH Reduct.se) 2 GSH + NADP+ 
NADPH + H+ + XSSX ~ NADP+ + 2 GSH 
Figure 5. Schematic of the Reactions that take Place in a HED Assay 
The substrate HED (~-hydroxyethylene disulfide; XSSX) is reacted with reduced 
glutathione (GSH) to produce a mixed disulfide (GSSX). GSSX is then reduced by the 
glutaredoxin being tested which uses GHS as a substrate. This results in reduced 
glutathione (GSSG) and the reduced product (XSH). GSSG is then reduced by 
glutathione reductase (GSH reductase) in the presence of NADPH and H+ to give two 
molecules of GSH and NADP+. The overall reaction is also shown. Taken from 
Holmgren and A.slund (1995). 
Table 3. GRX480 Lacks Classical Glutaredoxin Activity in the HED Assay 
Enzyme Signature Class 
GRX030 CGYC Classical 
GRX480 CCMC Novel 
Activity 
(Units/mg) 
J 
153 ± 14 
o 
Activity was measured in the HED assay as a loss of 
NADPH followed as a decrease at 340nm. 
One unit is defined as the consumption of l~mol ofNADPH 
per minute. 
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E.coli Grxl 
Human Grx2 
Grx2061 
Grx1562 
ROXYl 
ROXY2 
GRX030 
GRX4BO 
VPQIFVDQQHI&GYTDFAAWVKEN 
VPRIFVNGTFIGGATDTHRLHKEG 
LPQIFIDDQHIGGCDDIYALDGAG 
VPQI FVNDQGIGGCDQLYGLDSRG 
SPGSLPVVFIGGKLVGAMDRVMAS 
SPGALPVVFIGGKMVGAMERVMAS 
VPNVFIGGNHIGGCDATSNLHKDG 
LPAVYVGGRLFGGLDRVMATHISG 
Figure 6. Multiple Alignment Highlighting the GSH Binding Domain in GRX480 
Clustal W alignment of the C-terminal region of E. coli Grx 1 (P68688), Human Grx2 
(AAK72499), Synechocystis Grx 2061 (NP _440852) and Grx1562 (NP _442889) and the 
Arabidopsis glutaredoxins ROXYI (NP _186849), ROXY2 (ABY5517), GRX030 
(At5g63030) and GRX480 (Atlg28480). The underlined region indicates the GSH 
binding site with the critical glycine (G) residue shaded in dark grey. The C-terminal 99-
123 amino acids are aligned according to the numbering of GRX480. 
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Zachgo, 2008). ROXYI and ROXY2 are two novel glutaredoxins in Arabidopsis that 
contain the same atypical active as GRX480 (Xing and Zachgo, 2008). The importance of 
a glycine in the GSH binding site of this novel class of glutaredoxins is highlighted by 
ROXYl, where a mutant with the glycine mutated to an alanine was unable to rescue the 
phenotype when expressed in roxyl-5 mutant plants (Xing · et aI. , 2005). This would 
suggest that GSH binding is critical for the novel class of Arabidopsis glutaredoxins. 
Therefore, the potential lack of GRX480's ability to bind GSH likely does not account 
for its lack of activity in the HED assay. 
4.4.8 GRX480 Glutathionylates TGAI at Cys260 
One feature of glutaredoxins that has yet to be established as a common activity is 
the glutathionylation of proteins; this mechanism would involve the addition of 
glutathione, most likely from GSSG, to a cysteine. This activity has only been 
characterized for mammalian Grx1 (Starke et aI., 2003) and Grx 2 (Beer et aI., 2004). 
Since GRX480 exhibits none of the behavior associated with a classical 
glutaredoxin and selectively binds the reduced form of TGAI over the oxidized form, we 
postulated that GRX480 acts to glutathionylate TGAI. To address this issue we utilized 
our DNA-based pull-down assay to tether TGAI to a solid Jsupport in the presence of 
GRX480 and GSSG. In this instance, we used the TGAI mutant 
TGAIC172N/C266S/C287S to specifically address the glutathionylation of Cys260, 
which appears to be the critical cysteine based on our results thus far. Being aware that 
simply incubating TGAI with GSSG is sufficient for chemical glutathionylation, we 
reduced the concentration of GSSG (5mM instead of lOmM) and decreased the length of 
exposure to GSSG (30 minutes instead of 1 hour) as well as the conditions (room 
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temperature instead of 37°C). Once TGAI was coupled to the DNA-beads, it was 
incubated with GRX480 alone, GSSG alone or GRX480 in the presence of GSSG. After 
a 30 minute incubation, the bead-DNA-TGAIC172N/C266S/C287S mixtures were 
washed and incubated with 0.2mM MPB for 1 hour to label reduced Cys260. The 
different TGAIC172N/C266S/C287S treatments were then electrophoresed and detection 
was performed with streptavidin conjugated to the Alexa fluor 680 (Figure 7 A). Since 
TGA 1 C 1 72N/C266S/C287S was reduced before being HIS purified and applied to the 
DNA-coupled beads, incubation with GRX480 on its own represents 100% reduced 
Cys260 (Figure 7A, lane 1, S-H detection). The signal in lane 3 (S-H detection) 
represents incubation with just GSSG and gives the level of glutathionylation from 
chemical treatment. The signal in lane 2 (S-H detection), represents the level of 
glutathionylation by GSSG in the presence of GRX480. The loading control, which was 
established from an immunoblot of the membrane with anti-HIS antibody, indicates that 
loading was more or less even between all lanes. The intensity of the bands in each lane 
was estimated based on the number of pixels (table below each lane) and the relative 
intensity of each band was determined by dividing the intensity of S-H detection by the 
anti-HIS detection. Quantitatively, the decrease in relative intensity observed for TGAI 
J 
in the presence of GSSG and GRX480 (lane 2) compared to just GSSG (lane 3) indicates 
that glutathionylation of Cys260 in TGAI is increased in the presence of GRX480. 
Since mammalian Grx 1 and Grx 2 are able to glutathionylate and 
deglutathionylate their target proteins (Starke et aI., 2003; Beer et al., 2004), we were 
interested in examining the specificity of GRX480 for the glutathionylation of TGAI 
since it cannot reduce a mixed disulfide. In order to do this, we repeated the experiment 
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A 
SOH Detection 
• Loading Control (Anti-HIS) . 
1 2 3 
lnlensityS-H 548.76 66.40 289.68 
Intensity l oading Control 257.23 211 .16 304.92 
Relative Intensity (S-HlLoading ) 2.13 0.31 0.95 
B 
SOH Detection 
Loading Control (Anti-HIS) 
2 3 4 5 6 7 8 
IntensityS-H 54.74 15.15 17.58 18.47 54.54 84.17 39.83 64.68 
intensity loading Control 6.35 5.74 5.36 5.25 5.94 6.42 5.97 5.97 
Relalive Intensity (S-HlLoading ) 8.62 2.64 3.28 3.52 9.18 13.11 6.67 10.83 
Figure 7. GRX480 is able to Glutathionylate TGAI in the Presence of GSSG at 
Cysteines 260 
(A) Blot analysis of a TGAIC172N/C266S/C287S (TGAIN/S/S) pull-down to assess the 
redox status of Cys260 in the presence of GRX480. TGAIC172N/C266S/C287S HIS 
purified from E. coli was coupled to DNA-beads in the same manner described for Figure 
4A. An enzyme assay was then performed on TGAICI72N/C;266S/C287S by incubating 
it, in separate reactions, with GRX480 (lane 1), GRX480 and GSSG (lane 2) or GSSG 
(lane 3). Incubation proceeded for 30 minutes at which point TGAI was labeled for 
reduced cysteines by treatment with MPB. TGAIC172N/C266S/C287S was then eluted 
and electrophoresed on a 10% SDS-polyacrylamide gel and reduced cysteines were 
detected (S-H detection) using a streptavidin:Alexa fluor conjugate detected by infrared 
imaging. Loading was assessed with an anti-HIS immunoblot (Loading control). 
(B) Blot analysis of a TGAIC172N/C266S/C287S (TGAIN/S/S) pull-down to assess the 
redox status of Cys260 in the presence of GRX480 and GRX030. The experiment was 
repeated as described in (A) with the following assays on TGAICI72N/C266S/C287S: 
GRX480 (lane 1), GRX480 + GSSG (lane 2), GSSG (lane 3), GRX030 + GSSG (lane 4), 
GRX030 (lane 5), GRX030 + GSH (lane 6), GSH (lane 7) and GRX480 + GSH (lane 8). 
In (A) and (B), the intensity of each band was assessed with an identical sized box using 
the Odyssey Imaging software (LICOR). Relative intensity reflects the amount of 
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reduced Cys260 normalized for the level of protein present (S-H detection/Loading 
control). 
in Figure 7 A to include the classical glutaredoxin GRX030 and GSH as a substrate. 
Considering that GRX480 and TGAIC172N/C266SIC287S are both reduced, the 
addition of GSH, another reduced molecule, by GRX480 to TGAI is technically not 
possible. However considering the nature of the novel glutaredoxins and their lack of 
conformity, we did not want to rule anything out. The results of the expanded experiment 
can be seen in Figure 7B where the assays with TGAIC172N/C266SIC287S, GSSG and 
GRX480 were repeated in addition to the same experiment with GSH instead of GSSG 
and with GRX030 instead of GRX480. What can be surmised from Figure 7B is: (i) GSH 
is not a substrate for GRX480 glutathionylation of TGAI (compare lanes 2 and 8 and 1 
and 8, S-H detection as well as their corresponding relative intensities) nor is GSH 
capable of chemically modifying TGAI (compare lanes 3 and 7, S-H detection and their 
corresponding relative intensities), (ii) although the qualitative difference between 
TGAIC172N/C266SIC287S and GSSG versus TGAIC172N/C266SIC287S and GSSG in 
the presence of GRX480 appears as though there is no difference (compare lanes 2 and 3, 
S-H detection), the corresponding relative intensities indicate that there is, and (iii) the 
l 
qualitative difference between glutathionylation of TGAIC172N/C266S/C287S in the 
presence of GSSG by either GRX480 or GRX030 appears similar (compare lanes 2 and 
4, S-H detection) however the corresponding relative intensities indicate that the 
glutathionylation of TGAIC172N/C266S/C287S in the presence of GSSG and GRX030 
is in fact not different from TGAIC172N/C266S/C287S and GSSG alone (compare 
relative intensity of lanes 3 and 4). These results indicate that GRX480 can 
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glutathionylate TGA1 at Cys260 using GSSG and not GSH as a substrate and GRX030 
cannot. 
4.4.9 GRX480 Acts to Shut Down the Transactivation of the TGAI-NPRI 
Complex 
Since GRX480 is responsible for oxidizing TGA1, we sought to determine what 
its role could be during SAR. An interesting observation by Ndamukong et al. (2007) was 
that the expression of GRX480 is SA inducible. This led us to examine the expression 
profile of GRX480 during SAR to establish timing of expression and possibly relate it to 
the immediate-early or late timing displayed by many SAR genes (Horvath and Chua, 
1996). We performed quantitative PCR using gene specific primers on Arabidopsis 
leaves that were treated with 1mM SA for 0, 1 or 8 hours (Figure 8A). The level of 
expression of PRJ and GRX480 were monitored and normalized by the expression of 
VEJO, a constitutively expressed gene. Figure 8A illustrates that expression of GRX480 
follows the same profile and responsiveness as PRJ to SA suggesting that its expression 
correlates with late events in SAR. To this end, we examined the effect of GRX480 on 
the TGA1-NPR1 complex. By transfecting Arabidopsis leaves with TGA1:DB in the 
presence of NPR1 and GRX480 (both in empty vectors) compared to TGA1:DB with 
J 
NPR1, we determined that GRX480 almost completely abolishes the ability of the 
TGA1-NPR1 complex to transactivate in the absence (white bars, compare to GaI4DB, 
p<0.01) and presence (grey bars, compare to GaI4DB, p<0.01) of SA (Figure 8B). These 
data suggest that GRX480 acts to glutathionylate TGA1 at Cys260 to impede its 
interaction with NPR1. 
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Figure 8. GRX480 acts to Repress the Transactivation of the TGAI-NPRI Complex 
(A) Histogram illustrating the expression profile of PRJ and GRX480 after 0 (white), 1 
(light grey) and 8 (dark grey) hours of ImM SA treatment in Arabidopsis leaves. 
Expression was normalized to the expression of the constitutive gene VB 10. 
(B) Histogram illustrating the negative effect of GRX480 on the transcriptional activation 
of the TGAI-NPRI complex. TGAI is tethered to DNA through Gal4DB while NPRI 
and GRX480 are expressed without a fusion. Arabidopsis leaves were untreated (white 
bars) or treated for 24 hours (grey bars) with ImM SA. The constructs were transfected 
along with the 5X UASGALA:firefly luciferase reporter and the CaMV35S:Renilla internal 
standard. Relative luciferase units were obtained by dividing the value obtained for the 
reporter gene by the value obtained for the internal standard. Arabidopsis leaves were 
also transfected with an empty Gal4DB in the presence of the reporter and internal 
standard and represent the baseline level of transcriptional activation. Data are reported 
as relative luciferase units where the transcriptional activation of each protein or protein 
pair is divided by the level of transcription from the empty Gal4DB. Values consist ofn = 
25 samples and represent averages ± SD. Every bar represents five bombardments 
repeated five times. 
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4.5 DISCUSSION 
Our study has demonstrated that TGA1 has two activities depending on the 
oxidation state of Cys260 and Cys266. The reduced form of TGA1, which interacts with 
NPR1 and is predominant after SA treatment, is likely involved in the expression of PRJ 
(Despres et aI., 2003; Zhang et aI., 2003; Kesarwani et aI., 2007). The function of the 
oxidized, trans activating form of TGA1 is unclear, although it is believed to be NPR1-
independent. Furthermore, our data illustrate that a novel glutaredoxin, which lacks 
classical glutaredoxin activity, specifically interacts with the reduced form of TGA1 to 
glutathionylate it, abrogating interaction with NPR1 thereby providing a mechanism by 
which the TGAI-NPRI complex is regulated. 
4.5.1 The Transactivation Ability that Results from the Oxidation of Cys260 and 
Cys266 Suggests a Mutually Exclusive Regulation of TGA1 Through a Novel 
Redox Switch 
Despres et ai. (2003) initially established that the ability of TGAI to interact with 
NPR1 is dependent on the redox status of Cys260 and Cys266 in yeast and Arabidopsis 
leaves. When these two cysteines are oxidized, TGAI is not able to interact with NPRI. 
However when these two cysteines are reduced, TGA1 is ,Pompetent to interact with 
NPRI (Table 1). We further expanded on TGA1's behavior by examining its ability to 
activate transcription in yeast. We observed that transactivation of TGAI only occurs 
when Cys260 and Cys266 are oxidized. When these two cysteines are mutated, which 
mimics a reduced state by abrogating oxidation, transactivation was abolished (Table 1). 
This correlates with data from Despres et ai. (2003) who observed, using a transient 
transcription assay in plants, that TGAI activates transcription prior to SA treatment 
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only, which corresponds to a state when Cys260 and Cys266 are oxidized (Table 1). To 
date, NPRI is the only other example of a protein whose transactivation domain is 
positively regulated by cysteine oxidation (Rochon et aI., 2006). Interestingly, the 
transactivation ability of TGAI is not required for the transactivation of the TGAI-NPRI 
complex that forms in Arabidopsis leaves (Figure 2C and D). Instead, a novel 
transactivation domain identified in the C-terminus of NPRI (Rochon et al., 2006) is 
responsible for the transactivation of the complex (Figure 2F, compare TGAl:DB + 
NPRI to TGAl:DB + NPRIC521S/C529S). 
Based on the above results, the behavior of TGAI appears to be regulated in a 
mutually exclusive manner through a novel redox switch. A classical redox switch is 
normally regulated such that one state, either oxidized or reduced, is the active or ON 
form of the protein while the other state constitutes the OFF or inactive form (HeImann, 
2002; Shelton et aI., 2005). Contrastingly, the TGAI redox switch appears to be unique 
as the redox status appears to regulate which activity TGAI participates in rather than if 
it is ON or OFF; the oxidized form of TGAI activates transcription while the reduced 
form interacts with NPRl, neither form seems to constitute an OFF position. 
4.5.2 Cys260 is Critical for TGAI to Activate TranscPiption and Interact with 
GRX480 while Cys266 plays a Minor, Albeit Important Role 
Although TGAI has four cysteines, Cys172 and Cys287 are not involved in 
regulating TGAl's transactivation ability (Figure IB). A double mutant of Cys260 and 
Cys266 in TGAI has already been shown to abolish transactivation (Figure IB and 
Despres et aI., 2003). Examining the contribution of individual cysteines revealed that 
Cys260 plays a more important role in regulating TGAl's transactivation ability than 
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Cys266 (Figure IB, compare TGAI:DB to TGAIC260N:DB and TGAIC266S:DB). 
However, while a TGAI mutant where only Cys260 is wild-type is able to activate 
transcription above baseline (Figure IC, compare Gal4DB to 
TGAICI72N/C266S/C287S:DB), the presence of Cys266 is required to restore 
transactivation to the level of wild-type TGAI (Figure IC, compare TGAI 
C172N/C266S/C287S:DB to TGAICI72N/C287S:DB) . Additionally, mutating Cys266 
in the presence of Cys260 has a more drastic affect on TGAI's transactivation than just 
Cys260 mutated on its own (Figure IB, compare TGAIC260N/C266S:DB to 
TGAIC260N:DB). Kim et al. (2002) observed a similar phenomenon with the redox 
regulated transcription factor OxyR. They determined that the mutation of one critical 
cysteine in OxyR abolished transactivation but optimal transcriptional activity required 
the presence of the critical cysteine plus a second cysteine nine amino acids away. The N-
terminus of TGAI is also involved in regulating the transactivation ability of TGAI 
(Figure ID) indicating that Cys260, Cys266 and the N-terminal 83 amino acids of TGAI 
are necessary and sufficient for transcriptional activation. 
The ability of TGAI to interact with GRX480 depends differentially on the 
presence and redox status of Cys260 and Cys266 in TGAl. In the plant two-hybrid 
J 
system, when Cys260 is mutated, interaction with GRX480 prior to SA treatment is not 
affected whereas the enhanced interaction in response to SA is abolished (Figure 3B, 
compare TGAI:DB + GRX480:TA to TGAIC260N:DB + GRX480 white and grey bars). 
Mutation of Cys266 on the other hand, results in a level of interaction between TGA 1 and 
GRX480 before SA treatment comparable to that observed between wild-type TGAI and 
GRX480 following SA treatment (Figure 3B, compare TGAl:DB + GRX480:TA (grey 
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bar) to TGAIC266S:DB + GRX480:TA (white bar)). These data, combined with the 
results from Table 1, imply that interaction with GRX480 prior to SA treatment is 
prevented by the oxidation of Cys266. Interaction between TGAI and GRX480 after SA 
treatment does not differ upon Cys266 mutation indicating that it only negatively 
regulates interaction in unstimulated cells while its reduction is required for interaction 
following SA treatment. The importance of Cys260 in TGAI 's interaction with GRX480 
is more complex. Up to this point, we have assumed that the mutation of a cysteine is 
synonymous to a reduced state however this is not sufficient to explain the observations 
in this instance. If the oxidized versus reduced state of Cys260 was dictating interaction 
with GRX480, then interaction between GRX480 and wild-type TGAI or TGAIC260N 
should be the same after SA treatment. However, this is not the case (Figure 3B, grey 
bars, compare TGA1:DB + GRX480:TA to TGAIC260N:DB + GRX480:TA). It 
therefore appears that the presence of a cysteine at position 260, in combination with its 
redox status, is required for interaction with GRX480. This is further supported by the 
observation that the enhanced interaction between TGAI and GRX480 in the absence of 
SA is abolished when Cys260 is mutated in combination with Cys266 (Figure 3B, white 
bars, compare TGAIC260N/C266S:DB + GRX480:TA to TGAIC266S:DB + 
GRX480:TA). 
4.5.3 The Novel Glutaredoxin GRX480 Regulates TGAl's Redox Status and 
Activity through Glutathionylation of Cys260 
The selective interaction of the novel glutaredoxin GRX480 with the reduced 
form of TGAI over the glutathionylated form (Figure 4A) and the lack of activity in a 
classical glutaredoxin assay (Table 3) suggests GRX480 does not behave as a classical 
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glutaredoxin. Instead, our data demonstrates that GRX480 is capable of catalyzing the 
glutathionylation of Cys260 in TGAI using GSSG as a substrate (Figure 7 A). The fact 
that we did not observe this activity for the classical glutaredoxin GRX030 (Figure 7B) 
suggests that the novel class of glutaredoxins has potentially diverged in plants to fulfill 
the role of glutathionylation while the classical glutaredoxins maintain the function of 
reducing disulfides. 
The reduction of a disulfide by a glutaredoxin, whether between two proteins or 
with glutathione, involves the N-terminal cysteine of the active site. The pKa of a free 
cysteine is approximately 8.3, however the pKa of the N-terminal cysteine in a 
glutaredoxin active site is significantly lower due to stabilization by neighboring 
positively charged amino acids (Hofmann et aI., 2002; Jao et al., 2006). This lower pKa 
provides the N-terminal cysteine with the reactivity to perform the first step in a 
reduction which is to attack a cysteine in a disulfide bond or the glutathione in a mixed 
disulfide (Gravina and Mieyal, 1993; Yang et aI., 1998). The inability of GRX480 to 
reduce a mixed disulfide might be the result of a shift in the redox potential due to the 
amino acids between the two cysteines (CXl X2C) in the glutaredoxin active site (Joelson 
et aI., 1990; Aslund et al., 1997). In support of this, several groups have demonstrated 
J 
that the redox potential of thioredoxins could be made more oxidizing or more reducing 
by simply substituting the residues of Xl and X2 (Krause et aI., 1991; Grauschopf et al., 
1995). 
The glutathionylation activity and late expression of GRX480 after SA treatment 
(Figure 8A) suggest that GRX480 may playa role in regulating the TGAI-NPRI 
complex. Indeed, addition of GRX480 in the presence of TGAI and NPR1, in the 
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absence or presence of SA, results in a loss of transactivation of the complex (Figure 8B), 
presumably through GRX480's glutathionylation ofTGA1 which abolishes its interaction 
with NPRI. The loss of transactivation of the TGA1-NPR1 complex in the absence of SA 
would suggest that the interaction between TGA1 and GRX480 as well as GRX480's 
glutathionylation of TGA1 is not dependent on SA. More likely, expression of GRX480 
to a certain level in response to SA is required before sufficient interaction and 
glutathionylation of TGA1 can occur. This would also suggest that the effect of SA in 
enhancing the interaction between TGA1 and GRX480 observed in the plant two-hybrid 
(Figure 3A) is indirect, resulting from the SA-dependent reduction of TGA1, which is the 
form that GRX480 interacts with. The low level of interaction before SA treatment can 
be attributed to the population of reduced TGA1 that exists (Despres et aI., 2003) 
The results presented here report one of the first instances where a novel 
glutaredoxin target has been identified in plants and the first instance where a 
biochemical activity of a member of the novel class of plant glutaredoxins has been 
described. It is also one of the first instances where a redox switch has been defined 
which regulates two different functions of the same protein. Two roles for TGA1 based 
on the two different activities regulated by its redox status are supported by tgal-l 
i 
Arabidopsis mutants. Kesarwani et ai. (2007) observed that these mutants, untreated, 
were compromised in basal disease resitance, while PRl gene expression was lower 
following INA treatment. A model is illustrated in Figure 9 depicting how the two redox 
active forms of TGA1 behave before and during SAR. The treatment leading to the 
complete oxidation of Cys260 and Cys266 resulting in the transcriptionally active form 
of TGA1 is postulated to proceed via a yet identified oxidative stress whereas the exact 
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mechanism of how GRX480 returns TGA1 to the oxidized form observed in 
unchallenged Arabidopsis cells is unclear. It is possible that the glutathionylation of 
Cys260 in TGA1 is transient and only serves to impede interaction between TGA1 and 
NPR1. This glutathionylation could then collapse to an intramolecular disulfide bond as a 
consequence of the proximity of Cys266 (Shelton et al., 2005), resulting in the oxidized 
form of TGA1 believed to exist in resting Arabidopsis cells (Despres et aI., 2003). 
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Figure 9. Schematic Depicting a Working Model for the Role of TGAI and Function 
of GRX480 in SAR 
(A) In resting Arabidopsis cells, TGAI is present as a dimer in two approximately equal 
pools; one where Cys260 and Cys266 are oxidized and the other where these two 
cysteines are reduced. Both forms are able to bind the cognate DNA motif TGACG 
(Despres et al., 2003). The reduced form of TGA interacts with NPRI and this form is 
hypothesized to activate transcription of a yet identified disease resistance gene whereas 
the oxidized form of TGA1, which trans activates on its own, activates transcription of an 
unknown gene. Since neither form is present in higher than 50%, it is possible that the 
activation of their respective genes is only at the basal level. Expression of GRX480 is 
repressed or expressed at a very low level in resting Arabidopsis cells. 
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(B) An oxidative stress, like the oxidative burst that occurs early in SAR, could be 
responsible for completely oxidizing Cys260 and Cys266 in TGAl. This would result in 
the activation of the expression of the unknown gene. An immediate-early gene seems 
like a plausible target for oxidized TGAI since it is expressed immediately after the onset 
of SAR (corresponds with the oxidative burst) and its expression is only transient, lasting 
for several hours at the most (Horvath and Chua, 1996). 
(C) After SA treatment, NPRI nuclear localizes (Kinkema et al., 2002; Mou et aI., 2003) 
and TGAI is completely reduced. This results in optimal interaction between the two 
proteins which in turn results in PRJ activation. GRX480 expression is also induced 
under these conditions and after a period of SA exposure, sufficient levels of GRX480 
protein have been translated that it interacts with TGAl, glutathionylates it at cysteine 
260 (-SG) resulting in its oxidation which abrogates its interaction with NPRl. This 
returns the TGAI pool back to the 50/50 distribution observed in resting cells. The exact 
mechanism of how Cys260 glutathionylation (indicated by arrow returning to resting 
Arabidopsis, C260-SG) results in the oxidized state observed for both Cys260 and 
Cys266 remains unclear. It is possible that glutathionylation of Cys260 is transient and 
only serves to disrupt the TGAI-NPRI interaction. Once the interaction has been 
disrupted, a disulfide is formed between Cys260 and Cys266 which is the form postulated 
to exist in resting Arabidopsis cells (Despres et al., 2003). 
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CHAPTER 5 - GENERAL DISCUSSION AND 
CONCLUSIONS 
NPRI is a key modulator of SAR and its overexpression in several plant species 
results in enhanced resistance with little to no side-effects (Lin et aI., 2004; Malnoy et al., 
2007). However, little is known about the mechanism by which NPRI regulates gene 
expression. TGA TFs are known to bind as-i and as-i-like elements, the latter of which 
is over-represented in the promoters of many defense related genes. The fact that NPRI 
interacts with these TGA TFs provides a means for NPRI-regulated gene expression in 
SAR. However the interaction between NPRI and TGA TFs is complex and studies such 
as the two presented in this thesis help to unravel the complexities and expand our 
understanding of the SAR pathway. 
5.1 The Behavior of TGA1 and TGA2 in SAR 
Arabidopsis has ten TGA TFs, seven of which has been tested with respect to 
their ability to interact with NPRI. Based on sequence similarity, the seven TGA TFs 
have been clustered into three clades: (i) TGAI and 4, (ii) TGA2, 5 and 6, and (iii) TGA3 
and 7. In yeast, only the last two clades interact with NPRI while the first clade, 
containing TGAI and 4, does not. However work done by Dt!spres et aI. (2003) revealed 
that TGAI is able to interact with NPRI in Arabidopsis leaves after SA treatment. This 
resulted in the discovery that TGAI 's interaction with NPRI is redox regulated such that 
Cys260 and Cys266 need to be reduced for interaction to occur. The lack of interaction 
observed for TGAI and NPRI in yeast can be attributed to the oxidation of Cys260 and 
Cys266 in TGAI. Additionally, we discovered that the transcriptional activation ability 
of TGAI is controlled by the oxidation of these two cysteines. This led to the conclusion 
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that the activity of TGA1 is regulated in a mutually exclusive manner such that the 
oxidation of Cys260 and Cys266 preclude interaction with NPR1 but allow 
transactivation and vice versa when reduced. 
Similar to TGA1, TGA2 interacts with NPR1 following SA treatment in 
Arabidopsis leaves. Both the TGA1- and TGA2-NPR1 complexes are able to activate 
transcription and rely on the transactivation domain identified in the C-terminus of NPR1 
(Rochon et aI., 2006). Interestingly, although TGA1 is able to activate transcription, its 
transactivation domain is not involved in the transactivation of the complex. Evidence 
presented in Chapter 3 reveals that the TGA2-NPR1 complex that results following SA 
treatment is involved in activating PRJ expression while the role of the TGA1-NPR1 
complex has not been directly addressed. We have preliminary evidence that suggests 
that the TGA1-NPR1 complex is able to activate the expression of a reporter gene under 
the control of the PRJ promoter. 
Prior to SA treatment, we established that TGA2 acts as a repressor using a 
modified transient transcription assay in Arabidopsis (Rochon et al., 2006). We then went 
on to show that TGA2 represses the NPR1-dependent activation of PRJ supporting 
evidence from Zhang et aI. (2003) who observed an increase in PRJ expression in 
J 
untreated TGA2, 5, 6 knock-out Arabidopsis line compared to wild-type. The function of 
TGA1 before SA treatment is unclear although it appears as though it could be two-fold 
as TGA1 exists in approximately two equal populations, reduced and oxidized, and these 
two different forms of TGA1 have different functions (Despres et al., 2003 and Chapter 
4). In contrast to TGA2, oxidized TGA1, which is only observed before SA treatment, 
acts as a transcriptional activator. Despite the lack of a defined role before SA treatment, 
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TGA 1 appears to be critical for basal resistance based on results from Kesarwani et al. 
(2007) who observed that a tgal-l Arabidopsis mutant supported a higher level of 
pathogen growth compared to untreated wild-type plants. 
5.2 Redox Regulation as a General Mechanism Controlling Gene 
Expression during SAR 
Activation of certain aspects of the SAR pathway appears to be regulated by a 
population of pre-existing or latent proteins whose activity is regulated, in part, by PTMs. 
The redox environment of the cell plays an important role in regulating the PTM of 
proteins and in SAR. An increase in ROS (Lamb and Dixon, 1997) and a shift in the 
GSHlGSSG ratio (Mou et aI., 2003; Ball et aI., 2004) can act to mediate this regulation. 
TGA1 and NPR1 are two proteins in the SAR pathway whose activities are 
modulated by their redox status. Both TGA1 and NPR1 contain a transactivation domain 
that is activated by an oxidized state. Interestingly, in both instances, the transactivation 
domain is regulated by two cysteines. In the case of TGA 1, Cys260 appears to be more 
critical for transactivation however Cys266 is required for optimal transactivation. For 
NPR1, the dependence on each cysteine for transactivation is equal (Rochon et al., 2006). 
Only one other protein has been identified that containsl a transactivation domain 
regulated by its redox status, however it functions in the opposite manner such that 
oxidation prevents transactivation (Morel and Barouki, 2000). Another feature shared by 
TGA 1 and NPR 1 is that the reduction of both proteins is required for their interaction 
inside the nucleus (Despres et aI., 2003; Mou et aI., 2003). These two trends in the redox 
regulation of TGA1 and NPR1 hint at the possibility that an overall trend of this nature 
may exist to regulate proteins involved in SAR. 
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5.3 GRX480 and SAR 
There are 31 glutaredoxins in Arabidopsis and 21 of these constitute a novel class 
only observed in higher plants. This novel glutaredoxin class first appeared in bryophytes 
and has since expanded during the evolution of land plants suggesting an evolutionary 
requirement for its divergence (Lemaire, 2004; Xing et al., 2006). Classical glutaredoxins 
" have either a CXXC-type or CXXS-type active site while the active site of the novel class 
contains a cysteine at the second position and is defined as the CCXX-type. GRX480 is 
part of the novel class of glutaredoxins with a CCMC active site and interacts with the 
reduced form of TGA1 to glutathionylate it at Cys260. Mammalian Grx1 (Starke et aI., 
2003) and Grx2 (Beer et al., 2004) are the only other glutaredoxins know to have 
glutathionylation activity. Ndamukong et aI. (2007) observed that GRX480 is also able to 
interact with Arabidopsis TGA2, however the significance of this interaction is unclear as 
there is no evidence that TGA2, although it does contain one cysteine, is redox regulated. 
If TGA2 is not redox regulated, interaction with GRX480 might be required to recruit 
GRX480 to NPR1 to maintain the oxidation of Cys521 and Cys529 and therefore the 
transactivation ability of NPR1 after SA treatment (Rochon et al., 2006). Ndamukong et 
aI. (2007) observed that NPR1 does not directly interact wi)h GRX480 in a yeast two-
hybrid assay however when TGA2 is included, not fused to any domain, it is able to act 
as a bridge bringing GRX480 and NPR1 together. 
Further intrigue in the GRX480-TGA TF relationship comes from the presence of 
half an as-J-like element in the GRX480 promoter (Ndamukong et aI., 2007). The 
classical as-J-like element consists of two imperfect palindromes but GRX480 only has 
one of these palindromes. Niggeweg et al. (2000) found that there is a preference for 
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tobacco TGA hetero- and homodimers binding to one or both palindromes of an as-J-like 
element. Tobacco TGA2.1 and TGA2.2 as hetero- or homodimers allow occupation of 
both palindromes although the preference for single over double occupancy differs 
depending on the partners in the dimer. TGAla on the other hand, as a homodimer and as 
a heterodimer with either TGA2.1 or TGA2.2, only allows single occupancy of the as-J-
like element (Niggeweg et al., 2000). The presence of part of an as-J-like element in the 
promoter of GRX480 suggests a possible mechanism for auto-regulation, which is 
supported by the observation that GRX480 expression is abolished in the TGA2, 5, 6 
knock-out (Ndamukong et aI., 2007). 
5.4 Future Experiments 
Future experiments should focus on the redox status of proteins involved in SAR 
as this PTM appears to be an important regulatory principle in plant defense. I would 
examine the redox status of members of the other two clades of TGA TFs as well as 
examine different molecules (i.e. 2,4-D, H20 2, MeJA and ethylene) that would be 
responsible for triggering a shift in the redox status. I would also examine the nature of 
the oxidized state of TGAI and NPRI (i.e. glutathionylation versus a disulfide bond or 
other PTM modification of cysteine including hydroxylation find nitrosylation). It would 
also be of interest to identify targets of TGAI in Arabidopsis through ChIP experiments. 
These experiments would be conducted in the absence and presence of SA. Immediate-
early genes would be targeted in the absence of SA treatment based on results from 
Johnson et ai. (2001b) in tobacco and PRJ and other PR genes activated during SAR 
would be examined prior to and following SA treatment. 
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Determining enzyme activity for GRX480 is also critical. Initially it would be 
defined with respect to TGA1 and GSSG as substrates; radioactive glutathione (esS]-
GSH) would be employed, in an oxidized form, to establish the Km, V max and Kcat. 
Specificity for GSSG as a substrate would also be established as its concentrations are 
very low and availability may be an issue. Alternative donors would be the GS-thiyl 
radical (GS·) and S-nitrosoglutathione (GS-NO) (Shelton et al., 2005). 
Overall, the data presented in this thesis furthers our understanding of how TGA1, 
TGA2 and NPR1 behave in SAR. We may have also identified another level of 
regulation for the SAR defense pathway, redox regulation, which provides an additional 
target that could be studied and manipulated to enhance disease resistance. 
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APPENDIX 
Fraction 3 4 5 6 7 
-
-~ . ' . 
~.~.-
TGA1 
TGA 1 C172N/C266S/C287S 
GRX030 
GRX480 
Figure 1: Immunoblots of Proteins Purified by a HIS column. 
(A) Wilt-type TGAI was expressed in E. coli and purified on a HIS column. 
Approximately 250mL of culture, loaded onto the column as 2mL, was purified and 
500llL fractions were collected (see Section 4.3.10 and 4.3.11).5% of each fraction was 
electrophoresed on a 10% SDS-polyacrylamide gel along with an equivalent amount of 
crude, flow through and wash samples. TGAI was detected with His-probe (HI5) 
primary antibody at 1/1000 and goat anti-rabbit Alexa fluor 680 at 1/15000 was used as 
the secondary antibody in coordination with infrared imaging using the Odyssey imager 
(LI-COR, Lincoln, NE). 
(B) TGAIC172N/C266S/C287S was expressed in E. coli and freated as described in (A). 
(C) GRX030 (At5g63030) was expressed in E. coli and treated as described in (A) except 
proteins were electrophoresed on a 12% gel. 
(D) GRX480 (Atlg28480) was expressed in E. coli and treated as described in (C) except 
that 2.5L of culture was loaded onto the column as approximately 30mL. The method of 
protein isolation also differed (see Section 4.3.10). 10% of each fraction was 
electrophoresed. 
In (A), (B), (C) and (D) only fractions 3 to 7 are shown. Detection of the band of interest 
is shown and while detection in fractions other than 4 and 5 is observed, these lanes were 
contaminated by other proteins detected by coomassie staining (data not shown). 
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Table 1. The Glutaredoxin Family in Arabidopsis thaliana 
Accession Polypeptide Putative 
Number Type Active Site Length localizationa (amino acids) 
Atlg03020 CCMS 102 C 
Atlg03850 CCLG 150 CorMorP 
Atlg06930 CCLS 99 C 
Atlg28480 CCMC 137 C 
, At2g30540 CCMS 103 C 
At2g47870 CCMC 103 C 
At2g47880 CCLC 102 C 
At3g02000 CCMC 136 C 
At3g21460 CCMS 102 M 
At3g62930 Novel CCMS 103 C 
At3g62950 CCXX CCMC 102 C 
Atg3g62960 Type CCLC 103 C 
At4g15660 CCMS 102 C 
At4g15670 CCMS 102 C 
At4g15680 CCMS 102 C 
At4g15690 CCMS 102 C 
At4g15700 CCMS 102 C 
At4g33040 CCMC 145 C 
At5g11930 CCMC 145 CorMorP 
At5g14070 CCMC 140 C 
At5g18600 CCMS 102 C 
Atlg77370 CPYC 130 S orC 
At2g20270 Classical CSYS 179 P At4g28730 CXXC CFIS 176 P At5g20500 Type CPYC 135 SorC 
At5g40370 CPYC 111 CorM orP 
AtSg63030 CGYC 125 f C 
At2g38270 Classical CGFS 283 
P 
At3g15660 CXXS CGFS 169 MorP At3g54900 Type CGFS 173 MorP 
At4g04950 CGFS 488 C 
All data was compiled from Rouhier et al. (2004) and Lemaire et al. (2004). 
In bold are the two Grxs discussed in the thesis. 
aPutative localizations are based on several prediction softwares (TargetP, Predator and 
Psort; see references for details). More than one localization is listed in instances where 
prediction softwares gave different results. 
Abbreviations: C - cytosolic; M - mitochondrial; P - Plastidial; S - secreted protein. 
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Table 2. Mass List of 
Untreated, Trypsin Digested 
TGAI from MALDI TOF MS 
Signal 
to 
mlza Noiseb IntensityC 
832.637 161 11281.15 
833.637 85.3 5976.65 
834.630 37.7 2639.68 
1011.831 183.7 14373.89 
1012.835 109.2 8541.15 
1013.823 32.6 2585.43 
1140.954 14.7 1251.73 
1141.949 10.1 855.83 
1142.976 10.5 896.86 
1257.064 25.3 2288.25 
1258.057 17.2 1556.08 
1267.092 513.9 47351.3 
1268.103 419.7 38668.09 
1269.105 185.9 17129.51 
1270.106 53.7 4950.54 
1271.090 13.2 1219.79 
1289.084 9 829.91 
1324.130 20.4 1911.29 
1325.135 14.8 1383.44 
1410.126 27.2 2605.9 
1411.151 21.7 2092.47 
1412.153 12.9 1248.64 
1426.117 17.2 1654.14 
1427.152 15.6 1504.09 
1446.118 14.3 1385.79 
1447.130 11.4 1101.64 
1462.093 30.2 2926.55 
1463.102 23.9 2315.89 
1464.104 13.1 1265.52 
1478.085 27.7 2692.01 
1479.094 21.8 2118.68 
1480.099 12 1163.34 
1517.252 11.2 1090.78 
1518.267 10.2 992.6 
1538.068 8.9 864.5 
1588.292 16.4 1586.63 
1589.334 13.1 1266.34 
1624.254 7.9 759.48 
1625.262 8.5 821.23 
1640.251 22.6 2158.22 
Table 3. Mass List of GSSG 
Treated, Trypsin Digested 
TGAI from MALDI TOF MS 
Signal 
to 
mlza Noiseb IntensityC 
755.507 7.9 626 
755.632 6.7 534 
755.702 4.8 382 
756.430 4.2 332 
772.506 7.9 627 
832.559 104.6 8343 
833.527 53.5 4264 
833.605 52.6 4194 
834.557 22.5 1792 
834.648 19.2 1533 
835.455 6.4 509 
835.529 6.5 518 
835.643 6.1 483 
842.644 5.6 444 
886.606 4.7 376 
1011.697 212.4 17780 
1012.711 124.1 10386 
1013.697 34.6 2900 
1014.716 7.6 634 
1033.649 5.8 486 
1140.804 34.6 2888 
1141.784 20.9 1746 
1141.851 19.3 1615 
1142.680 4.1 345 
1142.797 8 668 
1142.912 6 500 
1161.293 6.1 506 
1161.529 4~ 359 
1162.343 4.3 359 
1168.836 5.3 438 
1169.752 6.1 511 
1169.892 5.3 439 
1194.811 12.4 1026.5 
1195.818 7.9 656.5 
1196.812 4.2 350.5 
1205.744 6.7 551.5 
1221.758 4.6 378 
1253.300 4.3 351.5 
1256.899 36.6 3018.5 
1256.900 38.9 3210.5 
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1641.254 21.2 2030.31 1257.928 25 2065.5 
1642.254 12.3 1174.77 1258.925 8.8 726.5 
1712.432 106.5 10026.18 1266.924 821.4 67511.5 
1713.438 105.1 9897.02 1267.950 637.6 52405.5 
1714.446 50.4 4745.28 1268.958 252.7 20767.5 
1715.442 17.5 1651.38 1269.508 6.8 562.5 
1796.560 133.8 12404.48 1269.961 71 5834.5 
1797.569 145.4 13482.74 1270.947 18.2 1493.5 
1798.582 76.4 7079.81 1274.903 4.7 384.5 
1799.593 29 2687.67 1288.900 22.3 1834.5 
1800.589 12.8 1190.61 1289.943 14.7 1209.5 
1812.553 47.5 4398.92 1290.822 4.9 398.5 
1813.562 49.5 4585.19 1290.869 5 410.5 
1814.569 28.5 2639.38 1304.872 5.8 478.5 
1815.579 9.5 881.61 1373.358 4.1 334 
1828.565 31 2869.87 1409.919 9.3 745 
1829.569 32.8 3038.62 1411.934 4.9 394 
1830.566 18.5 1709.75 1425.909 10.5 839 
1958.681 13.7 1154.06 1426.950 7.3 581 
1959.708 15 1268.13 1427.896 4.4 348 
1960.715 8.6 724.33 1461.879 6.8 534 
2075.754 9.9 763.75 1462.902 6.3 492 
2076.759 13.7 1058.28 1477.885 9.5 736 
2077.778 9.5 734.65 1478.895 8.2 638 
2111.622 12.6 947.53 1479.902 5.2 405 
2112.630 15.2 1144.02 1517.096 13.2 1009 
2113.641 11 827.87 1518.072 12.4 944 
2127.624 33.9 2550.85 1519.098 5.8 442 
2128.635 42.9 3122 1519.099 5.9 453 
2129.633 26.3 1919.14 1524.029 4.5 346 
2130.633 11.8 858.48 1535.604 8.6 652 
2144.693 9.9 721.84 1536.487 5.7 427 
2219.778 14.5 990.94 1536.651 6:"9 517 
2220.792 14.1 964.91 1588.014 11.8 862 
2231.946 50.5 3448.84 1588.099 12 873 
2232.969 69.3 4730.26 1589.065 11.6 844 
2233.933 47.6 3254.11 1590.067 6.4 469 
2234.908 20.4 1391.98 1606.679 4.2 305 
2267.764 45.7 3045.28 1639.988 14 982 
2268.776 61.6 4101.28 1641.005 13.7 962 
2269.787 42.8 2848.25 1641.970 7.5 527 
2270.789 21.3 1420.33 1697.651 6.5 443 
2271.765 12.2 813.02 1698.462 11.6 793 
2283.794 71 4560.1 1699.461 11.9 814 
2284.796 91.2 5856.27 1700.491 5.7 383 
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2285.798 66.3 4262.24 
2286.812 31 1989.89 
2287.815 12.8 823.44 
2288.853 14.6 938.4 
2289.850 22.6 1448.82 
2290.829 18.4 1180.13 
2299.808 14.1 908 
2300.812 17.4 1119.66 
2301.804 12.2 785.24 
2446.946 13.8 747.88 
2481.080 68.1 3678.79 
2482.074 100 5177.54 
2483.073 74.6 3864.4 
2484.062 39 2019.35 
2485.059 15.3 793.79 
Mass spectra were obtained using 
Autoflex II TOFITOF (Bruker 
Daltonics, Billerica, MA) in 
positive mode and 9% laser 
power. The mass list was obtained 
using FlexAnalysis Version 3.0 
(Bruker Daltonics). 
a m/z represents the charge to 
mass ratio for each peptide. 
b The signal to noise ratio is 
defined as the height of the mass 
peak above its baseline relative to 
the standard deviation of the 
noise. 
C The intensity indicates the 
relative abundance of each mass 
peak in the sample 
1712.192 
1713.201 
1714.213 
1715.217 
1716.247 
1717.235 
1720.458 
1726.229 
1727.228 
1734.190 
1735.188 
1736.181 
1737.210 
1750.176 
1751.158 
1829.197 
1994.265 
1995.265 
1996.263 
1997.227 
2231.512 
2232.540 
2233.542 
2234.563 
2238.487 
2267.378 
2268.382 
2269.374 
2270.374 
2283.376 
2284.373 
2285.383 
2286.368 
2289.409 
2290.403 
2299.361 
2300.377 
2301.383 
2393.651 
2394.742 
2395.702 
2396.682 
2431.491 
2445.495 
2446.485 
681.4 45716 
659.8 44265 
329.8 22125 
109.2 7324 
28.9 1941 
9 606 
4.4 298 
5.1 341 
4.i 278 
23.5 1544 
22.3 1467 
10.4 684 
5.4 353 
4.6 305 
4.5 293 
4.6 294 
20.3 1166 
21.6 1238 
11.1 635 
4.9 283 
11.7 578 
17.2 853 
9.5 470 
5.4 267 
4.3 213 
7 341 
8.5 414 
8.5 414 
4.5 218 
14.1 675 
20.1 960 
12.4 594 
IJ 334 
8.2 392 
6.3 303 
6.4 306.5 
6.6 318 
5 240.5 
8.8 406 
10.7 498 
8 372 
4.1 191 
4 184 
10 450 
14.3 646 
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2447.497 9 404 
2448.493 7.1 321 
2706.437 4.4 172.5 
2728.673 7.5 296.5 
2729.692 9.7 383.5 
2730.686 8.3 327.5 
2731.692 5.9 226.5 
2749.628 5 194.5 
2750.608 6.4- 246.5 
2751.637 6.5 250.5 
2752.641 5.5 213.5 
2808.593 5.2 195 
2969.681 4.1 139 
2969.866 4.2 141.25 
2970.702 5.7 192 
2971.755 5.1 170.5 
2992.916 16.2 546.5 
2993.062 18.5 625.5 
2994.031 37.4 1231.5 
2994.898 26.4 867.5 
2995.052 26.8 882.5 
2996.022 16.3 536.5 
2996.058 15.5 509.5 
2996.561 6.2 205.5 
2997.013 7.1 233.5 
2997.228 5.7 188.5 
3005.643 4.2 138.5 
3028.820 17.5 575.5 
3029.825 32 1052.5 
3030.800 27 886.5 
3031.814 17.1 561.5 
3032.802 9 294.5 
3033.765 4.1 154.5 
3033.889 5.2 169.5 
3044.838 14.8 474.5 
3045.849 30.8 987.5 
3046.860 26.4 846.5 
3047.856 15.3 490.5 
3048.785 7.2 230.5 
3049.788 4.7 150.5 
3061.855 6.7 214 
3062.812 4.1 131 
3339.125 8.1 221 
3340.129 12.8 347 
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